"[{'verified': False, 'country': 'USA', 'id': '1441112703192371202', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New video: Dr. Seheult breaks down new \u201creal world\u201d data on the efficacy of each US vaccine vs Delta\\nhttps://t.co/N9GvUXqcHV', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/N9GvUXqcHV'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New video: Dr. Seheult breaks down new \u201creal world\u201d data on the efficacy of each US vaccine vs Delta\\n'}, {'verified': False, 'country': 'USA', 'id': '1441112617829863432', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$ino #INOVIO #COVID19 #vaccine\\nINOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico\\nhttps://t.co/HerQ4LLzlh', 'tweet_lang': 'en', 'hashtags': ['INOVIO', 'COVID19', 'vaccine'], 'mentions': [], 'tweet_urls': ['https://t.co/HerQ4LLzlh'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$ino   \\nINOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico\\n'}, {'verified': False, 'country': 'USA', 'id': '1441112111657017354', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Vaccine Efficacy Versus Delta Variant: Real World Data (COVID 19 Update ... https://t.co/G1euqkn2TH via @YouTube', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['YouTube'], 'tweet_urls': ['https://t.co/G1euqkn2TH'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Vaccine Efficacy Versus Delta Variant: Real World Data (COVID 19 Update ...  via '}, {'verified': False, 'country': 'USA', 'id': '1441110294659428355', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Guess what? The people enrolled in the vaccine trials that looked at their efficacy, lived and worked around people who weren\u2019t vaccinated. If it worked for them, it should work for you..regardless of what I do.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Guess what? The people enrolled in the vaccine trials that looked at their efficacy, lived and worked around people who weren\u2019t vaccinated. If it worked for them, it should work for you..regardless of what I do.'}, {'verified': False, 'country': 'USA', 'id': '1441109750628847618', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'If you don\u2019t believe your vaccine protects you unless I get one too, then maybe you have doubts about efficacy too.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'If you don\u2019t believe your vaccine protects you unless I get one too, then maybe you have doubts about efficacy too.'}, {'verified': False, 'country': 'USA', 'id': '1441109676574208009', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Watch \"Vaccine Efficacy Versus Delta Variant: Real World Data (COVID 19 Update 129)\" on YouTube https://t.co/W3tGxYmKnq', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/W3tGxYmKnq'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Watch \"Vaccine Efficacy Versus Delta Variant: Real World Data (COVID 19 Update 129)\" on YouTube '}, {'verified': False, 'country': 'USA', 'id': '1441108288263708676', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The inventor of mRNA vaccine technology now spends his time  posting studies that prove the efficacy of Ivermectin. \\n\\nIn a world full of noise, this is what signal looks like. https://t.co/akdDDhyZP5', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/akdDDhyZP5'], 'tweet_date': '2021-09-23T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The inventor of mRNA vaccine technology now spends his time  posting studies that prove the efficacy of Ivermectin. \\n\\nIn a world full of noise, this is what signal looks like. '}, {'verified': False, 'country': 'USA', 'id': '1441107527182155780', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'This week, J&amp;J said a second #vaccine dose substantially boosted protection against #Covid19. Researchers found 2 doses offered 94% efficacy against mild/severe Covid, up from 74% with single shot - https://t.co/M1Gn0WQ96k \\n#NY #bronx #brooklyn #statenisland #queens #manhattan', 'tweet_lang': 'en', 'hashtags': ['vaccine', 'Covid19', 'NY', 'bronx', 'brooklyn', 'statenisland', 'queens', 'manhattan'], 'mentions': [], 'tweet_urls': ['https://t.co/M1Gn0WQ96k'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'This week, J&amp;J said a second  dose substantially boosted protection against . Researchers found 2 doses offered 94% efficacy against mild/severe Covid, up from 74% with single shot -  \\n     '}, {'verified': False, 'country': 'USA', 'id': '1441107473868361744', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Thank you @justthefacts85 who nails it on how vaccine efficacy can be overstated by including in the data periods both pre-Delta and before the widespread availability of vaccines. https://t.co/N0cLU5pJqj', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['justthefacts85'], 'tweet_urls': ['https://t.co/N0cLU5pJqj'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Thank you  who nails it on how vaccine efficacy can be overstated by including in the data periods both pre-Delta and before the widespread availability of vaccines. '}, {'verified': False, 'country': 'USA', 'id': '1441106549959643144', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Vaccine efficacy for Moderna (Spikevax) 14d after 2nd dose:\\n\\npreventing Covid-19 illness\\n93.2% (95% confidence interval [CI], 91.0 to 94.8)\\n\\npreventing severe disease\\n98.2% (95% CI, 92.8 to 99.6), \\n\\npreventing asymptomatic infection\\n63.0% (95% CI, 56.6 to 68.5) https://t.co/qPeYhAJjH5', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/qPeYhAJjH5'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Vaccine efficacy for Moderna (Spikevax) 14d after 2nd dose:\\n\\npreventing Covid-19 illness\\n93.2% (95% confidence interval [CI], 91.0 to 94.8)\\n\\npreventing severe disease\\n98.2% (95% CI, 92.8 to 99.6), \\n\\npreventing asymptomatic infection\\n63.0% (95% CI, 56.6 to 68.5) '}, {'verified': False, 'country': 'USA', 'id': '1441106148350857219', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'What a sick world they\u2019re trying to create. Indefinite booster shots of a vaccine never adequately tested for safety and efficacy. We are rapidly jumping the shark https://t.co/N6CPP0Vayi', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/N6CPP0Vayi'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'What a sick world they\u2019re trying to create. Indefinite booster shots of a vaccine never adequately tested for safety and efficacy. We are rapidly jumping the shark '}, {'verified': False, 'country': 'USA', 'id': '1441106005262172167', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'From BloombergTV: China\u2019s Clover vaccine shows 79% efficacy in late stage trials &amp; prevents 67% of severe cases caused by any strain.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'From BloombergTV: China\u2019s Clover vaccine shows 79% efficacy in late stage trials &amp; prevents 67% of severe cases caused by any strain.'}, {'verified': False, 'country': 'USA', 'id': '1441104548639100936', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Ask yourselves. Florida had one of the more robust vaccine rollout programs, those vaccinated- parents/grandparents are now in the waning phase of efficacy.They are spreading more virulent/easier mutating virus. This was PREDICTED/feared by the inventor of a man MRNa technology. https://t.co/MUMCVL3gsC', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/MUMCVL3gsC'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Ask yourselves. Florida had one of the more robust vaccine rollout programs, those vaccinated- parents/grandparents are now in the waning phase of efficacy.They are spreading more virulent/easier mutating virus. This was PREDICTED/feared by the inventor of a man MRNa technology. '}, {'verified': False, 'country': 'USA', 'id': '1441104014871908362', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"This is the one that said it would be ready by Sept 2020, then used a dosing cock up in efficacy figures, then denied any link with clots which was later proved and whose low efficacy vaccine has now been ditched even by the Tories.\\n\\nYeah - I'll listen to her.\\n\\n#JohnsonVariant\", 'tweet_lang': 'en', 'hashtags': ['JohnsonVariant'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"This is the one that said it would be ready by Sept 2020, then used a dosing cock up in efficacy figures, then denied any link with clots which was later proved and whose low efficacy vaccine has now been ditched even by the Tories.\\n\\nYeah - I'll listen to her.\\n\\n\"}, {'verified': False, 'country': 'USA', 'id': '1441098141571289092', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Don't mistake seasonality for vaccine efficacy.\\n\\nhttps://t.co/OzRh08kpUm https://t.co/OZxOT2qiU6\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/OzRh08kpUm', 'https://t.co/OZxOT2qiU6'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Don't mistake seasonality for vaccine efficacy.\\n\\n \"}, {'verified': False, 'country': 'USA', 'id': '1441097645645201413', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'So are you hoping to have them comeback to test vaccine efficacy?! https://t.co/fkaop5Fy4x', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/fkaop5Fy4x'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'So are you hoping to have them comeback to test vaccine efficacy?! '}, {'verified': False, 'country': 'USA', 'id': '1441097218803453975', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The over exaggeration of vaccine  efficacy also doesn\u2019t help much! Yes, they help a little, but that\u2019s all! https://t.co/2lJfXlsNEl', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/2lJfXlsNEl'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The over exaggeration of vaccine  efficacy also doesn\u2019t help much! Yes, they help a little, but that\u2019s all! '}, {'verified': False, 'country': 'USA', 'id': '1441097129779351558', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#FDA Advisory Committee Recording\\n\u26a0\ufe0f  Weak Evidence to Support #Efficacy and Safety.  Estimated 45k - 147k deaths of vaccinated. No cancer studies performed. Post #Covid #Vaccine Syndrome (#pCoVS ).  (watch 4:23:00 - 4:27:18)\\n https://t.co/3a21NiW0FB', 'tweet_lang': 'en', 'hashtags': ['FDA', 'Efficacy', 'Covid', 'Vaccine', 'pCoVS'], 'mentions': [], 'tweet_urls': ['https://t.co/3a21NiW0FB'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' Advisory Committee Recording\\n\u26a0\ufe0f  Weak Evidence to Support  and Safety.  Estimated 45k - 147k deaths of vaccinated. No cancer studies performed. Post   Syndrome ( ).  (watch 4:23:00 - 4:27:18)\\n '}, {'verified': False, 'country': 'USA', 'id': '1441095991382347790', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '1/\u201cIt was stunning to me that Mark Meadows thought he knew more than Peter Marks, with respect to how to evaluate the safety and efficacy of a vaccine,\u201d Hahn told others. \u201cHe thinks he knows things that he doesn\u2019t know and has expertise that he doesn\u2019t have.\u201d', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '1/\u201cIt was stunning to me that Mark Meadows thought he knew more than Peter Marks, with respect to how to evaluate the safety and efficacy of a vaccine,\u201d Hahn told others. \u201cHe thinks he knows things that he doesn\u2019t know and has expertise that he doesn\u2019t have.\u201d'}, {'verified': False, 'country': 'USA', 'id': '1441095698473127944', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Only six days until full vaccine efficacy!', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Only six days until full vaccine efficacy!'}, {'verified': False, 'country': 'USA', 'id': '1441095207928287233', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Reuters Aug 2021: \"the vaccinated could MORE EASILY transmit [delta]\"\\n\\nhttps://t.co/fP8AJVA3Vj https://t.co/Z7QuGoA9cs', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/fP8AJVA3Vj', 'https://t.co/Z7QuGoA9cs'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Reuters Aug 2021: \"the vaccinated could MORE EASILY transmit [delta]\"\\n\\n '}, {'verified': False, 'country': 'USA', 'id': '1441094793635921925', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/J2KgDa3Pui', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/J2KgDa3Pui'], 'tweet_date': '2021-09-23T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1441085647012331529', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\"Parties here are behind the curve on becoming tyrants who invade people\\'s right to medical freedom and privacy\". \\n\\nAlso - do you think that I am irresponsible for not taking a vaccine against a disease I am not at risk from, particularly a vaccine that\\'s efficacy is falling? https://t.co/jc179e8Fqs', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/jc179e8Fqs'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\"Parties here are behind the curve on becoming tyrants who invade people\\'s right to medical freedom and privacy\". \\n\\nAlso - do you think that I am irresponsible for not taking a vaccine against a disease I am not at risk from, particularly a vaccine that\\'s efficacy is falling? '}, {'verified': False, 'country': 'USA', 'id': '1441084789268762636', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Final analysis of US-funded Moderna Covid vaccine trial shows 98% efficacy against severe disease \u2013 Endpoints News https://t.co/LAqjDPMeCJ', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/LAqjDPMeCJ'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Final analysis of US-funded Moderna Covid vaccine trial shows 98% efficacy against severe disease \u2013 Endpoints News '}, {'verified': False, 'country': 'USA', 'id': '1441083701413101569', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u201cScientists had initially hoped that the vaccines would have an efficacy of 50 or 60%. \u201cFast forward to now, and we\u2019re debating whether 96.3 percent vaccine efficacy for Moderna versus 88.8 percent for Pfizer is a big deal.\u201d\u2019\\n\\nWe shouldn\u2019t lose sight of this point https://t.co/RbUv8vky3O', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/RbUv8vky3O'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u201cScientists had initially hoped that the vaccines would have an efficacy of 50 or 60%. \u201cFast forward to now, and we\u2019re debating whether 96.3 percent vaccine efficacy for Moderna versus 88.8 percent for Pfizer is a big deal.\u201d\u2019\\n\\nWe shouldn\u2019t lose sight of this point '}, {'verified': False, 'country': 'USA', 'id': '1441083088755331086', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Numbers that say nothing about the deceased &amp; the bereaved. How can we trust a Gov who got it so wrong about easing restrictions last Christmas ? Vaccine efficacy is waning, school children are being infected.  It\u2019s a potential disaster #ProtectOurChildren @ForgottenFamil3 #ROAR https://t.co/zvfBVQ3qob', 'tweet_lang': 'en', 'hashtags': ['ProtectOurChildren', 'ROAR'], 'mentions': ['ForgottenFamil3'], 'tweet_urls': ['https://t.co/zvfBVQ3qob'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Numbers that say nothing about the deceased &amp; the bereaved. How can we trust a Gov who got it so wrong about easing restrictions last Christmas ? Vaccine efficacy is waning, school children are being infected.  It\u2019s a potential disaster    '}, {'verified': False, 'country': 'USA', 'id': '1441082872299855882', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM @NEJM \\nhttps://t.co/pbworr8sMN https://t.co/98mPgNLLaH', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['NEJM'], 'tweet_urls': ['https://t.co/pbworr8sMN'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM  \\n https://t.co/98mPgNLLaH'}, {'verified': False, 'country': 'USA', 'id': '1441082289807499276', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Vaccine available for trials does not deal with issues of safety and efficacy that's how government became reckless with the lives of the people!! https://t.co/8JANDEBe0R\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Vaccine available for trials does not deal with issues of safety and efficacy that's how government became reckless with the lives of the people!! https://t.co/8JANDEBe0R\"}, {'verified': False, 'country': 'USA', 'id': '1441081588880531458', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Amazing project! Our superhero faculty fights misinformation that raise doubts about election integrity and vaccine efficacy. Congratulations, @borah! https://t.co/KRJqop3rT2', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['borah'], 'tweet_urls': ['https://t.co/KRJqop3rT2'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Amazing project! Our superhero faculty fights misinformation that raise doubts about election integrity and vaccine efficacy. Congratulations, ! '}, {'verified': False, 'country': 'USA', 'id': '1441080691974807552', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Pretty awesome #COVID19 vaccine news. @NEJM article on @moderna_tx 98% protective against serious illness, 93% protective against any illness. mRNA tech amazing. https://t.co/3sNDz8KBVp', 'tweet_lang': 'en', 'hashtags': ['COVID19'], 'mentions': ['NEJM', 'moderna_tx'], 'tweet_urls': ['https://t.co/3sNDz8KBVp'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Pretty awesome  vaccine news.  article on  98% protective against serious illness, 93% protective against any illness. mRNA tech amazing. '}, {'verified': False, 'country': 'USA', 'id': '1441080075953266689', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'It\u2019s cool how as soon as anyone hears you criticize the efficacy of any of the current COVID vaccines they immediately shift into \u201cdebunk the Trump MAGA anti-vaxxer guy\u201d mode because it\u2019s the only form of vaccine criticism they\u2019ve been exposed to for over a year.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'It\u2019s cool how as soon as anyone hears you criticize the efficacy of any of the current COVID vaccines they immediately shift into \u201cdebunk the Trump MAGA anti-vaxxer guy\u201d mode because it\u2019s the only form of vaccine criticism they\u2019ve been exposed to for over a year.'}, {'verified': False, 'country': 'USA', 'id': '1441079483415425031', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\"We have an unclear need with unclear motivation, significant safety concerns, poor evidence of sustained boost efficacy, and wrong priorities,\" said Dr. David Wiseman, a top Johnson &amp; Johnson researcher.\\nhttps://t.co/1157JbfthF', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/1157JbfthF'], 'tweet_date': '2021-09-23T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\"We have an unclear need with unclear motivation, significant safety concerns, poor evidence of sustained boost efficacy, and wrong priorities,\" said Dr. David Wiseman, a top Johnson &amp; Johnson researcher.\\n'}, {'verified': False, 'country': 'USA', 'id': '1441076055050113034', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Why would anyone use this vaccination when it has little efficacy and Kids are NOT a high risk of the disease? Yet, you are 100% taking a risk of your kid possibly having a nasty side effect with vaccination.\\nhttps://t.co/lBKt0HnrFh', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/lBKt0HnrFh'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Why would anyone use this vaccination when it has little efficacy and Kids are NOT a high risk of the disease? Yet, you are 100% taking a risk of your kid possibly having a nasty side effect with vaccination.\\n'}, {'verified': False, 'country': 'USA', 'id': '1441075742389964801', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Clover Pharma' vaccine efficacy data from its Phase 2/3 trial has 100% efficacy against severe COVID-19/hospitalization. Overall efficacy is 67% against any severity of COVID-19 caused by any variant.The vaccine showed a 79% efficacy against any severity caused by Delta variant.\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Clover Pharma' vaccine efficacy data from its Phase 2/3 trial has 100% efficacy against severe COVID-19/hospitalization. Overall efficacy is 67% against any severity of COVID-19 caused by any variant.The vaccine showed a 79% efficacy against any severity caused by Delta variant.\"}, {'verified': False, 'country': 'USA', 'id': '1441074487806492672', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Pfizer Covid-19 vaccine efficacy against severe disease due to COVID-19 was 96.7% and preserved up to (not only) six months.\\nPfizer\u2019s vaccine. 45,000+ participants. 6 countries. Real-world data. \\n*Includes the Delta variant\\nhttps://t.co/NW1SWaeCy4 https://t.co/zYa8lLYRjM', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/NW1SWaeCy4', 'https://t.co/zYa8lLYRjM'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Pfizer Covid-19 vaccine efficacy against severe disease due to COVID-19 was 96.7% and preserved up to (not only) six months.\\nPfizer\u2019s vaccine. 45,000+ participants. 6 countries. Real-world data. \\n*Includes the Delta variant\\n '}, {'verified': False, 'country': 'USA', 'id': '1441074008959569930', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'FACT OF THE DAY\\n\\n91%\\n\\nVaccine efficacy found through a six-month follow up period in a South African study.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'FACT OF THE DAY\\n\\n91%\\n\\nVaccine efficacy found through a six-month follow up period in a South African study.'}, {'verified': False, 'country': 'USA', 'id': '1441072059707236353', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Vaccine Efficacy Versus Delta Variant: Real World Data (COVID 19 Update 129)... https://t.co/9K97E0QaxC via @YouTube', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['YouTube'], 'tweet_urls': ['https://t.co/9K97E0QaxC'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Vaccine Efficacy Versus Delta Variant: Real World Data (COVID 19 Update 129)...  via '}, {'verified': False, 'country': 'USA', 'id': '1441070480551776257', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Induction of CREB1 &amp; its targets by ALVAC+Alum augments immunogenicity &amp; predicts reduced HIV-1 acquisition (RV144). Reduced CREB1 activity with ALVAC+MF59 (HVTN702) and lack of protection. Thus, CREB1 as a critical driver of vaccine efficacy.\\nhttps://t.co/PWQ3uHJrdx', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/PWQ3uHJrdx'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Induction of CREB1 &amp; its targets by ALVAC+Alum augments immunogenicity &amp; predicts reduced HIV-1 acquisition (RV144). Reduced CREB1 activity with ALVAC+MF59 (HVTN702) and lack of protection. Thus, CREB1 as a critical driver of vaccine efficacy.\\n'}, {'verified': False, 'country': 'USA', 'id': '1441069662180159492', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u201cAll COVID vaccines, COVID PCR and antigen tests, and masks are merely EUA-authorized, not approved or licensed, by the federal government. Long-term safety and efficacy have not been proven.\"\\nhttps://t.co/2wlY47rPsk', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/2wlY47rPsk'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u201cAll COVID vaccines, COVID PCR and antigen tests, and masks are merely EUA-authorized, not approved or licensed, by the federal government. Long-term safety and efficacy have not been proven.\"\\n'}, {'verified': False, 'country': 'USA', 'id': '1441068863731519489', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Japan prepares booster shots amid worries over waning vaccine efficacy | The Japan Times https://t.co/KjdykZY03c', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/KjdykZY03c'], 'tweet_date': '2021-09-23T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Japan prepares booster shots amid worries over waning vaccine efficacy | The Japan Times '}, {'verified': False, 'country': 'USA', 'id': '1441060482690035714', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#Biopharm2021 Prof. Thomas Fleming on disentangling waning vaccine efficacy and possible resistant variants - observational data comparing efficacy vs. time since vaccination for the same variant, and efficacy of different variants while controlling the time since vaccination', 'tweet_lang': 'en', 'hashtags': ['Biopharm2021'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' Prof. Thomas Fleming on disentangling waning vaccine efficacy and possible resistant variants - observational data comparing efficacy vs. time since vaccination for the same variant, and efficacy of different variants while controlling the time since vaccination'}, {'verified': False, 'country': 'USA', 'id': '1441060339588681735', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'https://t.co/3BDRPSVIZ8 Trials show efficacy of new Chinese vaccine on Delta Gamma MU variants. 400 milion doses to be distributed in covax program when approved by WHO #china #covd #variants #vaccine', 'tweet_lang': 'en', 'hashtags': ['china', 'covd', 'variants', 'vaccine'], 'mentions': [], 'tweet_urls': ['https://t.co/3BDRPSVIZ8'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' Trials show efficacy of new Chinese vaccine on Delta Gamma MU variants. 400 milion doses to be distributed in covax program when approved by WHO    '}, {'verified': True, 'country': 'USA', 'id': '1441060189269118976', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/9VWgVOSmU9', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/9VWgVOSmU9'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': True, 'country': 'USA', 'id': '1441060170000474112', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/CXWNRDg7pU', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/CXWNRDg7pU'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': True, 'country': 'USA', 'id': '1441060167685066753', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/fTcu1muVbv', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/fTcu1muVbv'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': True, 'country': 'USA', 'id': '1441060165348909060', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/EdIn7kBA40', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/EdIn7kBA40'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': True, 'country': 'USA', 'id': '1441060156285104131', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/xjtH2QRHC3 https://t.co/vPngJabUu5', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/xjtH2QRHC3'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows  https://t.co/vPngJabUu5'}, {'verified': True, 'country': 'USA', 'id': '1441060148785475585', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/Lio0m9MQEF', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Lio0m9MQEF'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': True, 'country': 'USA', 'id': '1441060146852122628', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/wcUA3x1pVt', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/wcUA3x1pVt'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': True, 'country': 'USA', 'id': '1441060128774574081', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/XAOtKYkujV', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/XAOtKYkujV'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': True, 'country': 'USA', 'id': '1441060121631670274', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/RCZmvnBm2C', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/RCZmvnBm2C'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': True, 'country': 'USA', 'id': '1441060121627463680', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/G2eZpUlTaw', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/G2eZpUlTaw'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': True, 'country': 'USA', 'id': '1441060037217034243', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/RXH0oz59G3', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/RXH0oz59G3'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': False, 'country': 'USA', 'id': '1441056521555636243', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"How to create a paranoid, pseudo-leftist attack on vaccine safety and efficacy, when you can't refute global data: https://t.co/VtB3gJqksY\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/VtB3gJqksY'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"How to create a paranoid, pseudo-leftist attack on vaccine safety and efficacy, when you can't refute global data: \"}, {'verified': False, 'country': 'USA', 'id': '1441056252021379076', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Montr\u00e9al InVivo est heureux de vous annoncer que le Centre des sciences de Montr\u00e9al ouvre ses portes aujourd'hui apr\u00e8s presque un an de fermeture ! \\n\\n@centresciences s'implique tant au niveau de l\u2019accessibilit\u00e9 que des relations avec les communaut\u00e9s. \\nhttps://t.co/wfxxBIn2K1\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['centresciences'], 'tweet_urls': ['https://t.co/wfxxBIn2K1'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Montr\u00e9al InVivo est heureux de vous annoncer que le Centre des sciences de Montr\u00e9al ouvre ses portes aujourd'hui apr\u00e8s presque un an de fermeture ! \\n\\n s'implique tant au niveau de l\u2019accessibilit\u00e9 que des relations avec les communaut\u00e9s. \\n\"}, {'verified': False, 'country': 'USA', 'id': '1441056197461753867', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'When we are already robust against delta , to the tune of 95% identified cases and far less in real world, what is the vaccine doing? Can you explain where the efficacy is calculated with an absurdly high baseline of no illness??? This math doesn\u2019t work.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'When we are already robust against delta , to the tune of 95% identified cases and far less in real world, what is the vaccine doing? Can you explain where the efficacy is calculated with an absurdly high baseline of no illness??? This math doesn\u2019t work.'}, {'verified': False, 'country': 'USA', 'id': '1441054750066290688', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'MUST WATCH: HHS whistleblower comes forward w/ statements from fellow HHS professionals admitting their concerns over the safety and efficacy of the #COVID19 vaccine and current protocols for treatment of infected patients in new #ProjectVeritas video --&gt; https://t.co/3sVnD9JjeY', 'tweet_lang': 'en', 'hashtags': ['COVID19', 'ProjectVeritas'], 'mentions': [], 'tweet_urls': ['https://t.co/3sVnD9JjeY'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'MUST WATCH: HHS whistleblower comes forward w/ statements from fellow HHS professionals admitting their concerns over the safety and efficacy of the  vaccine and current protocols for treatment of infected patients in new  video --&gt; '}, {'verified': False, 'country': 'USA', 'id': '1441053601049182218', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The second time ATAGI has thrown the most simple response to defeating Covid off course\u2014get all people vaccinated confidently and with maximum sustained efficacy. If one person dies from breakthrough while they dawdle, that death will be on them. #Auspol https://t.co/Z2GCH7jix0', 'tweet_lang': 'en', 'hashtags': ['Auspol'], 'mentions': [], 'tweet_urls': ['https://t.co/Z2GCH7jix0'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The second time ATAGI has thrown the most simple response to defeating Covid off course\u2014get all people vaccinated confidently and with maximum sustained efficacy. If one person dies from breakthrough while they dawdle, that death will be on them.  '}, {'verified': False, 'country': 'USA', 'id': '1441053275130789899', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Anti-vaxxers just assume everyones making shit up cuz thats what they do aaall the time. So many peer reviewed sources on the safety and efficacy of the vaccine, and the best sources they come up with are...YouTube videos.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Anti-vaxxers just assume everyones making shit up cuz thats what they do aaall the time. So many peer reviewed sources on the safety and efficacy of the vaccine, and the best sources they come up with are...YouTube videos.'}, {'verified': False, 'country': 'USA', 'id': '1441052369047986176', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'SARS-CoV-2 Vaccine \u2013 AIVITA Biomedical. A novel Covid vaccine with high efficacy, no side effects and local production.  https://t.co/DTUPTAzG0J', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/DTUPTAzG0J'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'SARS-CoV-2 Vaccine \u2013 AIVITA Biomedical. A novel Covid vaccine with high efficacy, no side effects and local production.  '}, {'verified': False, 'country': 'USA', 'id': '1441050006656540672', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"NEW: Colorado's largest Pharmaceutical marketing firm, @9NEWS, asks child video game critic for his expert advice on vaccine efficacy.\\n#HeyNext #copolitics #COVID19colorado https://t.co/qxrz7zj84m\", 'tweet_lang': 'en', 'hashtags': ['HeyNext', 'copolitics', 'COVID19colorado'], 'mentions': ['9NEWS'], 'tweet_urls': ['https://t.co/qxrz7zj84m'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"NEW: Colorado's largest Pharmaceutical marketing firm, , asks child video game critic for his expert advice on vaccine efficacy.\\n   \"}, {'verified': False, 'country': 'USA', 'id': '1441049117694648328', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Lancet did a study on the actual efficacy rate of each vaccine. Not good. https://t.co/8WTA7hCbts', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Lancet did a study on the actual efficacy rate of each vaccine. Not good. https://t.co/8WTA7hCbts'}, {'verified': False, 'country': 'USA', 'id': '1441048913532755974', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '4.5 months for vaccine efficacy, suckers https://t.co/No7MbbplBc', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/No7MbbplBc'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '4.5 months for vaccine efficacy, suckers '}, {'verified': False, 'country': 'USA', 'id': '1441048488968552449', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Pfizer Says Vaccine Efficacy Weakens Over Time, Cites Study Which Shows ... https://t.co/mjblRBwLgH via @YouTube', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['YouTube'], 'tweet_urls': ['https://t.co/mjblRBwLgH'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Pfizer Says Vaccine Efficacy Weakens Over Time, Cites Study Which Shows ...  via '}, {'verified': False, 'country': 'USA', 'id': '1441047719964028938', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Today on Rising @AmeshAA joined us to discuss the Delta variant and vaccine efficacy.\\n\\nWatch the whole conversation here:\\nhttps://t.co/Pi6QKLRYZH', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['AmeshAA'], 'tweet_urls': ['https://t.co/Pi6QKLRYZH'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Today on Rising  joined us to discuss the Delta variant and vaccine efficacy.\\n\\nWatch the whole conversation here:\\n'}, {'verified': False, 'country': 'USA', 'id': '1441047453839540227', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/Dc0Y9gv4P8 \\nDespu\u00e9s de 5 meses de seguimiento: Eficacia para enfermedad severa 98,2% (92,8-99,6) Eficacia para infecci\u00f3n asintom\u00e1tica 63%(56,6-68,5)', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Dc0Y9gv4P8'], 'tweet_date': '2021-09-23T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM  \\nDespu\u00e9s de 5 meses de seguimiento: Eficacia para enfermedad severa 98,2% (92,8-99,6) Eficacia para infecci\u00f3n asintom\u00e1tica 63%(56,6-68,5)'}, {'verified': False, 'country': 'USA', 'id': '1441046390621286401', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Novavax and the Serum Institute of India submitted to the World Health Organization (WHO) for Emergency Use Listing (EUL) of Novavax' COVID-19 vaccine\\n\\nIt has minimal side effects and greater and longer efficacy compared to existing approved vaccines.\\n\\n$NVAX\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Novavax and the Serum Institute of India submitted to the World Health Organization (WHO) for Emergency Use Listing (EUL) of Novavax' COVID-19 vaccine\\n\\nIt has minimal side effects and greater and longer efficacy compared to existing approved vaccines.\\n\\n$NVAX\"}, {'verified': False, 'country': 'USA', 'id': '1441046014828363776', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Shorts need to reassess their strategy for $dvax the cpg 1018 adjuvant is included in 3 vaccines as far as I know. 2 of them is directly supported by the Govmnts. Clover vaccine has already shown ~80% efficacy angst d-variant. BioE approval is due soon. Go long.. https://t.co/hx0pn1l1he', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Shorts need to reassess their strategy for $dvax the cpg 1018 adjuvant is included in 3 vaccines as far as I know. 2 of them is directly supported by the Govmnts. Clover vaccine has already shown ~80% efficacy angst d-variant. BioE approval is due soon. Go long.. https://t.co/hx0pn1l1he'}, {'verified': True, 'country': 'USA', 'id': '1441045601194479622', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"I've seen a few posts recently casting doubt on vaccine effectiveness, due to hospitalizations among vaccinated people, so I wanted to find out more. This interesting blog post explains how numbers are being misconstrued. Take a look: https://t.co/bKYeYWjrZx\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/bKYeYWjrZx'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"I've seen a few posts recently casting doubt on vaccine effectiveness, due to hospitalizations among vaccinated people, so I wanted to find out more. This interesting blog post explains how numbers are being misconstrued. Take a look: \"}, {'verified': True, 'country': 'USA', 'id': '1441043898307055616', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/8SjBPeIenE', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/8SjBPeIenE'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': True, 'country': 'USA', 'id': '1441043635970191361', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/U66kDmt1Ad', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/U66kDmt1Ad'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': False, 'country': 'USA', 'id': '1441042856760655872', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Vaccine efficacy is indisputable, say the people who can acquire and transmit the virus in far greater viral loads than pre-vaccination as they await their boosters.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Vaccine efficacy is indisputable, say the people who can acquire and transmit the virus in far greater viral loads than pre-vaccination as they await their boosters.'}, {'verified': True, 'country': 'USA', 'id': '1441040908703580165', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The Moderna COVID-19 vaccine remains effective and safe for an average of 5.3 months after individuals receive the second dose, with 93.2% efficacy 14 days afterward and greater than 90% efficacy for 4 or more months.\\n\\nLearn more: https://t.co/UodXPNJ8Oc https://t.co/tIh2TIcS74', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/UodXPNJ8Oc'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The Moderna COVID-19 vaccine remains effective and safe for an average of 5.3 months after individuals receive the second dose, with 93.2% efficacy 14 days afterward and greater than 90% efficacy for 4 or more months.\\n\\nLearn more:  https://t.co/tIh2TIcS74'}, {'verified': True, 'country': 'USA', 'id': '1441039962263203840', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Today on @HillTVLive\\'s \"Rising\" \u2014 Dr. Amesh Adalja, an infectious disease expert, answers @ryangrim and @Alyssafarah pressing questions about the Delta variant, COVID vaccine efficacy, and global vaccine distribution https://t.co/mFJGOAoE7j https://t.co/EkTaOnTmJJ', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['HillTVLive', 'ryangrim', 'Alyssafarah'], 'tweet_urls': ['https://t.co/mFJGOAoE7j'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Today on \\'s \"Rising\" \u2014 Dr. Amesh Adalja, an infectious disease expert, answers  and  pressing questions about the Delta variant, COVID vaccine efficacy, and global vaccine distribution  https://t.co/EkTaOnTmJJ'}, {'verified': False, 'country': 'USA', 'id': '1441039677310504961', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Biden Covid team sees vaccine efficacy waning in unpublished data from Israel https://t.co/Y73Q6esBc0 via @politico This was predictible to anyone paying attention.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['politico'], 'tweet_urls': ['https://t.co/Y73Q6esBc0'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Biden Covid team sees vaccine efficacy waning in unpublished data from Israel  via  This was predictible to anyone paying attention.'}, {'verified': False, 'country': 'USA', 'id': '1441038858905432064', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Vaccines Failing Against Serious Disease, Data From Israel Suggests \\n\\n\"Israel remains the gold standard when it comes to macro data for vaccine efficacy.\"\\n\\nhttps://t.co/6b0sRvf7Pb', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/6b0sRvf7Pb'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Vaccines Failing Against Serious Disease, Data From Israel Suggests \\n\\n\"Israel remains the gold standard when it comes to macro data for vaccine efficacy.\"\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441037084777660416', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/Ku7tddcCtM', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Ku7tddcCtM'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1441036904321933312', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#covid19 #coronavirusupdates \\n\\nThe latest on vaccine efficacy https://t.co/CXwsatVjuX', 'tweet_lang': 'en', 'hashtags': ['covid19', 'coronavirusupdates'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '  \\n\\nThe latest on vaccine efficacy https://t.co/CXwsatVjuX'}, {'verified': False, 'country': 'USA', 'id': '1441036494987276290', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'As more vaccinated people get covid, get sick, and die, I suspect their anger will not be towards the officials who lied &amp; gave them false hope, but instead towards those who resisted the coercion to take a new vaccine with unknown long-term effects &amp; iffy efficacy.  Backwards.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'As more vaccinated people get covid, get sick, and die, I suspect their anger will not be towards the officials who lied &amp; gave them false hope, but instead towards those who resisted the coercion to take a new vaccine with unknown long-term effects &amp; iffy efficacy.  Backwards.'}, {'verified': False, 'country': 'USA', 'id': '1441035042394820616', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy - https://t.co/2ZX918QZ7U https://t.co/XT29d1iyyI', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/2ZX918QZ7U'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy -  https://t.co/XT29d1iyyI'}, {'verified': False, 'country': 'USA', 'id': '1441035038653616130', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy - https://t.co/R3upOn4Py5 https://t.co/GvrvZR6eQH', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/R3upOn4Py5'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy -  https://t.co/GvrvZR6eQH'}, {'verified': False, 'country': 'USA', 'id': '1441033884209070084', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND,\\nDOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY,\\nIMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE\\nCANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS\\nhttps://t.co/czYLTbc9xK', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/czYLTbc9xK'], 'tweet_date': '2021-09-23T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND,\\nDOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY,\\nIMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE\\nCANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS\\n'}, {'verified': True, 'country': 'USA', 'id': '1441030848027840519', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\"No reason for anyone who has had one dose of J &amp; J to be alarmed or concerned at this point.\" Dr. Helen Boucher on @WCVB about Johnson &amp; Johnson saying there is good efficacy from two-doses of its #COVID19 vaccine. https://t.co/M1HAuLGBiY #TuftsMC', 'tweet_lang': 'en', 'hashtags': ['COVID19', 'TuftsMC'], 'mentions': ['WCVB'], 'tweet_urls': ['https://t.co/M1HAuLGBiY'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\"No reason for anyone who has had one dose of J &amp; J to be alarmed or concerned at this point.\" Dr. Helen Boucher on  about Johnson &amp; Johnson saying there is good efficacy from two-doses of its  vaccine.  '}, {'verified': False, 'country': 'USA', 'id': '1441028281965363204', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Moderna's vaccine efficacy held strong, did not wane after 5 months new study shows https://t.co/jfYbop0cUp\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/jfYbop0cUp'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Moderna's vaccine efficacy held strong, did not wane after 5 months new study shows \"}, {'verified': False, 'country': 'USA', 'id': '1441027259830255616', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'This has far more efficacy than any  vaccine, masks or washing hands. https://t.co/t4FLfsK95F', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/t4FLfsK95F'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'This has far more efficacy than any  vaccine, masks or washing hands. '}, {'verified': False, 'country': 'USA', 'id': '1441027156511887360', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Multiple Sclerosis (MS) patients may receive various treatments that are thought to interfere with coronavirus disease 2019 (COVID-19) disease progression and the efficacy of the COVID-19 vaccines..https://t.co/NUb4miTGxR', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/NUb4miTGxR'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Multiple Sclerosis (MS) patients may receive various treatments that are thought to interfere with coronavirus disease 2019 (COVID-19) disease progression and the efficacy of the COVID-19 vaccines..'}, {'verified': False, 'country': 'USA', 'id': '1441026085110484994', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy - Multiple Sclerosis (MS) patients may receive various treatments that are thought to interfere with coronavirus disease 2019 (COVID-19)... - https://t.co/LajWYtXANj https://t.co/sCPX0DQWED', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/LajWYtXANj'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy - Multiple Sclerosis (MS) patients may receive various treatments that are thought to interfere with coronavirus disease 2019 (COVID-19)... -  https://t.co/sCPX0DQWED'}, {'verified': False, 'country': 'USA', 'id': '1441024610087096320', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna shared data surrounding the efficacy of its #COVID19vaccine against the #Deltavariant, the risk of breakthrough infections, and the need for booster shots.\\nhttps://t.co/5dGo7lb8S8', 'tweet_lang': 'en', 'hashtags': ['COVID19vaccine', 'Deltavariant'], 'mentions': [], 'tweet_urls': ['https://t.co/5dGo7lb8S8'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna shared data surrounding the efficacy of its  against the , the risk of breakthrough infections, and the need for booster shots.\\n'}, {'verified': False, 'country': 'USA', 'id': '1441024265436893186', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/BvAoy1jvd1', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/BvAoy1jvd1'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1441024048683651075', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Our latest #COVID19 vaccine research update      Pfizer trial: 6m efficacy results; Moderna, J&amp;J, AZ effectiveness data; Pfizer in 5-11y @UniMelbMDHS @MCRI_for_kids @RCHMelbourne https://t.co/gNyFwRNjFg', 'tweet_lang': 'en', 'hashtags': ['COVID19'], 'mentions': ['UniMelbMDHS', 'MCRI_for_kids', 'RCHMelbourne'], 'tweet_urls': ['https://t.co/gNyFwRNjFg'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Our latest  vaccine research update      Pfizer trial: 6m efficacy results; Moderna, J&amp;J, AZ effectiveness data; Pfizer in 5-11y    '}, {'verified': False, 'country': 'USA', 'id': '1441023253372407810', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy\\n\\nMore medical news at https://t.co/ZUSc0GBBHI\\n#Pulmonology #MedTwitter #MedEd\\nhttps://t.co/Oba21uoOuC', 'tweet_lang': 'en', 'hashtags': ['Pulmonology', 'MedTwitter', 'MedEd'], 'mentions': [], 'tweet_urls': ['https://t.co/ZUSc0GBBHI', 'https://t.co/Oba21uoOuC'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy\\n\\nMore medical news at \\n  \\n'}, {'verified': False, 'country': 'USA', 'id': '1441022950493282306', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The Opposition Parties are sitting on the fence afraid of losing votes. They will be just as culpable if there is a health crisis in our school children , which would undoubtedly spread into communities as vaccine efficacy wanes #ROAR #RotectOurChildren https://t.co/p7KO86eyct', 'tweet_lang': 'en', 'hashtags': ['ROAR', 'RotectOurChildren'], 'mentions': [], 'tweet_urls': ['https://t.co/p7KO86eyct'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The Opposition Parties are sitting on the fence afraid of losing votes. They will be just as culpable if there is a health crisis in our school children , which would undoubtedly spread into communities as vaccine efficacy wanes   '}, {'verified': False, 'country': 'USA', 'id': '1441021522194223114', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'https://t.co/gG8FSaVUpS\\n\\nCloser to H , should be not less than 95% assuming efficacy = E = 90% , Ro ~ 7 to 8 .\\nH = (Ro - 1)/(Ro.E)', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/gG8FSaVUpS'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\\n\\nCloser to H , should be not less than 95% assuming efficacy = E = 90% , Ro ~ 7 to 8 .\\nH = (Ro - 1)/(Ro.E)'}, {'verified': False, 'country': 'USA', 'id': '1441020738132119552', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine https://t.co/xkN4gJ5DO4 Vaccineren blijft wat Covid-19 betreft het belangrijkst. Deze trial is een van de vele onweerlegbare bewijzen pro vaccinatie!', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/xkN4gJ5DO4'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine  Vaccineren blijft wat Covid-19 betreft het belangrijkst. Deze trial is een van de vele onweerlegbare bewijzen pro vaccinatie!'}, {'verified': False, 'country': 'USA', 'id': '1441019942443311109', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy\\n\\nMore medical news at https://t.co/Z2xEnRpr3X\\n#Oncology #MedTwitter #MedEd\\nhttps://t.co/uIuAAPlceB', 'tweet_lang': 'en', 'hashtags': ['Oncology', 'MedTwitter', 'MedEd'], 'mentions': [], 'tweet_urls': ['https://t.co/Z2xEnRpr3X', 'https://t.co/uIuAAPlceB'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy\\n\\nMore medical news at \\n  \\n'}, {'verified': False, 'country': 'USA', 'id': '1441019731746643978', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy https://t.co/tERTWaqZ9m', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/tERTWaqZ9m'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy '}, {'verified': False, 'country': 'USA', 'id': '1441019050658836480', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Safety and efficacy of 2 dose NVX-CoV2373 (nanoparticles of spike protein + adjuvant) Covid-19 vaccine. 14,000 healthy participants. Reasonable efficacy and safety relate to mRNA vaccines. Performed while alfa circulated primarily; delta?    https://t.co/maBQxZ4Jf3', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/maBQxZ4Jf3'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Safety and efficacy of 2 dose NVX-CoV2373 (nanoparticles of spike protein + adjuvant) Covid-19 vaccine. 14,000 healthy participants. Reasonable efficacy and safety relate to mRNA vaccines. Performed while alfa circulated primarily; delta?    '}, {'verified': False, 'country': 'USA', 'id': '1441018950821814281', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Congratulations to the COVE Study Group (including @PittGenAcadPeds's Dr. Judy Martin (@martjm)) on new publication in @NEJM: \\nEfficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase\\n#COVID19 #GetVaxxed \\nhttps://t.co/qYkzPRszV6\", 'tweet_lang': 'en', 'hashtags': ['COVID19', 'GetVaxxed'], 'mentions': ['PittGenAcadPeds', 'martjm', 'NEJM'], 'tweet_urls': ['https://t.co/qYkzPRszV6'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Congratulations to the COVE Study Group (including 's Dr. Judy Martin ()) on new publication in : \\nEfficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase\\n  \\n\"}, {'verified': False, 'country': 'USA', 'id': '1441017758687404034', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/Q96xkhhlPQ', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Q96xkhhlPQ'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1441017402091884553', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Those who deny our Climate Situation have the same mindset as those who deny the pandemic/vaccine efficacy. Easy and lazy to deny until your home washes away or you\u2019re about to be intubated @cspanwj Maybe it would be better to get prepared?', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['cspanwj'], 'tweet_urls': [], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Those who deny our Climate Situation have the same mindset as those who deny the pandemic/vaccine efficacy. Easy and lazy to deny until your home washes away or you\u2019re about to be intubated  Maybe it would be better to get prepared?'}, {'verified': False, 'country': 'USA', 'id': '1441017160957140996', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/CJ5ftBJONY', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/CJ5ftBJONY'], 'tweet_date': '2021-09-23T13:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': True, 'country': 'USA', 'id': '1441014897710489601', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Japan prepares booster shots amid worries over waning vaccine efficacy https://t.co/ptOcsKSZyo', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ptOcsKSZyo'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Japan prepares booster shots amid worries over waning vaccine efficacy '}, {'verified': False, 'country': 'USA', 'id': '1441014254958571527', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"China has developed the world's first #COVID19 #vaccine which could protect against different variants. Clinical trials on Wednesday revealed the recombinant protein vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. https://t.co/kwaWmPljV2\", 'tweet_lang': 'en', 'hashtags': ['COVID19', 'vaccine'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"China has developed the world's first   which could protect against different variants. Clinical trials on Wednesday revealed the recombinant protein vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. https://t.co/kwaWmPljV2\"}, {'verified': False, 'country': 'USA', 'id': '1441014155784372224', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/4Vreq62JYW', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/4Vreq62JYW'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1441013259012755456', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Vaccine efficacy in preventing severe Covid-19 was 98.2% for the mRNA-1273 group. Vaccine efficacy was consistently high in subgroups. \\nEfficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/IaGS5HA1sG', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/IaGS5HA1sG'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Vaccine efficacy in preventing severe Covid-19 was 98.2% for the mRNA-1273 group. Vaccine efficacy was consistently high in subgroups. \\nEfficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1441012802441809920', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The efficacy of the Pfizer-BioNTech vaccine against hospitalisation fell from 91 per cent to 77 per cent after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period. https://t.co/pWaHN0fV9P', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/pWaHN0fV9P'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The efficacy of the Pfizer-BioNTech vaccine against hospitalisation fell from 91 per cent to 77 per cent after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period. '}, {'verified': False, 'country': 'USA', 'id': '1441011271898329093', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Japan prepares booster shots amid worries over waning vaccine efficacy - The Japan Times https://t.co/5K9ycJGqpK', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/5K9ycJGqpK'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Japan prepares booster shots amid worries over waning vaccine efficacy - The Japan Times '}, {'verified': False, 'country': 'USA', 'id': '1441009308414713858', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'the efficacy of the vaccine debate has become overwhelmingly tribal.\\n\\nthere is no sin in taking or refusing it. segregating society is another matter altogether.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'the efficacy of the vaccine debate has become overwhelmingly tribal.\\n\\nthere is no sin in taking or refusing it. segregating society is another matter altogether.'}, {'verified': False, 'country': 'USA', 'id': '1441008427157819394', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Hilarious, they won\u2019t let you comment bc they know everyone will point out that the vaccine\u2019s efficacy are failing and the approved drug isn\u2019t even manufactured yet. Won\u2019t be for a yr or so. https://t.co/39z2I88Yln', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/39z2I88Yln'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Hilarious, they won\u2019t let you comment bc they know everyone will point out that the vaccine\u2019s efficacy are failing and the approved drug isn\u2019t even manufactured yet. Won\u2019t be for a yr or so. '}, {'verified': False, 'country': 'USA', 'id': '1441007194972041216', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'WATCH: Doug Ford\u2019s daughter counter signals father on vaccine efficacy \u2014 The Counter Signal https://t.co/EQTQaLSG5C', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/EQTQaLSG5C'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'WATCH: Doug Ford\u2019s daughter counter signals father on vaccine efficacy \u2014 The Counter Signal '}, {'verified': False, 'country': 'USA', 'id': '1441006006629068801', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"CDC, FDA, and WHO are dangerous.\\nThey make recommendations based on things besides your health.\\nIf there's a shortage of PPE, they say masks aren't needed.\\nNow they recommend booster shots to 65+ and vulnerable, when vaccine efficacy declines after only four months for everyone.\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"CDC, FDA, and WHO are dangerous.\\nThey make recommendations based on things besides your health.\\nIf there's a shortage of PPE, they say masks aren't needed.\\nNow they recommend booster shots to 65+ and vulnerable, when vaccine efficacy declines after only four months for everyone.\"}, {'verified': False, 'country': 'USA', 'id': '1441005982704930816', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Details out on a new Covid vaccine candidate from China ( Clover )  \\nVax efficacy, people without previous infection\\n- Moderate-severe: 83.7% (CI 56-95)\\n- Moderate-severe Delta-caused: 81.7% (CI 36-97)\\n- All symptomatic Covid: 67.2% (CI 55-77)\\n- All Delta-caused: 78.7% (CI 57-90) https://t.co/v0mGJD6uyJ', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/v0mGJD6uyJ'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Details out on a new Covid vaccine candidate from China ( Clover )  \\nVax efficacy, people without previous infection\\n- Moderate-severe: 83.7% (CI 56-95)\\n- Moderate-severe Delta-caused: 81.7% (CI 36-97)\\n- All symptomatic Covid: 67.2% (CI 55-77)\\n- All Delta-caused: 78.7% (CI 57-90) '}, {'verified': False, 'country': 'USA', 'id': '1441005889968803840', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'This is a very thorough and detailed chart that clearly supports the efficacy and science behind the vaccine passport @francoislegault https://t.co/k9ZlswU4ec', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['francoislegault'], 'tweet_urls': ['https://t.co/k9ZlswU4ec'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'This is a very thorough and detailed chart that clearly supports the efficacy and science behind the vaccine passport  '}, {'verified': False, 'country': 'USA', 'id': '1441005760633192455', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"#According to AstraZeneca's primary analysis of phase 3 trial data, the vaccine has a 76% efficacy rate after both doses.#Journal of Harmonized Research in Pharmacy\", 'tweet_lang': 'en', 'hashtags': ['According', 'Journal'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \" to AstraZeneca's primary analysis of phase 3 trial data, the vaccine has a 76% efficacy rate after both doses. of Harmonized Research in Pharmacy\"}, {'verified': False, 'country': 'USA', 'id': '1441005745143787524', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A final look at the results of the placebo-controlled Moderna trial in the New England Journal of Medicine shows how the vaccine continues to prevent #Covid19 and severe cases after more than five months following the second shot.\\n\\nhttps://t.co/kYnn17dEUU', 'tweet_lang': 'en', 'hashtags': ['Covid19'], 'mentions': [], 'tweet_urls': ['https://t.co/kYnn17dEUU'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A final look at the results of the placebo-controlled Moderna trial in the New England Journal of Medicine shows how the vaccine continues to prevent  and severe cases after more than five months following the second shot.\\n\\n'}, {'verified': True, 'country': 'USA', 'id': '1441005675295956995', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Cedarville Pharmacy professor to research Covid-19 vaccine efficacy https://t.co/nxPtP8oY3W', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/nxPtP8oY3W'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Cedarville Pharmacy professor to research Covid-19 vaccine efficacy '}, {'verified': False, 'country': 'USA', 'id': '1441004093875445766', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'It seems that Sinovac has the lowest efficacy rate. However this might be due to the fact that Sinovac was administered earlier compared to other vaccine, since vaccine effectiveness decrease over time. All vaccine brand were proven to help lower ICU and death rate, though. https://t.co/yJdEnIduul', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/yJdEnIduul'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'It seems that Sinovac has the lowest efficacy rate. However this might be due to the fact that Sinovac was administered earlier compared to other vaccine, since vaccine effectiveness decrease over time. All vaccine brand were proven to help lower ICU and death rate, though. '}, {'verified': False, 'country': 'USA', 'id': '1441003265634803717', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Final analysis of US-funded Moderna Covid vaccine trial shows 98% efficacy against severe disease.\\n\\nhttps://t.co/Z8xOu4NJJ0', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Z8xOu4NJJ0'], 'tweet_date': '2021-09-23T12:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Final analysis of US-funded Moderna Covid vaccine trial shows 98% efficacy against severe disease.\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1441001012668547077', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Started a position in $DVAX. Interesting data out yesterday on COVID vaccine Delta efficacy. \\n\\nLooking forward to learning more today.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Started a position in $DVAX. Interesting data out yesterday on COVID vaccine Delta efficacy. \\n\\nLooking forward to learning more today.'}, {'verified': False, 'country': 'USA', 'id': '1441000565157335041', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Covid vaccine efficacy?? https://t.co/aw7buwUW33', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/aw7buwUW33'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Covid vaccine efficacy?? '}, {'verified': False, 'country': 'USA', 'id': '1440999786996330498', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u201cScientists had initially hoped that the vaccines would have an efficacy of 50 or 60 percent. \u201cWe would have all seen that as great result and been happy with it \u2026 we\u2019re debating whether 96.3 percent vaccine efficacy for Moderna versus 88.8 percent for Pfizer is a big deal.\u201d https://t.co/q4MbZBwYqI', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/q4MbZBwYqI'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u201cScientists had initially hoped that the vaccines would have an efficacy of 50 or 60 percent. \u201cWe would have all seen that as great result and been happy with it \u2026 we\u2019re debating whether 96.3 percent vaccine efficacy for Moderna versus 88.8 percent for Pfizer is a big deal.\u201d '}, {'verified': False, 'country': 'USA', 'id': '1440998160218873859', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Study finds #schistosomiasis \u2193 efficacy of measles &amp; HepB vaccines; but no direct evidence if it affects #Covid19 vaccines. Study authors recommend including schistosomiasis treatment with Covid vaccination in endemic places https://t.co/AOb8kEDvA1 #HealthForAll https://t.co/vwAL50A9iw', 'tweet_lang': 'en', 'hashtags': ['schistosomiasis', 'Covid19', 'HealthForAll'], 'mentions': [], 'tweet_urls': ['https://t.co/AOb8kEDvA1'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Study finds  \u2193 efficacy of measles &amp; HepB vaccines; but no direct evidence if it affects  vaccines. Study authors recommend including schistosomiasis treatment with Covid vaccination in endemic places   https://t.co/vwAL50A9iw'}, {'verified': False, 'country': 'USA', 'id': '1440994965740523522', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Mask size: 5 \u03bcm info: https://t.co/4vIbGiR1Df\\nPCR Test info: https://t.co/Ytd90ORZC0\\nThe FDA fully approved vaccine will not be out till 2025: the name is \"COMIRNATY\": https://t.co/Or1z1wiJ1t\\nNIH-IVERMECTIN OFFERS FULL EFFICACY FOR ALL COVID VARIANTS: https://t.co/LMzQ9fP6iv', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/4vIbGiR1Df', 'https://t.co/Ytd90ORZC0', 'https://t.co/Or1z1wiJ1t', 'https://t.co/LMzQ9fP6iv'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Mask size: 5 \u03bcm info: \\nPCR Test info: \\nThe FDA fully approved vaccine will not be out till 2025: the name is \"COMIRNATY\": \\nNIH-IVERMECTIN OFFERS FULL EFFICACY FOR ALL COVID VARIANTS: '}, {'verified': False, 'country': 'USA', 'id': '1440994841270398978', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u201cVaccines cause more deaths than they save.\u201d \\n\u201cUnvaccinated are more intelligent than people give them credit for.\u201d \\u2066@KathyHochul\\u2069 \\u2066@NYCHealthSystem\\u2069 \\u2066@NYCMayor\\u2069 are wrong about mandates &amp; #vaccine efficacy.  https://t.co/EDhL4lZVn9', 'tweet_lang': 'en', 'hashtags': ['vaccine'], 'mentions': ['KathyHochul', 'NYCHealthSystem', 'NYCMayor'], 'tweet_urls': ['https://t.co/EDhL4lZVn9'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u201cVaccines cause more deaths than they save.\u201d \\n\u201cUnvaccinated are more intelligent than people give them credit for.\u201d \\u2066\\u2069 \\u2066\\u2069 \\u2066\\u2069 are wrong about mandates &amp;  efficacy.  '}, {'verified': False, 'country': 'USA', 'id': '1440994557001224197', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'There is an important limitation that assessment of vaccine efficacy against VOC is limited. But it has been shown in other specific studies. https://t.co/M8JeXZJba7', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/M8JeXZJba7'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'There is an important limitation that assessment of vaccine efficacy against VOC is limited. But it has been shown in other specific studies. '}, {'verified': True, 'country': 'USA', 'id': '1440994276050100225', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/AdvMavmDFe', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/AdvMavmDFe'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows '}, {'verified': False, 'country': 'USA', 'id': '1440994125273178114', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Episode 436 of the #YangDaily news podcast is out!\\n\\nCrime costs $2.6T annually, COVID $8T, New vaccine efficacy data, Chicago gets BI!\\n\\nPlease share, to keep #YangGang informed and engaged with the #HumanityFirst movement! https://t.co/ATGBRIorJK', 'tweet_lang': 'en', 'hashtags': ['YangDaily', 'YangGang', 'HumanityFirst'], 'mentions': [], 'tweet_urls': ['https://t.co/ATGBRIorJK'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Episode 436 of the  news podcast is out!\\n\\nCrime costs $2.6T annually, COVID $8T, New vaccine efficacy data, Chicago gets BI!\\n\\nPlease share, to keep  informed and engaged with the  movement! '}, {'verified': False, 'country': 'USA', 'id': '1440990909848383494', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'HUL funds study to delineate factors impacting COVID-19 vulnerability and vaccine efficacy\\n\\nhttps://t.co/ziQoZj4Y8L https://t.co/k83BUns0gP', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ziQoZj4Y8L'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'HUL funds study to delineate factors impacting COVID-19 vulnerability and vaccine efficacy\\n\\n https://t.co/k83BUns0gP'}, {'verified': False, 'country': 'USA', 'id': '1440989287101739010', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"This was an interesting analysis on vaccine efficacy and relative v absolute numbers, differential risks, also touches on @profnfenton 's recent blog. https://t.co/ISkhm7l9iM\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['profnfenton'], 'tweet_urls': ['https://t.co/ISkhm7l9iM'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"This was an interesting analysis on vaccine efficacy and relative v absolute numbers, differential risks, also touches on  's recent blog. \"}, {'verified': False, 'country': 'USA', 'id': '1440987003630329857', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Seeing these white flags truly hits hard as to how many we have lost. As more and more data comes out  the strength of vaccine efficacy, it is frustrating that so many remain unvaccinated. And yes we still need \ud83d\ude37at times due to #DeltaVariant #VaccinesSaveLives https://t.co/k6fATZci70', 'tweet_lang': 'en', 'hashtags': ['DeltaVariant', 'VaccinesSaveLives'], 'mentions': [], 'tweet_urls': ['https://t.co/k6fATZci70'], 'tweet_date': '2021-09-23T11:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Seeing these white flags truly hits hard as to how many we have lost. As more and more data comes out  the strength of vaccine efficacy, it is frustrating that so many remain unvaccinated. And yes we still need \ud83d\ude37at times due to   '}, {'verified': False, 'country': 'USA', 'id': '1440985598626607106', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Pfizer Booster Done! \\nResearch published on Friday by the CDC found that the efficacy of the Pfizer vaccine against hospitalization fell from 91% to 77% after a four-month period following the second shot. The Moderna vaccine showed no decline. Read this: https://t.co/jCOw1lt8Fv https://t.co/o5xli3jNT4', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/jCOw1lt8Fv'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Pfizer Booster Done! \\nResearch published on Friday by the CDC found that the efficacy of the Pfizer vaccine against hospitalization fell from 91% to 77% after a four-month period following the second shot. The Moderna vaccine showed no decline. Read this:  https://t.co/o5xli3jNT4'}, {'verified': False, 'country': 'USA', 'id': '1440985218635153408', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Shocking Chart Shows How Vaccine Efficacy PLUMMETS After Just A Few Months - https://t.co/ZGMcZOpF82', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ZGMcZOpF82'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Shocking Chart Shows How Vaccine Efficacy PLUMMETS After Just A Few Months - '}, {'verified': False, 'country': 'USA', 'id': '1440984362099556352', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'IMHO, Most doctors, are over-rampantly onboard with bigpharma and these callow vaccines.\\nPhysicians should never be reactionary!\\nThey should be looking very closely at lung and heart patients, when considering vaccine efficacy \\nvs more conservative/conventional options,\\n\ud83d\ude4f\ud83d\ude4f\ud83d\ude4f https://t.co/OPYTUHjqXE', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/OPYTUHjqXE'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'IMHO, Most doctors, are over-rampantly onboard with bigpharma and these callow vaccines.\\nPhysicians should never be reactionary!\\nThey should be looking very closely at lung and heart patients, when considering vaccine efficacy \\nvs more conservative/conventional options,\\n\ud83d\ude4f\ud83d\ude4f\ud83d\ude4f '}, {'verified': True, 'country': 'USA', 'id': '1440980659757932550', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Japan prepares booster shots amid worries over waning vaccine efficacy. https://t.co/VdBCI0rX3F', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/VdBCI0rX3F'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Japan prepares booster shots amid worries over waning vaccine efficacy. '}, {'verified': False, 'country': 'USA', 'id': '1440980573154013200', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/0SnraOfRZf', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/0SnraOfRZf'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1440980414856790020', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Novavax vaccine shows 89.7% efficacy against Covid, UK clinical trial results show\\n\\n@MohanaBasu reports\\n\\n#ThePrintTracksCovid\\n\\nhttps://t.co/yoSABdmJ5J', 'tweet_lang': 'en', 'hashtags': ['ThePrintTracksCovid'], 'mentions': ['MohanaBasu'], 'tweet_urls': ['https://t.co/yoSABdmJ5J'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Novavax vaccine shows 89.7% efficacy against Covid, UK clinical trial results show\\n\\n reports\\n\\n\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440979968528461824', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'are covid boosters accentuating covid deaths in israel?\\nassessing the 2 week \"worry window\" of negative vaccine efficacy https://t.co/KjHQHRCk0T', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/KjHQHRCk0T'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'are covid boosters accentuating covid deaths in israel?\\nassessing the 2 week \"worry window\" of negative vaccine efficacy '}, {'verified': False, 'country': 'USA', 'id': '1440979401223675906', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Study shows Pfizer vaccine had an effectiveness of 88.8% vs Moderna\u2019s 96.3%. Pfizer\u2019s efficacy  against hospitalization fell from 91% to 77% after a 4-month period after the 2nd shot. Moderna showed no decline over the same period. @NYTHealth @apoorva_nyc https://t.co/Ie5OielDYb', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['NYTHealth', 'apoorva_nyc'], 'tweet_urls': ['https://t.co/Ie5OielDYb'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Study shows Pfizer vaccine had an effectiveness of 88.8% vs Moderna\u2019s 96.3%. Pfizer\u2019s efficacy  against hospitalization fell from 91% to 77% after a 4-month period after the 2nd shot. Moderna showed no decline over the same period.   '}, {'verified': False, 'country': 'USA', 'id': '1440979089532334085', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'PNN for Sept. 23, 2021 - NEJM: Efficacy of mRNA-1273 SARS-CoV-2 Vaccine; mRNA COVID-19 Vaccine Effectiveness Among U.S. Health Care Personnel. Booster doses approved for Pfizer COVID-19 vaccine. https://t.co/uNe8HLhIqV https://t.co/Xams6jMibo', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/uNe8HLhIqV'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'PNN for Sept. 23, 2021 - NEJM: Efficacy of mRNA-1273 SARS-CoV-2 Vaccine; mRNA COVID-19 Vaccine Effectiveness Among U.S. Health Care Personnel. Booster doses approved for Pfizer COVID-19 vaccine.  https://t.co/Xams6jMibo'}, {'verified': False, 'country': 'USA', 'id': '1440977924576796673', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Be careful of any study claiming overly high vaccine efficacy. Most if not all of them are pre-delta and do not satisfy the \"rechallenge\" criteria.\\n\\nWinter is coming is not a joke. #COVID19 #CovidVaccine', 'tweet_lang': 'en', 'hashtags': ['COVID19', 'CovidVaccine'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Be careful of any study claiming overly high vaccine efficacy. Most if not all of them are pre-delta and do not satisfy the \"rechallenge\" criteria.\\n\\nWinter is coming is not a joke.  '}, {'verified': True, 'country': 'USA', 'id': '1440974628088811529', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Novavax vaccine shows 89.7% efficacy against Covid, UK clinical trial results show\\n\\n@MohanaBasu reports\\n\\n#ThePrintTracksCovid\\n\\nhttps://t.co/md8EnabDpK', 'tweet_lang': 'en', 'hashtags': ['ThePrintTracksCovid'], 'mentions': ['MohanaBasu'], 'tweet_urls': ['https://t.co/md8EnabDpK'], 'tweet_date': '2021-09-23T10:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Novavax vaccine shows 89.7% efficacy against Covid, UK clinical trial results show\\n\\n reports\\n\\n\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440969508408102918', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Important! Kya Hai Flu Vaccine, things you need to know \\n#fluvaccine #flushots #Vaccine #healthNews #influenza #oneworldnews\\nhttps://t.co/uMLJqpvBl6', 'tweet_lang': 'en', 'hashtags': ['fluvaccine', 'flushots', 'Vaccine', 'healthNews', 'influenza', 'oneworldnews'], 'mentions': [], 'tweet_urls': ['https://t.co/uMLJqpvBl6'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Important! Kya Hai Flu Vaccine, things you need to know \\n     \\n'}, {'verified': False, 'country': 'USA', 'id': '1440969144384503809', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Good news. Recombinant protein vaccine. Clover Biopharmaceuticals announces positive efficacy data from Phase 2/3 trial https://t.co/xZG2PtkYr2', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/xZG2PtkYr2'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Good news. Recombinant protein vaccine. Clover Biopharmaceuticals announces positive efficacy data from Phase 2/3 trial '}, {'verified': False, 'country': 'USA', 'id': '1440968572696731648', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Hyv\u00e4 uutinen,jos lasten rokotusohjelmassa jo saama rokote ehk\u00e4isee heill\u00e4 my\u00f6s vaikeaa Koronamuotoa!\\nEFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL https://t.co/Fc0xIfHE6q', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Fc0xIfHE6q'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Hyv\u00e4 uutinen,jos lasten rokotusohjelmassa jo saama rokote ehk\u00e4isee heill\u00e4 my\u00f6s vaikeaa Koronamuotoa!\\nEFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL '}, {'verified': False, 'country': 'USA', 'id': '1440967813846294536', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Japan prepares booster shots amid worries over waning vaccine efficacy https://t.co/0ughClGKJm https://t.co/T3rLxTOFnD', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/0ughClGKJm'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Japan prepares booster shots amid worries over waning vaccine efficacy  https://t.co/T3rLxTOFnD'}, {'verified': False, 'country': 'USA', 'id': '1440966339758329856', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Though your final point is obviously not true, the rest of your observations are valid insofar as vaccine efficacy issues go. Covid-19 vaccinations ate clearly much newer &amp; have not had the test of time. https://t.co/GBKjENVX0k', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/GBKjENVX0k'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Though your final point is obviously not true, the rest of your observations are valid insofar as vaccine efficacy issues go. Covid-19 vaccinations ate clearly much newer &amp; have not had the test of time. '}, {'verified': False, 'country': 'USA', 'id': '1440963205396942851', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u2018We have an unclear need with unclear motivation, significant safety concerns, poor evidence of sustained boost efficacy, and wrong priorities,\u2019 said Dr. David Wiseman, a top Johnson &amp; Johnson researcher. https://t.co/sQLtJoFCiB', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/sQLtJoFCiB'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u2018We have an unclear need with unclear motivation, significant safety concerns, poor evidence of sustained boost efficacy, and wrong priorities,\u2019 said Dr. David Wiseman, a top Johnson &amp; Johnson researcher. '}, {'verified': False, 'country': 'USA', 'id': '1440959272880377858', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'There is no long term trial on vaccine safety.\\n\\nThe control group was vaxxed the moment they got emergency release from the FDA.\\n\\nVaccine efficacy is fading. https://t.co/pY4phyP1RN', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/pY4phyP1RN'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'There is no long term trial on vaccine safety.\\n\\nThe control group was vaxxed the moment they got emergency release from the FDA.\\n\\nVaccine efficacy is fading. '}, {'verified': False, 'country': 'USA', 'id': '1440958706905194501', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL | medRxiv https://t.co/JqpajK3QlC', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/JqpajK3QlC'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL | medRxiv '}, {'verified': False, 'country': 'USA', 'id': '1440958190053625856', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'If Irish Dr\\'s were being treated the same as Nurses, Student Nurses, Midwives &amp; Care staff, if we were being threatened with injection OR \"redeployment\" by the HSE, there would actually be a \\ndebate on RTE about the safety and efficacy of the vaccine.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'If Irish Dr\\'s were being treated the same as Nurses, Student Nurses, Midwives &amp; Care staff, if we were being threatened with injection OR \"redeployment\" by the HSE, there would actually be a \\ndebate on RTE about the safety and efficacy of the vaccine.'}, {'verified': False, 'country': 'USA', 'id': '1440958007110737920', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna edges out Pfizer-BioNTech and J&amp;J in CDC study of COVID-19 vaccine efficacy\\nhttps://t.co/7MeJIkwGPK\\n\\nShared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/d37srT9rST', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/7MeJIkwGPK', 'https://t.co/6B3jbzYYWk'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna edges out Pfizer-BioNTech and J&amp;J in CDC study of COVID-19 vaccine efficacy\\n\\n\\nShared from Epocrates, The #1 medical reference app.  https://t.co/d37srT9rST'}, {'verified': False, 'country': 'USA', 'id': '1440956915715088386', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Most Israelis have been double vaxxed too and are now lining up for a THIRD shot! What does that tell us about the Pfizer-BioNTech \u201cinvestigational vaccine\u201d @US_FDA and its efficacy in protecting us from re-infection? What about the other vaccines?\ud83e\udd14 https://t.co/5caFEGKvUw', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['US_FDA'], 'tweet_urls': ['https://t.co/5caFEGKvUw'], 'tweet_date': '2021-09-23T09:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Most Israelis have been double vaxxed too and are now lining up for a THIRD shot! What does that tell us about the Pfizer-BioNTech \u201cinvestigational vaccine\u201d  and its efficacy in protecting us from re-infection? What about the other vaccines?\ud83e\udd14 '}, {'verified': False, 'country': 'USA', 'id': '1440954090733907970', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Malaysia is enduring a devastating fourth wave of Covid-19, but China-made vaccines have been relegated to a secondary role over efficacy concerns https://t.co/pF1F0twbWF', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/pF1F0twbWF'], 'tweet_date': '2021-09-23T08:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Malaysia is enduring a devastating fourth wave of Covid-19, but China-made vaccines have been relegated to a secondary role over efficacy concerns '}, {'verified': False, 'country': 'USA', 'id': '1440953129227341828', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Can\u2019t reduce something that\u2019s basically nonexistent to begin with. The efficacy of this so-called vaccine is a complete joke. The current situation in Israel is the glaring proof of that. https://t.co/6rjrdtKmZw', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/6rjrdtKmZw'], 'tweet_date': '2021-09-23T08:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Can\u2019t reduce something that\u2019s basically nonexistent to begin with. The efficacy of this so-called vaccine is a complete joke. The current situation in Israel is the glaring proof of that. '}, {'verified': False, 'country': 'USA', 'id': '1440952171688706060', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL https://t.co/PFNhJvQBNL', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/PFNhJvQBNL'], 'tweet_date': '2021-09-23T08:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL '}, {'verified': False, 'country': 'USA', 'id': '1440951957179576320', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Chinese drugmaker Clover Biopharmaceuticals says its experimental coronavirus vaccine prevented COVID-19 in a large Phase 3 trial with efficacy of 67% against disease of any severity and 85% against moderate-to-severe disease https://t.co/pmqPYps54y @ByJonGardner', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['ByJonGardner'], 'tweet_urls': ['https://t.co/pmqPYps54y'], 'tweet_date': '2021-09-23T08:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Chinese drugmaker Clover Biopharmaceuticals says its experimental coronavirus vaccine prevented COVID-19 in a large Phase 3 trial with efficacy of 67% against disease of any severity and 85% against moderate-to-severe disease  '}, {'verified': False, 'country': 'USA', 'id': '1440950280384811010', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Withdrawal of vaccine authorisation\\nhttps://t.co/NiGiagkbOQ\\nNederland moet toch altijd aan de leiband van Europa lopen? Waarom nu niet?\\nRapport lijkt mij heel duidelijk.....\\nwithdraw or suspend authorisation for the use of those vaccines owing to the lack of safety and efficacy https://t.co/CoO2PR5Ika', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/NiGiagkbOQ'], 'tweet_date': '2021-09-23T08:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Withdrawal of vaccine authorisation\\n\\nNederland moet toch altijd aan de leiband van Europa lopen? Waarom nu niet?\\nRapport lijkt mij heel duidelijk.....\\nwithdraw or suspend authorisation for the use of those vaccines owing to the lack of safety and efficacy https://t.co/CoO2PR5Ika'}, {'verified': False, 'country': 'USA', 'id': '1440944533663928326', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase - https://t.co/2fdIuTlvct https://t.co/L2N0BOHvPO', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/2fdIuTlvct', 'https://t.co/L2N0BOHvPO'], 'tweet_date': '2021-09-23T08:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase -  '}, {'verified': False, 'country': 'USA', 'id': '1440944533169074185', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase - https://t.co/eM58rUcq4g https://t.co/tZZ3A7RjVT', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/eM58rUcq4g', 'https://t.co/tZZ3A7RjVT'], 'tweet_date': '2021-09-23T08:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase -  '}, {'verified': False, 'country': 'USA', 'id': '1440941484073705473', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'These photos were taken a day apart...does the difference make any sense whatsoever? People need to start questioning stuff because we are sleepwalking into oblivion, frankly. It\u2019s all for show...masks, distancing, restrictions even vaccine efficacy...look closer, people! https://t.co/8DOPMIGPc1', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'These photos were taken a day apart...does the difference make any sense whatsoever? People need to start questioning stuff because we are sleepwalking into oblivion, frankly. It\u2019s all for show...masks, distancing, restrictions even vaccine efficacy...look closer, people! https://t.co/8DOPMIGPc1'}, {'verified': False, 'country': 'USA', 'id': '1440938422336643072', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#Efficacy of the #mRNA-1273 #SARS-CoV-2 #Vaccine at Completion of Blinded Phase | NEJM https://t.co/syhWYh3FLe', 'tweet_lang': 'en', 'hashtags': ['Efficacy', 'mRNA', 'SARS', 'Vaccine'], 'mentions': [], 'tweet_urls': ['https://t.co/syhWYh3FLe'], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' of the -1273 -CoV-2  at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1440937967086940160', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'INOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico $INO https://t.co/G8peJRsWW1', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/G8peJRsWW1'], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'INOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico $INO '}, {'verified': False, 'country': 'USA', 'id': '1440937926087659521', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"\ud83d\uded1But Still China Not Allowing Vaccinated International Students\\n\ud83d\udc47\ud83d\udc47\ud83d\udc47\\nChina has developed the world's first #vaccine which could protect against different variants. Vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. https://t.co/25FxQM2G1M\", 'tweet_lang': 'en', 'hashtags': ['vaccine'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"\ud83d\uded1But Still China Not Allowing Vaccinated International Students\\n\ud83d\udc47\ud83d\udc47\ud83d\udc47\\nChina has developed the world's first  which could protect against different variants. Vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. https://t.co/25FxQM2G1M\"}, {'verified': False, 'country': 'USA', 'id': '1440934684305903617', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"China has developed the world's first #COVID19 #vaccine which could protect against different variants. Clinical trials on Wednesday revealed the recombinant protein vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. https://t.co/Z1B5Bqdh1e\", 'tweet_lang': 'en', 'hashtags': ['COVID19', 'vaccine'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"China has developed the world's first   which could protect against different variants. Clinical trials on Wednesday revealed the recombinant protein vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. https://t.co/Z1B5Bqdh1e\"}, {'verified': False, 'country': 'USA', 'id': '1440934622842470400', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM #Moderna #Spikevax \\n\\nhttps://t.co/z2G8ubFrIr', 'tweet_lang': 'en', 'hashtags': ['Moderna', 'Spikevax'], 'mentions': [], 'tweet_urls': ['https://t.co/z2G8ubFrIr'], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM   \\n\\n'}, {'verified': True, 'country': 'USA', 'id': '1440933953590857733', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"China has developed the world's first #COVID19 #vaccine which could protect against different variants. Clinical trials on Wednesday revealed the recombinant protein vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. https://t.co/yU4EBXIsgs\", 'tweet_lang': 'en', 'hashtags': ['COVID19', 'vaccine'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"China has developed the world's first   which could protect against different variants. Clinical trials on Wednesday revealed the recombinant protein vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. https://t.co/yU4EBXIsgs\"}, {'verified': False, 'country': 'USA', 'id': '1440933234100088833', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM https://t.co/KBLWLBj5ER', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/KBLWLBj5ER'], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1440933072707493889', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Like it or not, this presumably has nothing to do with vaccine efficacy and everything to do with corruption/the relative ease of faking a tatty piece of paper.  https://t.co/iO2iCrsZG5', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/iO2iCrsZG5'], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Like it or not, this presumably has nothing to do with vaccine efficacy and everything to do with corruption/the relative ease of faking a tatty piece of paper.  '}, {'verified': False, 'country': 'USA', 'id': '1440932566169706496', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase - https://t.co/cRJReo6StP https://t.co/2AzTj18PFL via @rhotwire https://t.co/HJLJ9ft4gv', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['rhotwire'], 'tweet_urls': ['https://t.co/cRJReo6StP', 'https://t.co/2AzTj18PFL'], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase -   via  https://t.co/HJLJ9ft4gv'}, {'verified': False, 'country': 'USA', 'id': '1440929638222483456', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u30ce\u30d0\u30d0\u30c3\u30af\u30b9 \u30ef\u30af\u30c1\u30f3\\nNEJM \u65e5\u672c\u8a9e\u7248Abstract\\nNVX-CoV2373 Covid-19 \u30ef\u30af\u30c1\u30f3\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027 \\nSafety and Efficacy of NVX-CoV2373 Covid-19 Vaccine\\nhttps://t.co/lVjPpNZAEt', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/lVjPpNZAEt'], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u30ce\u30d0\u30d0\u30c3\u30af\u30b9 \u30ef\u30af\u30c1\u30f3\\nNEJM \u65e5\u672c\u8a9e\u7248Abstract\\nNVX-CoV2373 Covid-19 \u30ef\u30af\u30c1\u30f3\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027 \\nSafety and Efficacy of NVX-CoV2373 Covid-19 Vaccine\\n'}, {'verified': True, 'country': 'USA', 'id': '1440929116635623428', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Agree this is completely illogical and seems discriminatory. Astra-Zeneca states that its vaccine is of identical quality wherever it is made - here in Thailand you might get locally-made AZ or AZ from Korea - both have exactly the same efficacy. https://t.co/S4OlOC5E9A', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/S4OlOC5E9A'], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Agree this is completely illogical and seems discriminatory. Astra-Zeneca states that its vaccine is of identical quality wherever it is made - here in Thailand you might get locally-made AZ or AZ from Korea - both have exactly the same efficacy. '}, {'verified': False, 'country': 'USA', 'id': '1440927347868377092', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Unfortunately Monica is incorrect https://t.co/OsG5mp8Nb7 she\u2019s not looking at all US states, mistaking seasonality for vaccine efficacy https://t.co/JEQhv8klpv', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/OsG5mp8Nb7', 'https://t.co/JEQhv8klpv'], 'tweet_date': '2021-09-23T07:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Unfortunately Monica is incorrect  she\u2019s not looking at all US states, mistaking seasonality for vaccine efficacy '}, {'verified': False, 'country': 'USA', 'id': '1440925635959005186', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Government received more than 1.6 million doses of Pfizer from the United States and is set to start vaccination on Monday.\\n\\nPfizer vaccine has an efficacy of 95% while the efficacy of AstraZeneca vaccine is at 63 per cent.\\n\\nHave you been vaccinated?\\n\\n#TheFatboyShow #Covid_19 https://t.co/pd8mDkq5tE', 'tweet_lang': 'en', 'hashtags': ['TheFatboyShow', 'Covid_19'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Government received more than 1.6 million doses of Pfizer from the United States and is set to start vaccination on Monday.\\n\\nPfizer vaccine has an efficacy of 95% while the efficacy of AstraZeneca vaccine is at 63 per cent.\\n\\nHave you been vaccinated?\\n\\n  https://t.co/pd8mDkq5tE'}, {'verified': False, 'country': 'USA', 'id': '1440924499692515334', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'With vaccinated still catching the covid, @POTUS how do you expect the vaccine to solve the problem? Are you that far gone that you haven\\'t researched the efficacy of your \"magic-save-all\" vaccine? \\n\\nQuit denying GOD and the natural immune system... \ud83d\ude4f\u261d\ud83c\udf20\ud83d\udc9bLOVE https://t.co/bQIydBRzHp', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['POTUS'], 'tweet_urls': ['https://t.co/bQIydBRzHp'], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'With vaccinated still catching the covid,  how do you expect the vaccine to solve the problem? Are you that far gone that you haven\\'t researched the efficacy of your \"magic-save-all\" vaccine? \\n\\nQuit denying GOD and the natural immune system... \ud83d\ude4f\u261d\ud83c\udf20\ud83d\udc9bLOVE '}, {'verified': False, 'country': 'USA', 'id': '1440922783471570944', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'are covid boosters accentuating covid deaths in israel?\\nassessing the 2 week \"worry window\" of negative vaccine efficacy\\n\\nel gato malo https://t.co/KjHQHRCk0T', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/KjHQHRCk0T'], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'are covid boosters accentuating covid deaths in israel?\\nassessing the 2 week \"worry window\" of negative vaccine efficacy\\n\\nel gato malo '}, {'verified': False, 'country': 'USA', 'id': '1440921700548452355', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"China's Clover Biopharma (uses Dynavax adjuvant) says its COVID-19 vaccine shows 67% overall efficacy and 79% against Delta variant in Phase II/III trials. Plans to seek WHO nod #COVID19 #vaccines #pharmaceutical https://t.co/TCFfPR66bx\", 'tweet_lang': 'en', 'hashtags': ['COVID19', 'vaccines', 'pharmaceutical'], 'mentions': [], 'tweet_urls': ['https://t.co/TCFfPR66bx'], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"China's Clover Biopharma (uses Dynavax adjuvant) says its COVID-19 vaccine shows 67% overall efficacy and 79% against Delta variant in Phase II/III trials. Plans to seek WHO nod    \"}, {'verified': False, 'country': 'USA', 'id': '1440921573066563591', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"#Alabama Health Officer: In 2020, for the first time on record, more deaths than births - 65k deaths to 58k births, with 11% of the deaths attributed to COVID.\\n\\nThat's some \u201cflu.\u201d\\n\\nVaccine safety/efficacy data in thread \ud83d\udc47\\nhttps://t.co/T2jbHHRpqc\", 'tweet_lang': 'en', 'hashtags': ['Alabama'], 'mentions': [], 'tweet_urls': ['https://t.co/T2jbHHRpqc'], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \" Health Officer: In 2020, for the first time on record, more deaths than births - 65k deaths to 58k births, with 11% of the deaths attributed to COVID.\\n\\nThat's some \u201cflu.\u201d\\n\\nVaccine safety/efficacy data in thread \ud83d\udc47\\n\"}, {'verified': True, 'country': 'USA', 'id': '1440919756647792641', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"China has developed the world's first #COVID19 #vaccine which could protect against different variants. Clinical trials on Wednesday revealed the recombinant protein vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. https://t.co/krCa3BudWS\", 'tweet_lang': 'en', 'hashtags': ['COVID19', 'vaccine'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"China has developed the world's first   which could protect against different variants. Clinical trials on Wednesday revealed the recombinant protein vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. https://t.co/krCa3BudWS\"}, {'verified': False, 'country': 'USA', 'id': '1440919110825779200', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Worms can affect vaccine efficacy: lessons for COVID-19? \\n\\nhttps://t.co/ujrhmdEEia https://t.co/zIbcPiwtA5', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ujrhmdEEia'], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Worms can affect vaccine efficacy: lessons for COVID-19? \\n\\n https://t.co/zIbcPiwtA5'}, {'verified': False, 'country': 'USA', 'id': '1440918746609168389', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/IGLOcW3Zyw', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/IGLOcW3Zyw'], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1440918268479483905', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'are covid boosters accentuating covid deaths in israel?\\nassessing the 2 week \"worry window\" of negative vaccine efficacy\\n\\nhttps://t.co/ZvBLYfwoTl', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ZvBLYfwoTl'], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'are covid boosters accentuating covid deaths in israel?\\nassessing the 2 week \"worry window\" of negative vaccine efficacy\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440916400843882496', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The #Moderna #mRNA #vaccine continued to be efficacious in preventing #Covid19 illness and severe disease at more than 5 months, with an acceptable safety profile, and protection against asymptomatic infection was observed. Vaccine efficacy in preventing\u2026https://t.co/jV7hIXOpH8', 'tweet_lang': 'en', 'hashtags': ['Moderna', 'mRNA', 'vaccine', 'Covid19'], 'mentions': [], 'tweet_urls': ['https://t.co/jV7hIXOpH8'], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The    continued to be efficacious in preventing  illness and severe disease at more than 5 months, with an acceptable safety profile, and protection against asymptomatic infection was observed. Vaccine efficacy in preventing\u2026'}, {'verified': False, 'country': 'USA', 'id': '1440916292530102272', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u4eca\u6d41\u308c\u3066\u304d\u307e\u3057\u305f\u304c\u3001\u6628\u65e5\u4ed8\u3051\u306eNEJM\\n\u3053\u308c\u3068\u540c\u3058\u4e8b\u3067\u3059\u304b\uff1f\\n\\nEfficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase\\nSeptember 22, 2021\\nDOI: 10.1056/NEJMoa2113017\\nhttps://t.co/TgDf7rC8Ns https://t.co/8PI0weEq7o https://t.co/HrDB7pBMHh', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/TgDf7rC8Ns', 'https://t.co/8PI0weEq7o'], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u4eca\u6d41\u308c\u3066\u304d\u307e\u3057\u305f\u304c\u3001\u6628\u65e5\u4ed8\u3051\u306eNEJM\\n\u3053\u308c\u3068\u540c\u3058\u4e8b\u3067\u3059\u304b\uff1f\\n\\nEfficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase\\nSeptember 22, 2021\\nDOI: 10.1056/NEJMoa2113017\\n  https://t.co/HrDB7pBMHh'}, {'verified': True, 'country': 'USA', 'id': '1440914069083488265', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"China has developed the world's first #COVID19 #vaccine which could protect against different variants. Clinical trials on Wednesday revealed the recombinant protein vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. https://t.co/O0IK7f2ka7\", 'tweet_lang': 'en', 'hashtags': ['COVID19', 'vaccine'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"China has developed the world's first   which could protect against different variants. Clinical trials on Wednesday revealed the recombinant protein vaccine has a 79% efficacy against Delta, whilst it shows 92% and 59% efficacy against Gamma and Mu respectively. https://t.co/O0IK7f2ka7\"}, {'verified': False, 'country': 'USA', 'id': '1440913382933159936', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Need to have a specific scientific or health reason not to take a vaccine that has proved its efficacy.  Last report was 97.5% of ALL Doctors are taking the vaccine for themselves and their families. https://t.co/yaNQodedxW', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/yaNQodedxW'], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Need to have a specific scientific or health reason not to take a vaccine that has proved its efficacy.  Last report was 97.5% of ALL Doctors are taking the vaccine for themselves and their families. '}, {'verified': False, 'country': 'USA', 'id': '1440911707522568193', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Surprised to find out that a lot of people believe in the efficacy of the vaccine but refuse to be vaccinated because they only want to benefit from the herd immunity when 90% of the population is vaccinated. They wanna be the 10% that are not vaccinated but are still protected.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T06:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Surprised to find out that a lot of people believe in the efficacy of the vaccine but refuse to be vaccinated because they only want to benefit from the herd immunity when 90% of the population is vaccinated. They wanna be the 10% that are not vaccinated but are still protected.'}, {'verified': False, 'country': 'USA', 'id': '1440909899987361792', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Moderna's vaccine efficacy held strong, did not wane after 5 months, new study shows https://t.co/qGku9x0KGU\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/qGku9x0KGU'], 'tweet_date': '2021-09-23T05:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Moderna's vaccine efficacy held strong, did not wane after 5 months, new study shows \"}, {'verified': True, 'country': 'USA', 'id': '1440908704358993920', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The decline in the #COVID19 fatality rate in vaccinated populations is evidence of the efficacy of vaccines.\\n\\nRead this insightful opinion piece by @daktari1 and Charles Okeahalam: The World Needs More Equity in #CovidVaccine Access. Via @NewsweekOpinion https://t.co/mcabttDwfc', 'tweet_lang': 'en', 'hashtags': ['COVID19', 'CovidVaccine'], 'mentions': ['daktari1', 'NewsweekOpinion'], 'tweet_urls': ['https://t.co/mcabttDwfc'], 'tweet_date': '2021-09-23T05:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The decline in the  fatality rate in vaccinated populations is evidence of the efficacy of vaccines.\\n\\nRead this insightful opinion piece by  and Charles Okeahalam: The World Needs More Equity in  Access. Via  '}, {'verified': True, 'country': 'USA', 'id': '1440901643097108487', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Research published on Friday by the CDC found that the efficacy of the Pfizer-BioNTech vaccine against hospitalization fell from 91% to 77% after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period. https://t.co/6AbUw1dNzH', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/6AbUw1dNzH'], 'tweet_date': '2021-09-23T05:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Research published on Friday by the CDC found that the efficacy of the Pfizer-BioNTech vaccine against hospitalization fell from 91% to 77% after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period. '}, {'verified': False, 'country': 'USA', 'id': '1440901608951271425', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The dam breaks\\n\\n\"In the original clinical trials of the three vaccines eventually authorized in the United States ... it was clear that the J.&amp;J. vaccine had a lower efficacy than the other two. Research since then has borne out that trend\"\\n\\nhttps://t.co/HrZh1hJLjU', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/HrZh1hJLjU'], 'tweet_date': '2021-09-23T05:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The dam breaks\\n\\n\"In the original clinical trials of the three vaccines eventually authorized in the United States ... it was clear that the J.&amp;J. vaccine had a lower efficacy than the other two. Research since then has borne out that trend\"\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440898624485871619', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Good readable paper on looking at vaccine efficacy versus severe disease outcomes. \\n\\nhttps://t.co/udVHfICpWf', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/udVHfICpWf'], 'tweet_date': '2021-09-23T05:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Good readable paper on looking at vaccine efficacy versus severe disease outcomes. \\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440892380631109634', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'This is important to know if/when you need to understand the stats around COVID-19 vaccine effectiveness and explain them to others. =&gt; https://t.co/yoYTU3cTwG', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/yoYTU3cTwG'], 'tweet_date': '2021-09-23T04:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'This is important to know if/when you need to understand the stats around COVID-19 vaccine effectiveness and explain them to others. =&gt; '}, {'verified': False, 'country': 'USA', 'id': '1440891946826829827', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#afternoonagenda @Kieran_Gilbert @aclennell @SkyNewsAust 80-90% ? What does that even mean? Example -When 15% had 2 doses 6months ago and are soon due for boosters? Every individual will be at a different stage of immunity as vaccine efficacy WANES...', 'tweet_lang': 'en', 'hashtags': ['afternoonagenda'], 'mentions': ['Kieran_Gilbert', 'aclennell', 'SkyNewsAust'], 'tweet_urls': [], 'tweet_date': '2021-09-23T04:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '    80-90% ? What does that even mean? Example -When 15% had 2 doses 6months ago and are soon due for boosters? Every individual will be at a different stage of immunity as vaccine efficacy WANES...'}, {'verified': False, 'country': 'USA', 'id': '1440890805225361422', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/gS7yCUwGeS', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/gS7yCUwGeS'], 'tweet_date': '2021-09-23T04:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1440890748790927364', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM https://t.co/eUUcqifr1D', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/eUUcqifr1D'], 'tweet_date': '2021-09-23T04:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1440890131213430787', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Audio Interview: Vaccine Efficacy and Boosters in Covid-19 | NEJM https://t.co/gy6hWbkc9b', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/gy6hWbkc9b'], 'tweet_date': '2021-09-23T04:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Audio Interview: Vaccine Efficacy and Boosters in Covid-19 | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1440888553567764482', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows - Boston Herald https://t.co/pGyD6orChF https://t.co/bpZYYyXugW', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/pGyD6orChF'], 'tweet_date': '2021-09-23T04:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months, new study shows - Boston Herald  https://t.co/bpZYYyXugW'}, {'verified': False, 'country': 'USA', 'id': '1440878719191584773', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Commented on $JNJ $BNTX $PFE - Moderna shot shows highest vaccine efficacy based on ER COVID-related visits. https://t.co/JANe3QskzK', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/JANe3QskzK'], 'tweet_date': '2021-09-23T03:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Commented on $JNJ $BNTX $PFE - Moderna shot shows highest vaccine efficacy based on ER COVID-related visits. '}, {'verified': True, 'country': 'USA', 'id': '1440876817175379979', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"This breaks down the Israeli data by age and vaccination  \\nrates, and is the clearest account I've seen of what's happening there. The Pfizer vaccine is still protecting &gt; 80% against severe disease in all age groups, mostly &gt;90%.  https://t.co/83df5gEYyb https://t.co/aWJLFK13Kk\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/83df5gEYyb', 'https://t.co/aWJLFK13Kk'], 'tweet_date': '2021-09-23T03:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"This breaks down the Israeli data by age and vaccination  \\nrates, and is the clearest account I've seen of what's happening there. The Pfizer vaccine is still protecting &gt; 80% against severe disease in all age groups, mostly &gt;90%.   \"}, {'verified': False, 'country': 'USA', 'id': '1440875188006973443', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna efficacy in preventing severe COVID-19 was 98.2% (95% CI, 92.8 - 99.6) with 106 severe cases in placebo group &amp; 2 in vaccine group.\\n\\nDuration of follow up was &gt;5 months; again showing that effectiveness in preventing severe disease did not drop.\\n\\nhttps://t.co/mSwJRe3y2t https://t.co/PeU2cGFHRp', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/mSwJRe3y2t'], 'tweet_date': '2021-09-23T03:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna efficacy in preventing severe COVID-19 was 98.2% (95% CI, 92.8 - 99.6) with 106 severe cases in placebo group &amp; 2 in vaccine group.\\n\\nDuration of follow up was &gt;5 months; again showing that effectiveness in preventing severe disease did not drop.\\n\\n https://t.co/PeU2cGFHRp'}, {'verified': False, 'country': 'USA', 'id': '1440874595205083141', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine https://t.co/r50PH7IEdz \\nNovavax has signed a contract to supply 150 million doses of new COVID-19 vaccine, which is expected to be manufactured in Jp by the beginning of next year. The UK study showed good efficacy.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/r50PH7IEdz'], 'tweet_date': '2021-09-23T03:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine  \\nNovavax has signed a contract to supply 150 million doses of new COVID-19 vaccine, which is expected to be manufactured in Jp by the beginning of next year. The UK study showed good efficacy.'}, {'verified': False, 'country': 'USA', 'id': '1440874108636565504', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Covid vaccine efficacy, re hospitalizations, United States.\\n(If vaccines are efficacious, this should be a diagonal line going down from left to right) https://t.co/RMPlw7ub0z https://t.co/rftM8bjUwt', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/RMPlw7ub0z'], 'tweet_date': '2021-09-23T03:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Covid vaccine efficacy, re hospitalizations, United States.\\n(If vaccines are efficacious, this should be a diagonal line going down from left to right)  https://t.co/rftM8bjUwt'}, {'verified': False, 'country': 'USA', 'id': '1440869163564605442', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Shocking Chart Shows How Vaccine Efficacy PLUMMETS After Just A Few Months - https://t.co/RsTfKEi0MF', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/RsTfKEi0MF'], 'tweet_date': '2021-09-23T03:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Shocking Chart Shows How Vaccine Efficacy PLUMMETS After Just A Few Months - '}, {'verified': False, 'country': 'USA', 'id': '1440868948006748162', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM \\nSeptember 23, 2021 @Novavax @NEJM \\n\\n#NOVAVAX\\n$NVAX\\n#NVAX \\n\\nhttps://t.co/sA4SPUetoF', 'tweet_lang': 'en', 'hashtags': ['NOVAVAX', 'NVAX'], 'mentions': ['Novavax', 'NEJM'], 'tweet_urls': ['https://t.co/sA4SPUetoF'], 'tweet_date': '2021-09-23T03:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM \\nSeptember 23, 2021   \\n\\n\\n$NVAX\\n \\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440867858746015752', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'I see a TON of anti-v*x people use the \u201cvaccinated people can still get and spread COVID\u201d argument as a point against vaccine passports and, like, are they being deliberately obtuse? Or do they genuinely not know vaccine efficacy isn\u2019t binary?', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T03:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'I see a TON of anti-v*x people use the \u201cvaccinated people can still get and spread COVID\u201d argument as a point against vaccine passports and, like, are they being deliberately obtuse? Or do they genuinely not know vaccine efficacy isn\u2019t binary?'}, {'verified': True, 'country': 'USA', 'id': '1440866257964830720', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Johnson &amp; Johnson Says Second Dose of Vaccine Increases Efficacy to 94% https://t.co/lQUflhgN4y', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/lQUflhgN4y'], 'tweet_date': '2021-09-23T03:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Johnson &amp; Johnson Says Second Dose of Vaccine Increases Efficacy to 94% '}, {'verified': False, 'country': 'USA', 'id': '1440866044881485833', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Research published on Friday by @CDCgov found that efficacy of the Pfizer-BioNTech vaccine against hospitalization fell from 91% to 77% after a 4-month period following the 2nd shot. The Moderna vaccine showed no decline over the same period. #COVID19\\n\\nhttps://t.co/5EgUiR5jwj', 'tweet_lang': 'en', 'hashtags': ['COVID19'], 'mentions': ['CDCgov'], 'tweet_urls': ['https://t.co/5EgUiR5jwj'], 'tweet_date': '2021-09-23T03:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Research published on Friday by  found that efficacy of the Pfizer-BioNTech vaccine against hospitalization fell from 91% to 77% after a 4-month period following the 2nd shot. The Moderna vaccine showed no decline over the same period. \\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440866015483662338', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'In a new clinical trial looking at the efficacy of a third @moderna_tx vaccine dose for coronavirus disease 2019 in people living with an organ (liver or kidney) transplant. #COVID19Vaccine #Moderna #OrganTransplant #FeinsteinInstitutes #NorthwellHealth https://t.co/duYvY8RIqG', 'tweet_lang': 'en', 'hashtags': ['COVID19Vaccine', 'Moderna', 'OrganTransplant', 'FeinsteinInstitutes', 'NorthwellHealth'], 'mentions': ['moderna_tx'], 'tweet_urls': ['https://t.co/duYvY8RIqG'], 'tweet_date': '2021-09-23T03:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'In a new clinical trial looking at the efficacy of a third  vaccine dose for coronavirus disease 2019 in people living with an organ (liver or kidney) transplant.      '}, {'verified': False, 'country': 'USA', 'id': '1440864574211723271', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'So many \"experts\" are now mistaking seasonality for vaccine efficacy.  It is going to make for a large winter of discontent in high latitude countries in the Northern hemisphere.  Where vax % is high, I expect a ton of hospitalizations and higher death rate in the face of low CFR https://t.co/Iot8r2bzts', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T02:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'So many \"experts\" are now mistaking seasonality for vaccine efficacy.  It is going to make for a large winter of discontent in high latitude countries in the Northern hemisphere.  Where vax % is high, I expect a ton of hospitalizations and higher death rate in the face of low CFR https://t.co/Iot8r2bzts'}, {'verified': False, 'country': 'USA', 'id': '1440862694983102471', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Interested in seeing mixed vaccine trial results. Had pfizer so eligible for booster as soon as they are ready but I wonder about efficacy of a Moderna booster. I have some time to sort out. I\u2019m expecting I\u2019ll need more boosters as the years go on so probably doesn\u2019t matter now.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T02:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Interested in seeing mixed vaccine trial results. Had pfizer so eligible for booster as soon as they are ready but I wonder about efficacy of a Moderna booster. I have some time to sort out. I\u2019m expecting I\u2019ll need more boosters as the years go on so probably doesn\u2019t matter now.'}, {'verified': False, 'country': 'USA', 'id': '1440862333304066053', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u05db\u05d9\u05d3\u05d5\u05e2 \u05d4\u05d4\u05d9\u05ea\u05e8 \u05dc\u05e9\u05d9\u05de\u05d5\u05e9 \u05d7\u05d9\u05e8\u05d5\u05dd \u05d1\u05d7\u05d9\u05e1\u05d5\u05df \u05de\u05d5\u05d3\u05e8\u05e0\u05d4 \u05e0\u05d9\u05ea\u05df \u05dc\u05d0\u05d7\u05e8 \u05d4\u05d4\u05e6\u05dc\u05d7\u05d4 \u05d1\u05d0\u05e0\u05dc\u05d9\u05d6\u05ea \u05d4\u05d1\u05d9\u05e0\u05d9\u05d9\u05dd \u05e9\u05d4\u05e8\u05d0\u05ea\u05d4 \u05d9\u05e2\u05d9\u05dc\u05d5\u05ea \u05e7\u05dc\u05d9\u05e0\u05d9\u05ea. \u05d4\u05d9\u05e0\u05d4 \u05d4\u05d3\u05d5\u05d7 \u05d4\u05e2\u05d3\u05db\u05e0\u05d9 \u05e9\u05dc \u05d4\u05d0\u05e0\u05dc\u05d9\u05d6\u05d4 \u05e9\u05e0\u05e2\u05e9\u05ea\u05d4 \u05e2\u05dc \u05db\u05dc \u05d4\u05ea\u05e7\u05d5\u05e4\u05d4 \u05e9\u05d4\u05e0\u05d9\u05e1\u05d5\u05d9 \u05d4\u05d9\u05d4 \u05db\u05e4\u05d5\u05dc \u05e1\u05de\u05d9\u05d5\u05ea.\\nEfficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/S8HZFG8zs9', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/S8HZFG8zs9'], 'tweet_date': '2021-09-23T02:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u05db\u05d9\u05d3\u05d5\u05e2 \u05d4\u05d4\u05d9\u05ea\u05e8 \u05dc\u05e9\u05d9\u05de\u05d5\u05e9 \u05d7\u05d9\u05e8\u05d5\u05dd \u05d1\u05d7\u05d9\u05e1\u05d5\u05df \u05de\u05d5\u05d3\u05e8\u05e0\u05d4 \u05e0\u05d9\u05ea\u05df \u05dc\u05d0\u05d7\u05e8 \u05d4\u05d4\u05e6\u05dc\u05d7\u05d4 \u05d1\u05d0\u05e0\u05dc\u05d9\u05d6\u05ea \u05d4\u05d1\u05d9\u05e0\u05d9\u05d9\u05dd \u05e9\u05d4\u05e8\u05d0\u05ea\u05d4 \u05d9\u05e2\u05d9\u05dc\u05d5\u05ea \u05e7\u05dc\u05d9\u05e0\u05d9\u05ea. \u05d4\u05d9\u05e0\u05d4 \u05d4\u05d3\u05d5\u05d7 \u05d4\u05e2\u05d3\u05db\u05e0\u05d9 \u05e9\u05dc \u05d4\u05d0\u05e0\u05dc\u05d9\u05d6\u05d4 \u05e9\u05e0\u05e2\u05e9\u05ea\u05d4 \u05e2\u05dc \u05db\u05dc \u05d4\u05ea\u05e7\u05d5\u05e4\u05d4 \u05e9\u05d4\u05e0\u05d9\u05e1\u05d5\u05d9 \u05d4\u05d9\u05d4 \u05db\u05e4\u05d5\u05dc \u05e1\u05de\u05d9\u05d5\u05ea.\\nEfficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1440861914544820230', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Typhoid fever is a public health problem in low to middle-income countries, especially among children, and the widespread use of TCV, a more effective vaccine, is desired.\\nSafety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children | NEJM https://t.co/YApPtoNHgY', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/YApPtoNHgY'], 'tweet_date': '2021-09-23T02:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Typhoid fever is a public health problem in low to middle-income countries, especially among children, and the widespread use of TCV, a more effective vaccine, is desired.\\nSafety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1440859020722675713', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Clover\u2019s COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern\\xa0an https://t.co/I8HhMoMZDD', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/I8HhMoMZDD'], 'tweet_date': '2021-09-23T02:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Clover\u2019s COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern\\xa0an '}, {'verified': False, 'country': 'USA', 'id': '1440858020548780036', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Do you wanna know about a company like Pfizer, and why their vaccine he\u2019s getting approval ahead of all the others. Watch the movie CRISIS!!   That\u2019s all you need to know.        How did they get A vaccine to market without Long term clinical Studies for safety and efficacy', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T02:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Do you wanna know about a company like Pfizer, and why their vaccine he\u2019s getting approval ahead of all the others. Watch the movie CRISIS!!   That\u2019s all you need to know.        How did they get A vaccine to market without Long term clinical Studies for safety and efficacy'}, {'verified': False, 'country': 'USA', 'id': '1440856537581371392', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase \u2013\\xa0https://t.co/ZYBwqO9hdm https://t.co/tdqRIGpYWM', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ZYBwqO9hdm', 'https://t.co/tdqRIGpYWM'], 'tweet_date': '2021-09-23T02:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase \u2013\\xa0 '}, {'verified': False, 'country': 'USA', 'id': '1440856251060027394', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Shocking Chart Shows How Vaccine Efficacy PLUMMETS After Just A Few Months https://t.co/JL641EieBE', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/JL641EieBE'], 'tweet_date': '2021-09-23T02:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Shocking Chart Shows How Vaccine Efficacy PLUMMETS After Just A Few Months '}, {'verified': False, 'country': 'USA', 'id': '1440852430393073664', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Both Moderna and Pfizer shared data with the FDA that their Covid vaccine efficacy declines naturally over time \u2014 not because of any strain in particular. \\n\\n#vaccines #covid19 #CovidVaccine   (@Eimear_Shea) https://t.co/LjsfcGxaaN', 'tweet_lang': 'en', 'hashtags': ['vaccines', 'covid19', 'CovidVaccine'], 'mentions': ['Eimear_Shea'], 'tweet_urls': ['https://t.co/LjsfcGxaaN'], 'tweet_date': '2021-09-23T02:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Both Moderna and Pfizer shared data with the FDA that their Covid vaccine efficacy declines naturally over time \u2014 not because of any strain in particular. \\n\\n     () '}, {'verified': False, 'country': 'USA', 'id': '1440852059100569604', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Remember the insanity of this post, in the face of easily accessible data, in ~3 weeks\\n\\nEver wonder why we're still doing this 18 months in?\\n\\nThis is precisely why\\n\\nhttps://t.co/ARu3kPlFWB\\n\\nhttps://t.co/UHXVae0wpq\\n\\nhttps://t.co/OMu4vzUrZU https://t.co/rNrpdxAgt8\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ARu3kPlFWB', 'https://t.co/UHXVae0wpq', 'https://t.co/OMu4vzUrZU', 'https://t.co/rNrpdxAgt8'], 'tweet_date': '2021-09-23T02:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Remember the insanity of this post, in the face of easily accessible data, in ~3 weeks\\n\\nEver wonder why we're still doing this 18 months in?\\n\\nThis is precisely why\\n\\n\\n\\n\\n\\n \"}, {'verified': False, 'country': 'USA', 'id': '1440851535781453831', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'I\u2019ve been hospitalized about 9x over the past year for non-Covid reasons. I\u2019m terrified of getting Covid, as I already have a litany of symptoms that make life awful. Vaccine efficacy wanes over time. I don\u2019t want my continued protection held hostage by people refusing their \ud83d\udc89 https://t.co/eol37TTKfn', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/eol37TTKfn'], 'tweet_date': '2021-09-23T02:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'I\u2019ve been hospitalized about 9x over the past year for non-Covid reasons. I\u2019m terrified of getting Covid, as I already have a litany of symptoms that make life awful. Vaccine efficacy wanes over time. I don\u2019t want my continued protection held hostage by people refusing their \ud83d\udc89 '}, {'verified': False, 'country': 'USA', 'id': '1440851388506914820', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Come on Prof. Shaun Hendy, trying to convince us if we all got vaccinated, the virus wouldn\u2019t have anyone left to infect. We weren\u2019t born yesterday, we\u2019re aware of breakthrough infections, waning vaccine efficacy and can see what\u2019s happening overseas.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T02:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Come on Prof. Shaun Hendy, trying to convince us if we all got vaccinated, the virus wouldn\u2019t have anyone left to infect. We weren\u2019t born yesterday, we\u2019re aware of breakthrough infections, waning vaccine efficacy and can see what\u2019s happening overseas.'}, {'verified': False, 'country': 'USA', 'id': '1440850713748201478', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Sinovac vaccine has an efficacy rate of 50.4% while the Pfizer vaccine has 10X more antibodies and people are still mad the US donated these vaccines? Like were trying to help them! #StudentsTweetPolitics', 'tweet_lang': 'en', 'hashtags': ['StudentsTweetPolitics'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T01:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Sinovac vaccine has an efficacy rate of 50.4% while the Pfizer vaccine has 10X more antibodies and people are still mad the US donated these vaccines? Like were trying to help them! '}, {'verified': False, 'country': 'USA', 'id': '1440849718938984448', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Apparently 1 in 6 NZers are gonna get covid even with high vaccine efficacy, 70% double dose over 5\u2019s, rapid testing, vaccine passports, contact tracing and isolation payments \ud83d\udc7b Yeah right https://t.co/oFbVkTwxsh https://t.co/2p3wGtYhwC', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/oFbVkTwxsh'], 'tweet_date': '2021-09-23T01:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Apparently 1 in 6 NZers are gonna get covid even with high vaccine efficacy, 70% double dose over 5\u2019s, rapid testing, vaccine passports, contact tracing and isolation payments \ud83d\udc7b Yeah right  https://t.co/2p3wGtYhwC'}, {'verified': False, 'country': 'USA', 'id': '1440847160568795141', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Handing out a vaccine that only has a 50% efficacy rate should never be a thing. This just blows me lol.  #StudentsTweetPolitics', 'tweet_lang': 'en', 'hashtags': ['StudentsTweetPolitics'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T01:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Handing out a vaccine that only has a 50% efficacy rate should never be a thing. This just blows me lol.  '}, {'verified': True, 'country': 'USA', 'id': '1440843356158976000', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'DISPATCHES | In the United States, @JNJGlobalHealth said a second shot of its #COVID19 #vaccine given two months after the first dose increased efficacy to 94%. This was found to be the case against moderate to severe courses.\\n\\nhttps://t.co/YD1nbSDEwU', 'tweet_lang': 'en', 'hashtags': ['COVID19', 'vaccine'], 'mentions': ['JNJGlobalHealth'], 'tweet_urls': ['https://t.co/YD1nbSDEwU'], 'tweet_date': '2021-09-23T01:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'DISPATCHES | In the United States,  said a second shot of its   given two months after the first dose increased efficacy to 94%. This was found to be the case against moderate to severe courses.\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440839867932430337', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Being unvaccinated is the default.\\nIt is up to the government to provide New Zealanders with information as to\\n\\n\ud83d\udc89the safety and efficacy of the vaccine\\n\\nBut we now know it does not stop infection, transmission or death and has side effects that are being downplayed. \ud83d\ude33\\n\\n#nzpol', 'tweet_lang': 'en', 'hashtags': ['nzpol'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T01:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Being unvaccinated is the default.\\nIt is up to the government to provide New Zealanders with information as to\\n\\n\ud83d\udc89the safety and efficacy of the vaccine\\n\\nBut we now know it does not stop infection, transmission or death and has side effects that are being downplayed. \ud83d\ude33\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440835832961667086', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The Ministry of Health has said that the efficacy of Sinovac-CoronaVac COVID-19 vaccine is suitable for booster shots and more effective to protect people from Covid-19 infections, especially the Delta variant.\\n\\nhttps://t.co/9EHjvbvpF0', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/9EHjvbvpF0'], 'tweet_date': '2021-09-23T01:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The Ministry of Health has said that the efficacy of Sinovac-CoronaVac COVID-19 vaccine is suitable for booster shots and more effective to protect people from Covid-19 infections, especially the Delta variant.\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440833536601178114', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Per the FDA, Pfizer\u2019s jab only 95% efficacy after 7 days\u2026runs downhill from there.  It\u2019s not a vaccine, it\u2019s an mRNA therapy and it\u2019s not working.  Well, except for the billions Big Pharma is receiving. https://t.co/qAQYgDLcTJ https://t.co/X0POnGA4zt', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/qAQYgDLcTJ'], 'tweet_date': '2021-09-23T00:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Per the FDA, Pfizer\u2019s jab only 95% efficacy after 7 days\u2026runs downhill from there.  It\u2019s not a vaccine, it\u2019s an mRNA therapy and it\u2019s not working.  Well, except for the billions Big Pharma is receiving.  https://t.co/X0POnGA4zt'}, {'verified': False, 'country': 'USA', 'id': '1440832858499653638', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Dynavax Shares Shoot Up 30% After Its Partner Clover Biopharma Met All Key Efficacy Endpoints in Ph. 2/3 COVID-19 Vaccine Trial: https://t.co/4kfFeI9LmR\\n\\n$DVAX #biopharma #covid19 #stocks @DynavaxCorp', 'tweet_lang': 'en', 'hashtags': ['biopharma', 'covid19', 'stocks'], 'mentions': ['DynavaxCorp'], 'tweet_urls': ['https://t.co/4kfFeI9LmR'], 'tweet_date': '2021-09-23T00:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Dynavax Shares Shoot Up 30% After Its Partner Clover Biopharma Met All Key Efficacy Endpoints in Ph. 2/3 COVID-19 Vaccine Trial: \\n\\n$DVAX    '}, {'verified': False, 'country': 'USA', 'id': '1440832773938286595', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Dynavax Shares Shoot Up 30% After Its Partner Clover Biopharma Met All Key Efficacy Endpoints in Ph. 2/3 COVID-19 Vaccine Trial: https://t.co/8qzFWHFp9q\\n\\n$DVAX #biopharma #covid19 #stocks', 'tweet_lang': 'en', 'hashtags': ['biopharma', 'covid19', 'stocks'], 'mentions': [], 'tweet_urls': ['https://t.co/8qzFWHFp9q'], 'tweet_date': '2021-09-23T00:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Dynavax Shares Shoot Up 30% After Its Partner Clover Biopharma Met All Key Efficacy Endpoints in Ph. 2/3 COVID-19 Vaccine Trial: \\n\\n$DVAX   '}, {'verified': False, 'country': 'USA', 'id': '1440831332448292866', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The Pfizer vaccine has been shown to be safe in school-age children, a potentially key development in the fight to bring the pandemic under control. But experts say agency must make final call on safety, efficacy @Harvard @mohpnep @BasnyatBuddha @drbhatta \\nhttps://t.co/L4pQYFIOwt', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['Harvard', 'mohpnep', 'BasnyatBuddha', 'drbhatta'], 'tweet_urls': ['https://t.co/L4pQYFIOwt'], 'tweet_date': '2021-09-23T00:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The Pfizer vaccine has been shown to be safe in school-age children, a potentially key development in the fight to bring the pandemic under control. But experts say agency must make final call on safety, efficacy     \\n'}, {'verified': False, 'country': 'USA', 'id': '1440830885423505414', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Awesome mRNA vaccine news. \\u2066@moderna_tx\\u2069 FTW. &gt;90% efficacy at &gt;120 days &amp; counting = \ud83d\udc89\ud83e\uddbe\ud83d\udcaf @medpagetoday: \u201cOne COVID Vaccine Held Up Best Over Time, CDC Study Suggests.\u201d $MRNA #getvaccinated #dontdie #getthejab  https://t.co/UggwDoEobW', 'tweet_lang': 'en', 'hashtags': ['getvaccinated', 'dontdie', 'getthejab'], 'mentions': ['moderna_tx', 'medpagetoday'], 'tweet_urls': ['https://t.co/UggwDoEobW'], 'tweet_date': '2021-09-23T00:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Awesome mRNA vaccine news. \\u2066\\u2069 FTW. &gt;90% efficacy at &gt;120 days &amp; counting = \ud83d\udc89\ud83e\uddbe\ud83d\udcaf : \u201cOne COVID Vaccine Held Up Best Over Time, CDC Study Suggests.\u201d $MRNA     '}, {'verified': False, 'country': 'USA', 'id': '1440830531898200077', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Expect a fast turnaround when data is submitted for a children's #COVID-19 #vaccine. The #FDA has received additional funding to dedicate time and resources to the data review. Multi-disciplinary experts will follow all required steps to ensure vaccine safety and efficacy. https://t.co/prh3z5dZ0Y\", 'tweet_lang': 'en', 'hashtags': ['COVID', 'vaccine', 'FDA'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T00:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Expect a fast turnaround when data is submitted for a children's -19 . The  has received additional funding to dedicate time and resources to the data review. Multi-disciplinary experts will follow all required steps to ensure vaccine safety and efficacy. https://t.co/prh3z5dZ0Y\"}, {'verified': False, 'country': 'USA', 'id': '1440828690154209286', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Example of Facebook influence:\\nMe: Here\\'s three articles from Johns Hopkins, New England Journal of Medicine and Yale declaring the efficacy of the vaccines.... (two likes)\\nGuy I know: \"The vaccine is monkey piss\".... (365 likes)', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T00:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Example of Facebook influence:\\nMe: Here\\'s three articles from Johns Hopkins, New England Journal of Medicine and Yale declaring the efficacy of the vaccines.... (two likes)\\nGuy I know: \"The vaccine is monkey piss\".... (365 likes)'}, {'verified': False, 'country': 'USA', 'id': '1440827175796572164', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Good summary, @NEJM \\n\\n\"In this audio interview conducted Sept 21, 2021, the editors discuss vaccine booster recommendations from an FDA advisory committee, as well as new data on #SARSCoV2 vaccine effectiveness.\"\\n\\nVaccine Efficacy and #Boosters in #Covid19\\nhttps://t.co/v2kWnNM0wo', 'tweet_lang': 'en', 'hashtags': ['SARSCoV2', 'Boosters', 'Covid19'], 'mentions': ['NEJM'], 'tweet_urls': ['https://t.co/v2kWnNM0wo'], 'tweet_date': '2021-09-23T00:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Good summary,  \\n\\n\"In this audio interview conducted Sept 21, 2021, the editors discuss vaccine booster recommendations from an FDA advisory committee, as well as new data on  vaccine effectiveness.\"\\n\\nVaccine Efficacy and  in \\n'}, {'verified': False, 'country': 'USA', 'id': '1440826588489084935', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Quick! List the chemical compositions, efficacy and contraindications of every vaccine and medication that you\u2019ve ever had in your life.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-23T00:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Quick! List the chemical compositions, efficacy and contraindications of every vaccine and medication that you\u2019ve ever had in your life.'}, {'verified': False, 'country': 'USA', 'id': '1440824697923399690', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded\\xa0Phase https://t.co/qoDRhP8AOk', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/qoDRhP8AOk'], 'tweet_date': '2021-09-23T00:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded\\xa0Phase '}, {'verified': False, 'country': 'USA', 'id': '1440822477777616898', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase - https://t.co/kuPP2R4LWk https://t.co/nz29MqRJ1L', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/kuPP2R4LWk', 'https://t.co/nz29MqRJ1L'], 'tweet_date': '2021-09-23T00:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase -  '}, {'verified': False, 'country': 'USA', 'id': '1440819653794680835', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Fact check: False\\n\"Pfizer Comirnaty vax has been proven safe &amp; effective for children under 12!\"\\nReality: Its safety is debatable, but they definitely have yet to prove efficacy. Because the non-vax\\'d children in their study aren\\'t getting sick, either: https://t.co/cL6x72iMl9', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/cL6x72iMl9'], 'tweet_date': '2021-09-22T23:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Fact check: False\\n\"Pfizer Comirnaty vax has been proven safe &amp; effective for children under 12!\"\\nReality: Its safety is debatable, but they definitely have yet to prove efficacy. Because the non-vax\\'d children in their study aren\\'t getting sick, either: '}, {'verified': False, 'country': 'USA', 'id': '1440819434742960134', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A lot of chatter about how Moderna is the best vaccine but like, nah dude, whatever vaccine you got shot in your arm is the best. Efficacy waning is a normal thing for vaccines to do, and boosters are also normal. Stop comparing numbers like nerds.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T23:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A lot of chatter about how Moderna is the best vaccine but like, nah dude, whatever vaccine you got shot in your arm is the best. Efficacy waning is a normal thing for vaccines to do, and boosters are also normal. Stop comparing numbers like nerds.'}, {'verified': False, 'country': 'USA', 'id': '1440817720375713801', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of Moderna vaccine against #COVID19 &amp; severe disease was maintained for &gt;5 mo. after 2nd dose among all subgroups in trial, including those at risk for severe complications. Asymptomatic #SARSCoV2 infections were also reduced. https://t.co/vppaPoJOfM @NEJM', 'tweet_lang': 'en', 'hashtags': ['COVID19', 'SARSCoV2'], 'mentions': ['NEJM'], 'tweet_urls': ['https://t.co/vppaPoJOfM'], 'tweet_date': '2021-09-22T23:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of Moderna vaccine against  &amp; severe disease was maintained for &gt;5 mo. after 2nd dose among all subgroups in trial, including those at risk for severe complications. Asymptomatic  infections were also reduced.  '}, {'verified': False, 'country': 'USA', 'id': '1440817521737666560', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The Lancet Peer reviewed study confirms efficacy, not as 95% stated by the vaccine companies, but as\\nAstra Zeneca 1.3%\\nModerna 1.2%J&amp;J 1.2%\\nPfizer 0.84%\\nThey deceived everyone by presenting the Relative Risk Reduction (RRR) rather than Absolute Risk Reduction (ARR). https://t.co/lP1YROdgbi', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/lP1YROdgbi'], 'tweet_date': '2021-09-22T23:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The Lancet Peer reviewed study confirms efficacy, not as 95% stated by the vaccine companies, but as\\nAstra Zeneca 1.3%\\nModerna 1.2%J&amp;J 1.2%\\nPfizer 0.84%\\nThey deceived everyone by presenting the Relative Risk Reduction (RRR) rather than Absolute Risk Reduction (ARR). '}, {'verified': False, 'country': 'USA', 'id': '1440817499692437510', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'New article: Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase https://t.co/R5yrJs6Bh0 #coronavirus #COVID19 #2019ncov https://t.co/rxr6kZbLTG', 'tweet_lang': 'en', 'hashtags': ['coronavirus', 'COVID19', '2019ncov'], 'mentions': [], 'tweet_urls': ['https://t.co/R5yrJs6Bh0'], 'tweet_date': '2021-09-22T23:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'New article: Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase     https://t.co/rxr6kZbLTG'}, {'verified': True, 'country': 'USA', 'id': '1440816945029279744', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The study focuses on prolonged efficacy of the vaccine, and it is still under peer review. https://t.co/MQFbbkPfaS', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/MQFbbkPfaS'], 'tweet_date': '2021-09-22T23:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The study focuses on prolonged efficacy of the vaccine, and it is still under peer review. '}, {'verified': False, 'country': 'USA', 'id': '1440816822303875077', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The study focuses on prolonged efficacy of the vaccine, and it is still under peer review. https://t.co/gYMm5qENKu', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/gYMm5qENKu'], 'tweet_date': '2021-09-22T23:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The study focuses on prolonged efficacy of the vaccine, and it is still under peer review. '}, {'verified': False, 'country': 'USA', 'id': '1440812900008955907', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Interesting analysis of Sinovac real world impact in Malaysia - efficacy not as high as Pfizer, but still highly effective - breakthrough infections and deaths are uncommon with any vaccine used https://t.co/mCXgrFeu3F', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/mCXgrFeu3F'], 'tweet_date': '2021-09-22T23:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Interesting analysis of Sinovac real world impact in Malaysia - efficacy not as high as Pfizer, but still highly effective - breakthrough infections and deaths are uncommon with any vaccine used '}, {'verified': False, 'country': 'USA', 'id': '1440811584071213069', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/ocBRYIqRmy', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ocBRYIqRmy'], 'tweet_date': '2021-09-22T23:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1440809893275987970', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM https://t.co/P6IMCwUvUy', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/P6IMCwUvUy'], 'tweet_date': '2021-09-22T23:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM '}, {'verified': False, 'country': 'USA', 'id': '1440808015318290437', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Phase 3 #Moderna #vaccine results in 30,415 participants where &gt;96% of participants received both injections with a median follow-up of 5.3 months showed:\\n-93% efficacy in preventing #covid19\\n-98.2% efficacy in preventing severe disease\\n\\nhttps://t.co/KAwICScQu0', 'tweet_lang': 'en', 'hashtags': ['Moderna', 'vaccine', 'covid19'], 'mentions': [], 'tweet_urls': ['https://t.co/KAwICScQu0'], 'tweet_date': '2021-09-22T23:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Phase 3   results in 30,415 participants where &gt;96% of participants received both injections with a median follow-up of 5.3 months showed:\\n-93% efficacy in preventing \\n-98.2% efficacy in preventing severe disease\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440806145531076608', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'good thread on vaccine efficacy https://t.co/xAjbKAq4BX', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/xAjbKAq4BX'], 'tweet_date': '2021-09-22T23:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'good thread on vaccine efficacy '}, {'verified': False, 'country': 'USA', 'id': '1440805344012234753', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'When they say 95% effectiveness they mean relative not absolute\\n\\nOf two 21.8k person samples 162 with the placebo, or .79% got covid and only 8 with the vaccine, or .04% got covid.  8 is 95% less than 160 which is the relative effectiveness\\n\\nhttps://t.co/2Gao8YeAKs', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/2Gao8YeAKs'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'When they say 95% effectiveness they mean relative not absolute\\n\\nOf two 21.8k person samples 162 with the placebo, or .79% got covid and only 8 with the vaccine, or .04% got covid.  8 is 95% less than 160 which is the relative effectiveness\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440802879938252806', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"there's a extremely recurrent pattern, with vaccine efficacy being the current salient example, of experts communicating with the public using statistics that are great for researchers but really misleading for anyone else\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"there's a extremely recurrent pattern, with vaccine efficacy being the current salient example, of experts communicating with the public using statistics that are great for researchers but really misleading for anyone else\"}, {'verified': False, 'country': 'USA', 'id': '1440802396783869953', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM #Novavax 89% VE against Alpha and prior variants https://t.co/vA5CUjJWTz', 'tweet_lang': 'en', 'hashtags': ['Novavax'], 'mentions': [], 'tweet_urls': ['https://t.co/vA5CUjJWTz'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM  89% VE against Alpha and prior variants '}, {'verified': True, 'country': 'USA', 'id': '1440802086120083470', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase @NEJM  https://t.co/gIAHJCfNFD Vaccine efficacy in preventing Covid-19 illness was 93.2% and 98.2% in preventing severe disease. Efficacy in preventing asymptomatic infection was 63.0%.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['NEJM'], 'tweet_urls': ['https://t.co/gIAHJCfNFD'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase    Vaccine efficacy in preventing Covid-19 illness was 93.2% and 98.2% in preventing severe disease. Efficacy in preventing asymptomatic infection was 63.0%.'}, {'verified': False, 'country': 'USA', 'id': '1440800963535663115', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Final analysis of US-funded Moderna Covid vaccine trial shows 98% efficacy against severe disease https://t.co/KJL5rio9Vc #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #pharma #healthcare #productmarketing https://t.co/NTJxU72jxE', 'tweet_lang': 'en', 'hashtags': ['strategy', 'competitiveintelligence', 'marketing', 'biotech', 'pharmaceutical', 'pharma', 'healthcare', 'productmarketing'], 'mentions': [], 'tweet_urls': ['https://t.co/KJL5rio9Vc'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Final analysis of US-funded Moderna Covid vaccine trial shows 98% efficacy against severe disease          https://t.co/NTJxU72jxE'}, {'verified': False, 'country': 'USA', 'id': '1440799949201965058', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\"Many speakers doubted the COVID vaccine\u2019s efficacy and some expressed a deep distrust of the media.\"\\nYup. \\nLawmakers Hear From Those Concerned About Vaccine Mandates https://t.co/iRp0qtdG6h via @CTNewsJunkie', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['ctnewsjunkie'], 'tweet_urls': ['https://t.co/iRp0qtdG6h'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\"Many speakers doubted the COVID vaccine\u2019s efficacy and some expressed a deep distrust of the media.\"\\nYup. \\nLawmakers Hear From Those Concerned About Vaccine Mandates  via @CTNewsJunkie'}, {'verified': False, 'country': 'USA', 'id': '1440799887130431498', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"I've said this before, but I'm going to say it again: \\n\\nThe denial of climate change or vaccine efficacy/safety is bad not just because of the obvious primary negative effects they have, but also because such beliefs undermine our societies belief in science and innovation.\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"I've said this before, but I'm going to say it again: \\n\\nThe denial of climate change or vaccine efficacy/safety is bad not just because of the obvious primary negative effects they have, but also because such beliefs undermine our societies belief in science and innovation.\"}, {'verified': False, 'country': 'USA', 'id': '1440799344693633025', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Scientists had hoped that the vaccines would have an efficacy of 50 or 60 percent. We would have all seen that as great result, now we\u2019re debating whether 96.3 percent vaccine efficacy for Moderna versus 88.8 percent for Pfizer is a big deal. https://t.co/gswTtahwTK Tx science!', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/gswTtahwTK'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Scientists had hoped that the vaccines would have an efficacy of 50 or 60 percent. We would have all seen that as great result, now we\u2019re debating whether 96.3 percent vaccine efficacy for Moderna versus 88.8 percent for Pfizer is a big deal.  Tx science!'}, {'verified': False, 'country': 'USA', 'id': '1440797208178167811', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Join us tomorrow 2p EDT when @jbloom_lab @sarahcobey @KoelleLab @dylanhmorris discuss research about how coronavirus evolution can impact immunity and vaccine efficacy, p/b the @ASMicrobiology COVID-19 Research Registry https://t.co/FoXsbpOpOQ', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['jbloom_lab', 'sarahcobey', 'KoelleLab', 'dylanhmorris', 'ASMicrobiology'], 'tweet_urls': ['https://t.co/FoXsbpOpOQ'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Join us tomorrow 2p EDT when     discuss research about how coronavirus evolution can impact immunity and vaccine efficacy, p/b the  COVID-19 Research Registry '}, {'verified': False, 'country': 'USA', 'id': '1440796697899143171', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#Cuba #Havana, Sept.22 (RHC/Prensa Latina) \\n\u201cThe Center for Genetic Engineering and Biotechnology (#CIGB) reported that its #Abdala #Covid_19 vaccine has an efficacy rate of 90% in seriously ill patients affected by the #SARS_CoV_2 virus.\u201d\ud83d\udc4f\ud83c\udffd\ud83d\udc4f\ud83c\udffd\ud83d\udcaa\ud83c\udffdhttps://t.co/TTmBVRWAMo', 'tweet_lang': 'en', 'hashtags': ['Cuba', 'Havana', 'CIGB', 'Abdala', 'Covid_19', 'SARS_CoV_2'], 'mentions': [], 'tweet_urls': ['https://t.co/TTmBVRWAMo'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' , Sept.22 (RHC/Prensa Latina) \\n\u201cThe Center for Genetic Engineering and Biotechnology () reported that its   vaccine has an efficacy rate of 90% in seriously ill patients affected by the  virus.\u201d\ud83d\udc4f\ud83c\udffd\ud83d\udc4f\ud83c\udffd\ud83d\udcaa\ud83c\udffd'}, {'verified': False, 'country': 'USA', 'id': '1440795993822273540', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'At the close of the blinded phase of the mRNA-1273 vaccine trial, the efficacy in preventing COVID19 illness was 93.2% and against severe disease was 98.2%\\n\\nhttps://t.co/LRS47eo04f', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/LRS47eo04f'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'At the close of the blinded phase of the mRNA-1273 vaccine trial, the efficacy in preventing COVID19 illness was 93.2% and against severe disease was 98.2%\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440795032051601408', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Those results highlights a problem with the \"vaccine efficacy\" metric, which is that it decreases with exposure, even when exposure is the same for vaccinated and unvaccinated people. So the exact same vaccine will come out as more or less \"effective\" in different contexts. https://t.co/lOArxqPIUu', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/lOArxqPIUu'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Those results highlights a problem with the \"vaccine efficacy\" metric, which is that it decreases with exposure, even when exposure is the same for vaccinated and unvaccinated people. So the exact same vaccine will come out as more or less \"effective\" in different contexts. '}, {'verified': True, 'country': 'USA', 'id': '1440794288539897856', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'At the close of the blinded phase of the mRNA-1273 vaccine trial, the efficacy in preventing #COVID19 illness was 93.2% and against severe disease was 98.2%. #IDTwitter https://t.co/ZKUYqYl2mb https://t.co/cZrAy0TEJu', 'tweet_lang': 'en', 'hashtags': ['COVID19', 'IDTwitter'], 'mentions': [], 'tweet_urls': ['https://t.co/ZKUYqYl2mb'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'At the close of the blinded phase of the mRNA-1273 vaccine trial, the efficacy in preventing  illness was 93.2% and against severe disease was 98.2%.   https://t.co/cZrAy0TEJu'}, {'verified': False, 'country': 'USA', 'id': '1440794199079616522', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Why don't the Dims want an honest discussion about the efficacy of the vaccine and the possible benefits of drugs like Ivermectin?\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Why don't the Dims want an honest discussion about the efficacy of the vaccine and the possible benefits of drugs like Ivermectin?\"}, {'verified': False, 'country': 'USA', 'id': '1440793595401760778', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s Vaccine Efficacy May Be Winning Out Over Pfizer\u2019s Against COVID @NYTimes \\u2066@moderna_tx\\u2069 \\u2066@pfizer\\u2069 \\u2066@BioNTech_Group\\u2069 \\u2066@CDCgov\\u2069 \\u2066@US_FDA\\u2069 \\u2066@emoryhealthcare\\u2069 #COVID19 #covidvaccine #pfizer #moderna #getvaccinated https://t.co/1qscNOt5GM', 'tweet_lang': 'en', 'hashtags': ['COVID19', 'covidvaccine', 'pfizer', 'moderna', 'getvaccinated'], 'mentions': ['nytimes', 'moderna_tx', 'pfizer', 'BioNTech_Group', 'CDCgov', 'US_FDA', 'emoryhealthcare'], 'tweet_urls': ['https://t.co/1qscNOt5GM'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s Vaccine Efficacy May Be Winning Out Over Pfizer\u2019s Against COVID @NYTimes \\u2066\\u2069 \\u2066\\u2069 \\u2066\\u2069 \\u2066\\u2069 \\u2066\\u2069 \\u2066\\u2069      '}, {'verified': False, 'country': 'USA', 'id': '1440793255524798471', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Safety and Efficacy of $NVAX NVX-CoV2373 Covid-19 Vaccine\\nhttps://t.co/Iqb8HZw0gc https://t.co/pTOusAJGjJ', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Iqb8HZw0gc'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Safety and Efficacy of $NVAX NVX-CoV2373 Covid-19 Vaccine\\n https://t.co/pTOusAJGjJ'}, {'verified': False, 'country': 'USA', 'id': '1440792747141582855', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the $MRNA mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase  https://t.co/HII4bnozCy https://t.co/deVJbS5gEd', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/HII4bnozCy'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the $MRNA mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase   https://t.co/deVJbS5gEd'}, {'verified': True, 'country': 'USA', 'id': '1440792389644218371', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Final analysis of US-funded 30k+ Moderna Covid vaccine trial in NEJM shows 98% efficacy against severe disease - and for preventing asymptomatic infection 14 days post-2nd shot, efficacy was 63%, w/214 asymp. cases in the Spikevax group and 498 in placebo https://t.co/kHHmGfy7t0', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/kHHmGfy7t0'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Final analysis of US-funded 30k+ Moderna Covid vaccine trial in NEJM shows 98% efficacy against severe disease - and for preventing asymptomatic infection 14 days post-2nd shot, efficacy was 63%, w/214 asymp. cases in the Spikevax group and 498 in placebo '}, {'verified': False, 'country': 'USA', 'id': '1440792100711251969', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Radio Havana Cuba | Cuban vaccine Abdala has high efficacy rate in serious COVID-19 patients: https://t.co/UFaOlQMX46 @RadioHabanaCuba', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['RadioHabanaCuba'], 'tweet_urls': ['https://t.co/UFaOlQMX46'], 'tweet_date': '2021-09-22T22:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Radio Havana Cuba | Cuban vaccine Abdala has high efficacy rate in serious COVID-19 patients:  '}, {'verified': False, 'country': 'USA', 'id': '1440788939938226188', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'INOVIO recibe autorizaci\u00f3n regulatoria para realizar una prueba de eficacia de fase 3 de su candidata a la vacuna de ADN COVID-19, INO-4800, en #M\u00e9xico.\\nhttps://t.co/4wcSKY2ddF', 'tweet_lang': 'en', 'hashtags': ['M\u00e9xico'], 'mentions': [], 'tweet_urls': ['https://t.co/4wcSKY2ddF'], 'tweet_date': '2021-09-22T21:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'INOVIO recibe autorizaci\u00f3n regulatoria para realizar una prueba de eficacia de fase 3 de su candidata a la vacuna de ADN COVID-19, INO-4800, en .\\n'}, {'verified': False, 'country': 'USA', 'id': '1440787490592354306', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\"..efficacy of the Pfizer-BioNTech vaccine against hospitalization\\xa0fell from 91 percent to 77 percent\\xa0after a four-month period following the second shot.Moderna vaccine showed no decline over the same period.\" Get vaxxed\\nhttps://t.co/IRSBRxFFlO', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/IRSBRxFFlO'], 'tweet_date': '2021-09-22T21:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\"..efficacy of the Pfizer-BioNTech vaccine against hospitalization\\xa0fell from 91 percent to 77 percent\\xa0after a four-month period following the second shot.Moderna vaccine showed no decline over the same period.\" Get vaxxed\\n'}, {'verified': False, 'country': 'USA', 'id': '1440783851601596417', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Final analysis of US-funded Moderna Covid vaccine trial shows 98% efficacy against severe disease https://t.co/gVwzcrWqsz', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/gVwzcrWqsz'], 'tweet_date': '2021-09-22T21:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Final analysis of US-funded Moderna Covid vaccine trial shows 98% efficacy against severe disease '}, {'verified': True, 'country': 'USA', 'id': '1440783685490380805', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months new study shows https://t.co/RbSd5EnFuh', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/RbSd5EnFuh'], 'tweet_date': '2021-09-22T21:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine efficacy held strong, did not wane after 5 months new study shows '}, {'verified': True, 'country': 'USA', 'id': '1440783349929299983', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The vaccines are safe and effective for pregnant women and they do not pass to your baby. There is robust data that demonstrates the safety and efficacy of these vaccines during pregnancy. \\n\\nIf you have questions, talk to your OB or midwife.\\n\\nSelf-schedule your vaccine at: Vaccin https://t.co/4c5YGoF8j3', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T21:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The vaccines are safe and effective for pregnant women and they do not pass to your baby. There is robust data that demonstrates the safety and efficacy of these vaccines during pregnancy. \\n\\nIf you have questions, talk to your OB or midwife.\\n\\nSelf-schedule your vaccine at: Vaccin https://t.co/4c5YGoF8j3'}, {'verified': False, 'country': 'USA', 'id': '1440781229851234308', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'This is good if you got Moderna: CDC research published Friday found the efficacy of the Pfizer-BioNTech vaccine against hospitalization fell from 91 to 77 percent after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T21:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'This is good if you got Moderna: CDC research published Friday found the efficacy of the Pfizer-BioNTech vaccine against hospitalization fell from 91 to 77 percent after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period.'}, {'verified': False, 'country': 'USA', 'id': '1440780441146044416', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T2a. In summary, there is still much to be learned on how to best assess COVID-19 vaccine efficacy in patients with CKD. mABs are a useful tool to fight against SARS-COV2 though a lot of barriers to adoption and distribution remain. #NephJC', 'tweet_lang': 'en', 'hashtags': ['NephJC'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T21:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T2a. In summary, there is still much to be learned on how to best assess COVID-19 vaccine efficacy in patients with CKD. mABs are a useful tool to fight against SARS-COV2 though a lot of barriers to adoption and distribution remain. '}, {'verified': False, 'country': 'USA', 'id': '1440780357276557312', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"I want Pfizer vaccine.  I want the same type of vaccine as Scummo had. The Olympic squad had. I vote and I pay tax. \\nSo how come I'm stuck with no choice? Az 11% and 49% efficacy with Delta. Many died here from side affectsNot approved for overseas travel either?\\n#Wheresmypfizer\", 'tweet_lang': 'en', 'hashtags': ['Wheresmypfizer'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T21:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"I want Pfizer vaccine.  I want the same type of vaccine as Scummo had. The Olympic squad had. I vote and I pay tax. \\nSo how come I'm stuck with no choice? Az 11% and 49% efficacy with Delta. Many died here from side affectsNot approved for overseas travel either?\\n\"}, {'verified': False, 'country': 'USA', 'id': '1440779372433010692', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Two key aspects to vaccine decision making. \\xa0Efficacy and safety. \\xa0This report only addresses one of those. \\xa0I am getting so, so tired of this gaming by the press.\\u3000#EPSEMS\\n\uff08The Washington Post\uff09\\nhttps://t.co/8noYiCnYQg https://t.co/FNgpX5p2tq', 'tweet_lang': 'en', 'hashtags': ['EPSEMS'], 'mentions': [], 'tweet_urls': ['https://t.co/8noYiCnYQg'], 'tweet_date': '2021-09-22T21:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Two key aspects to vaccine decision making. \\xa0Efficacy and safety. \\xa0This report only addresses one of those. \\xa0I am getting so, so tired of this gaming by the press.\\u3000\\n\uff08The Washington Post\uff09\\n https://t.co/FNgpX5p2tq'}, {'verified': True, 'country': 'USA', 'id': '1440778417855610882', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\"the efficacy of the Pfizer-BioNTech vaccine against hospitalization\\xa0fell from 91 percent to 77 percent\\xa0after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period.\"\\n\\n https://t.co/EuDyXafMhf', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/EuDyXafMhf'], 'tweet_date': '2021-09-22T21:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\"the efficacy of the Pfizer-BioNTech vaccine against hospitalization\\xa0fell from 91 percent to 77 percent\\xa0after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period.\"\\n\\n '}, {'verified': False, 'country': 'USA', 'id': '1440776198062104581', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'In March/April 2021, Rodney the homeless blind man post data that was coming out off Israel about the efficacy of the Pfizer accident. Toronto, Ontario Vaccine passport, UK, EU, Trudeau, Israeli Star of ISIS, AstraZeneca, moderna, Election, NDP, CPC,https://t.co/paAPCpmvD5', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T21:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'In March/April 2021, Rodney the homeless blind man post data that was coming out off Israel about the efficacy of the Pfizer accident. Toronto, Ontario Vaccine passport, UK, EU, Trudeau, Israeli Star of ISIS, AstraZeneca, moderna, Election, NDP, CPC,https://t.co/paAPCpmvD5'}, {'verified': False, 'country': 'USA', 'id': '1440774731959975939', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\u0622\u06cc\u0627 \u0646\u06cc\u0627\u0632\u06cc \u0628\u0647 \u062a\u0633\u062a \u0622\u0646\u062a\u06cc\\u200c\u0628\u0627\u062f\u06cc \u0628\u0631\u0627\u06cc \u0628\u0631\u0631\u0633\u06cc \u0627\u062b\u0631\u0628\u062e\u0634\u06cc \u0648\u0627\u06a9\u0633\u0646 \u0648\u062c\u0648\u062f \u062f\u0627\u0631\u062f\u061f (https://t.co/WFWIrjDupc)                                                       #\u062a\u0633\u062a_\u0622\u0646\u062a\u06cc\\u200c\u0628\u0627\u062f\u06cc\\n#\u0627\u0633\u067e\u0627\u06cc\u06a9\u0648\u0698\u0646\\n#\u06a9\u0631\u0648\u0646\u0627\\n#\u0648\u0627\u06a9\u0633\u0646_\u06a9\u0631\u0648\u0646\u0627\\n#\u062a\u0633\u062a_\u0622\u0646\u062a\u06cc\\u200c\u0628\u0627\u062f\u06cc_\u0648\u0627\u06a9\u0633\u0646_\u06a9\u0631\u0648\u0646\u0627\\n#\u062a\u0633\u062a_\u0622\u0646\u062a\u06cc\\u200c\u0628\u0627\u062f\u06cc_\u06a9\u0631\u0648\u0646\u0627\\nhttps://t.co/WoqAHCP4mz https://t.co/ttxOu0PiJ0', 'tweet_lang': 'en', 'hashtags': ['\u062a\u0633\u062a_\u0622\u0646\u062a\u06cc\\u200c\u0628\u0627\u062f\u06cc', '\u0627\u0633\u067e\u0627\u06cc\u06a9\u0648\u0698\u0646', '\u06a9\u0631\u0648\u0646\u0627', '\u0648\u0627\u06a9\u0633\u0646_\u06a9\u0631\u0648\u0646\u0627', '\u062a\u0633\u062a_\u0622\u0646\u062a\u06cc\\u200c\u0628\u0627\u062f\u06cc_\u0648\u0627\u06a9\u0633\u0646_\u06a9\u0631\u0648\u0646\u0627', '\u062a\u0633\u062a_\u0622\u0646\u062a\u06cc\\u200c\u0628\u0627\u062f\u06cc_\u06a9\u0631\u0648\u0646\u0627'], 'mentions': [], 'tweet_urls': ['https://t.co/WFWIrjDupc', 'https://t.co/WoqAHCP4mz'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\u0622\u06cc\u0627 \u0646\u06cc\u0627\u0632\u06cc \u0628\u0647 \u062a\u0633\u062a \u0622\u0646\u062a\u06cc\\u200c\u0628\u0627\u062f\u06cc \u0628\u0631\u0627\u06cc \u0628\u0631\u0631\u0633\u06cc \u0627\u062b\u0631\u0628\u062e\u0634\u06cc \u0648\u0627\u06a9\u0633\u0646 \u0648\u062c\u0648\u062f \u062f\u0627\u0631\u062f\u061f ()                                                       \\n\\n\\n\\n_\u0648\u0627\u06a9\u0633\u0646_\u06a9\u0631\u0648\u0646\u0627\\n_\u06a9\u0631\u0648\u0646\u0627\\n https://t.co/ttxOu0PiJ0'}, {'verified': False, 'country': 'USA', 'id': '1440773989798842380', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Research findings posted by #USA \\u2066@CDCgov\\u2069 found efficacy of the #Pfizer #SarsCov2 vaccine against a #covid19 hospitalization, fell from 91% to 77%, after a four-month, second-shot period. The #Moderna #vaccine showed no decline over the same period: https://t.co/TMPyEpGdU0', 'tweet_lang': 'en', 'hashtags': ['USA', 'Pfizer', 'SarsCov2', 'covid19', 'Moderna', 'vaccine'], 'mentions': ['CDCgov'], 'tweet_urls': ['https://t.co/TMPyEpGdU0'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Research findings posted by  \\u2066\\u2069 found efficacy of the   vaccine against a  hospitalization, fell from 91% to 77%, after a four-month, second-shot period. The   showed no decline over the same period: '}, {'verified': True, 'country': 'USA', 'id': '1440773401778397185', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"This week's #EaglesEyeView summarizes articles on empagliflozin improving #CV outcomes irrespective of blood pressure, the efficacy of the #COVID19 vaccine at 6 months post-vaccination, &amp; more. Listen to the full episode here: https://t.co/g4XX6v2VVQ @keaglemd https://t.co/2o8ucpkmSP\", 'tweet_lang': 'en', 'hashtags': ['EaglesEyeView', 'CV', 'COVID19'], 'mentions': ['keaglemd'], 'tweet_urls': ['https://t.co/g4XX6v2VVQ'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"This week's  summarizes articles on empagliflozin improving  outcomes irrespective of blood pressure, the efficacy of the  vaccine at 6 months post-vaccination, &amp; more. Listen to the full episode here:   https://t.co/2o8ucpkmSP\"}, {'verified': False, 'country': 'USA', 'id': '1440772033780928514', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'FDA Rejects Pfizer\u2019s Initiative to Offer Booster Jabs After Reports on Vaccine\u2019s Plummeting Efficacy https://t.co/0OAcrOomeI', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/0OAcrOomeI'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'FDA Rejects Pfizer\u2019s Initiative to Offer Booster Jabs After Reports on Vaccine\u2019s Plummeting Efficacy '}, {'verified': False, 'country': 'USA', 'id': '1440771633191526401', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T0g: Here is a table summarizing COVID-19 vaccine efficacy in transplant patients. There is poor effect in terms of antibodies and cellular response. Immunosuppressive agents might interfere with the antigen presentation with the mRNA vaccines \u2192 Leading to booster dose!  #NephJC https://t.co/7URCu6bTvf', 'tweet_lang': 'en', 'hashtags': ['NephJC'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T0g: Here is a table summarizing COVID-19 vaccine efficacy in transplant patients. There is poor effect in terms of antibodies and cellular response. Immunosuppressive agents might interfere with the antigen presentation with the mRNA vaccines \u2192 Leading to booster dose!   https://t.co/7URCu6bTvf'}, {'verified': False, 'country': 'USA', 'id': '1440771530321895435', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Research posted by #USA \\u2066@CDCgov\\u2069 found efficacy of the #Pfizer #covid19 vaccine against hospitalization, fell from 91% to 77% after a four-month period following a second shot. The #Moderna #sarscov2 vaccine showed no decline over the same period. https://t.co/Vj0KJxFsrN', 'tweet_lang': 'en', 'hashtags': ['USA', 'Pfizer', 'covid19', 'Moderna', 'sarscov2'], 'mentions': ['CDCgov'], 'tweet_urls': ['https://t.co/Vj0KJxFsrN'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Research posted by  \\u2066\\u2069 found efficacy of the   vaccine against hospitalization, fell from 91% to 77% after a four-month period following a second shot. The   vaccine showed no decline over the same period. '}, {'verified': False, 'country': 'USA', 'id': '1440770626843668480', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T0f: Here is a summary of COVID-19 vaccine efficacy in dialysis patients. antibody response after 1 dose is suboptimal and increases after 2 doses\\n #NephJC https://t.co/osZBYDPLZW', 'tweet_lang': 'en', 'hashtags': ['NephJC'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T0f: Here is a summary of COVID-19 vaccine efficacy in dialysis patients. antibody response after 1 dose is suboptimal and increases after 2 doses\\n  https://t.co/osZBYDPLZW'}, {'verified': False, 'country': 'USA', 'id': '1440770374849888256', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T0e: Assessing vaccine efficacy has been also addressed by @EdjCarr. Check out https://t.co/TORLhhiViu and https://t.co/TuNVTWsU4Q\\nWhat are your thoughts? #NephJC', 'tweet_lang': 'en', 'hashtags': ['NephJC'], 'mentions': ['EdjCarr'], 'tweet_urls': ['https://t.co/TORLhhiViu', 'https://t.co/TuNVTWsU4Q'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T0e: Assessing vaccine efficacy has been also addressed by . Check out  and \\nWhat are your thoughts? '}, {'verified': False, 'country': 'USA', 'id': '1440769871525015564', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T0c: How should we assess vaccine efficacy among CKD patients? #NephJC\\n\\n1- Antibody titer\\n2- Antibody threshold\\n3- Cellular Response\\n4- Infection/Hospitalization/Death\\n5-All', 'tweet_lang': 'en', 'hashtags': ['NephJC'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T0c: How should we assess vaccine efficacy among CKD patients? \\n\\n1- Antibody titer\\n2- Antibody threshold\\n3- Cellular Response\\n4- Infection/Hospitalization/Death\\n5-All'}, {'verified': False, 'country': 'USA', 'id': '1440769368175022081', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T0a: I honestly am still waiting for the pandemic to pass, but since we are still dealing with COVID-19 let\u2019s delve into vaccine efficacy in kidney patients. Here is an excellent resource that we will be using https://t.co/9JoPozVGcb  #NephJC', 'tweet_lang': 'en', 'hashtags': ['NephJC'], 'mentions': [], 'tweet_urls': ['https://t.co/9JoPozVGcb'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T0a: I honestly am still waiting for the pandemic to pass, but since we are still dealing with COVID-19 let\u2019s delve into vaccine efficacy in kidney patients. Here is an excellent resource that we will be using   '}, {'verified': False, 'country': 'USA', 'id': '1440768318772711432', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'There is no \u201cmainstream narrative\u201d. Conspiracy theorists who say \u201cfollow the money\u201d are the opposite of \u201ccritical thinkers\u201d. When the data is so overwhelming in support of vaccine efficacy, people who spout nonsense about ivermectin are nothing but equivalent of 9/11 truthers. https://t.co/uWYZyXZ5Ls', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/uWYZyXZ5Ls'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'There is no \u201cmainstream narrative\u201d. Conspiracy theorists who say \u201cfollow the money\u201d are the opposite of \u201ccritical thinkers\u201d. When the data is so overwhelming in support of vaccine efficacy, people who spout nonsense about ivermectin are nothing but equivalent of 9/11 truthers. '}, {'verified': False, 'country': 'USA', 'id': '1440768311965282317', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '\"Research published on Friday by the #CDC found the efficacy of the #Pfizer-BioNTech vaccine against hospitalization\\xa0fell from 9% to 77%\\xa0after a four-month period following the second shot. The #Moderna vaccine showed no decline over the same period.\"\\n https://t.co/JDxV4wPmaD', 'tweet_lang': 'en', 'hashtags': ['CDC', 'Pfizer', 'Moderna'], 'mentions': [], 'tweet_urls': ['https://t.co/JDxV4wPmaD'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\"Research published on Friday by the  found the efficacy of the -BioNTech vaccine against hospitalization\\xa0fell from 9% to 77%\\xa0after a four-month period following the second shot. The  vaccine showed no decline over the same period.\"\\n '}, {'verified': False, 'country': 'USA', 'id': '1440764613662953479', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"$DVAX NEW ARTICLE : Dynavax surges 27%, reach 52-week high on partner Clover's COVID vaccine efficacy https://t.co/HId9yIcq4u Get all the latest $DVAX related news here : https://t.co/RqPKzDNLKt\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/HId9yIcq4u', 'https://t.co/RqPKzDNLKt'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"$DVAX NEW ARTICLE : Dynavax surges 27%, reach 52-week high on partner Clover's COVID vaccine efficacy  Get all the latest $DVAX related news here : \"}, {'verified': False, 'country': 'USA', 'id': '1440764578913157129', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Well all you Pfizer bros can eat a dick, Moderna is kicking your ass in efficacy. So much for the Fakebook braggarts pimping there name brand vaccine. Silly fucks.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Well all you Pfizer bros can eat a dick, Moderna is kicking your ass in efficacy. So much for the Fakebook braggarts pimping there name brand vaccine. Silly fucks.'}, {'verified': False, 'country': 'USA', 'id': '1440763737430917123', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Dynavax surges 27%, reach 52-week high on partner Clover's COVID vaccine efficacy $DVAX https://t.co/HCrROE0Hqu\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/HCrROE0Hqu'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Dynavax surges 27%, reach 52-week high on partner Clover's COVID vaccine efficacy $DVAX \"}, {'verified': False, 'country': 'USA', 'id': '1440762762523643913', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"$DVAX - Dynavax surges 27%, reach 52-week high on partner Clover's COVID vaccine efficacy https://t.co/m4dym1eVwt\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/m4dym1eVwt'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"$DVAX - Dynavax surges 27%, reach 52-week high on partner Clover's COVID vaccine efficacy \"}, {'verified': False, 'country': 'USA', 'id': '1440762706382897172', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'There is another way to put it: It is unconstitutional to mandate medical treatments. \\n\\nThe \u201cvaccines\u201d are non-sterilizing (unlike for ex, smallpox vaccine), efficacy rates are plummeting w/ \u201cboosters\u201d necessary\u2014proving the shots to be more of a therapeutic than a prophylactic. https://t.co/MEsIQ9cZS9', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/MEsIQ9cZS9'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'There is another way to put it: It is unconstitutional to mandate medical treatments. \\n\\nThe \u201cvaccines\u201d are non-sterilizing (unlike for ex, smallpox vaccine), efficacy rates are plummeting w/ \u201cboosters\u201d necessary\u2014proving the shots to be more of a therapeutic than a prophylactic. '}, {'verified': False, 'country': 'USA', 'id': '1440762645460623363', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'We are a lot smarter than you @POTUS because we know Natural Immunity is now 27x more powerful than your fading-in-efficacy vaccine that has a long list of side effects, collected from over 2M people, asshole! https://t.co/rZiAFU5a8T https://t.co/Z4W7oG7vlF', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['POTUS'], 'tweet_urls': ['https://t.co/rZiAFU5a8T'], 'tweet_date': '2021-09-22T20:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'We are a lot smarter than you  because we know Natural Immunity is now 27x more powerful than your fading-in-efficacy vaccine that has a long list of side effects, collected from over 2M people, asshole!  https://t.co/Z4W7oG7vlF'}, {'verified': False, 'country': 'USA', 'id': '1440759161013235715', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"We're really okay with social media platforms and mainstream media shutting up and shunning anyone who questions the efficacy of this vaccine..\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"We're really okay with social media platforms and mainstream media shutting up and shunning anyone who questions the efficacy of this vaccine..\"}, {'verified': False, 'country': 'USA', 'id': '1440758415987335170', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'You don\u2019t need to downplay what women experienced post vaccination to avoid discrediting vaccine efficacy. Two things can be true at once. https://t.co/E9bDi2hRAe', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/E9bDi2hRAe'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'You don\u2019t need to downplay what women experienced post vaccination to avoid discrediting vaccine efficacy. Two things can be true at once. '}, {'verified': False, 'country': 'USA', 'id': '1440758270797357062', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Today 3 booster shot, tomorrow 4th booster, then 5th, 12th until you realise that the natural body and immunity God gave you no longer works because you\u2019re living and breathing on endless booster shots\ud83d\ude05. \\nThis is why they take years to test vaccine efficacy not months', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Today 3 booster shot, tomorrow 4th booster, then 5th, 12th until you realise that the natural body and immunity God gave you no longer works because you\u2019re living and breathing on endless booster shots\ud83d\ude05. \\nThis is why they take years to test vaccine efficacy not months'}, {'verified': False, 'country': 'USA', 'id': '1440757287501524999', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Johnson &amp; Johnson says additional dose boosts Covid vaccine efficacy https://t.co/QnBkWw4e0t', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/QnBkWw4e0t'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Johnson &amp; Johnson says additional dose boosts Covid vaccine efficacy '}, {'verified': False, 'country': 'USA', 'id': '1440756325630103554', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Bears can\u2019t see what\u2019s beneath the fraudulent veneers.\\n\\nHow quickly they forgot that the \u201ctapering\u201d was promised THIS MONTH, and then OCTOBER.\\n\\n\u201cNoone could have seen the virus impact coming\u201d\\n\\nActually was pretty obvious vaccine efficacy had fallen off a cliff by June.\\n\\nNo taper.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Bears can\u2019t see what\u2019s beneath the fraudulent veneers.\\n\\nHow quickly they forgot that the \u201ctapering\u201d was promised THIS MONTH, and then OCTOBER.\\n\\n\u201cNoone could have seen the virus impact coming\u201d\\n\\nActually was pretty obvious vaccine efficacy had fallen off a cliff by June.\\n\\nNo taper.'}, {'verified': False, 'country': 'USA', 'id': '1440754806780416007', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of the Measles-Mumps-Rubella (MMR) vaccine in reducing severity of COVID-19: an interim analysis of a RCT https://t.co/SlfCzbnmq5\\n\\nThe MMR vaccine can stimulate the innate immunity:\\nAbout 50% reduction in symptomatic COVID infx\\n77% reduction in need for COVID treatment', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/SlfCzbnmq5'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of the Measles-Mumps-Rubella (MMR) vaccine in reducing severity of COVID-19: an interim analysis of a RCT \\n\\nThe MMR vaccine can stimulate the innate immunity:\\nAbout 50% reduction in symptomatic COVID infx\\n77% reduction in need for COVID treatment'}, {'verified': False, 'country': 'USA', 'id': '1440753659696930822', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Progress!\\n\\nBut the numbers do support the efficacy of a vaccine mandate. The healthcare side of the campus, with a mandate is at 90%, whereas the non-healthcare side, without a mandate is at 84.6%. https://t.co/AAt7rUjHyE', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/AAt7rUjHyE'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Progress!\\n\\nBut the numbers do support the efficacy of a vaccine mandate. The healthcare side of the campus, with a mandate is at 90%, whereas the non-healthcare side, without a mandate is at 84.6%. '}, {'verified': False, 'country': 'USA', 'id': '1440752644406931457', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'COVID-19 vaccine efficacy lower for older people, smokers and drinkers | The Japan Times https://t.co/6cQ1f5epA2', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/6cQ1f5epA2'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'COVID-19 vaccine efficacy lower for older people, smokers and drinkers | The Japan Times '}, {'verified': False, 'country': 'USA', 'id': '1440751816279347209', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Encouraging!\\nPress release\\nClover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest #IDTwitter #medtwitter #TwitteRx https://t.co/DaTSEk7VDE\", 'tweet_lang': 'en', 'hashtags': ['IDTwitter', 'medtwitter', 'TwitteRx'], 'mentions': [], 'tweet_urls': ['https://t.co/DaTSEk7VDE'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Encouraging!\\nPress release\\nClover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest    \"}, {'verified': False, 'country': 'USA', 'id': '1440750248444370946', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Johnson &amp; Johnson said a booster shot of its #COVID19 #vaccine given 2 months after the first dose improved efficacy against symptomatic illness to 94%. https://t.co/9WeopEl6rK #GetVaxxed #MSSNY', 'tweet_lang': 'en', 'hashtags': ['COVID19', 'vaccine', 'GetVaxxed', 'MSSNY'], 'mentions': [], 'tweet_urls': ['https://t.co/9WeopEl6rK'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Johnson &amp; Johnson said a booster shot of its   given 2 months after the first dose improved efficacy against symptomatic illness to 94%.   '}, {'verified': False, 'country': 'USA', 'id': '1440748652939526148', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Having studied Clinical Trials, I knew when the Covid-19 vaccine came out that it's certainly safe for use. Why? Vaccines go through tons of testing before given to the masses. Safety &amp; efficacy being part of those tests.\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Having studied Clinical Trials, I knew when the Covid-19 vaccine came out that it's certainly safe for use. Why? Vaccines go through tons of testing before given to the masses. Safety &amp; efficacy being part of those tests.\"}, {'verified': False, 'country': 'USA', 'id': '1440747763633819653', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The #CDC \"found that the efficacy of the Pfizer-BioNTech #vaccine against hospitalization\\xa0fell from 91 percent to 77 percent\\xa0after a four-month period following the second shot.\"\\n\\nhttps://t.co/a5EJdftRWG', 'tweet_lang': 'en', 'hashtags': ['CDC', 'vaccine'], 'mentions': [], 'tweet_urls': ['https://t.co/a5EJdftRWG'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The  \"found that the efficacy of the Pfizer-BioNTech  against hospitalization\\xa0fell from 91 percent to 77 percent\\xa0after a four-month period following the second shot.\"\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440747483760513027', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance: * COVID-19 Vaccine\u2026 https://t.co/H2xDrtoVR3 #IndiaBehindThreats #PAKvENG #WeDonotTrustTEPS\", 'tweet_lang': 'en', 'hashtags': ['IndiaBehindThreats', 'PAKvENG', 'WeDonotTrustTEPS'], 'mentions': [], 'tweet_urls': ['https://t.co/H2xDrtoVR3'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance: * COVID-19 Vaccine\u2026    \"}, {'verified': False, 'country': 'USA', 'id': '1440747244693569536', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance https://t.co/VT17EHIWNz\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/VT17EHIWNz'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance \"}, {'verified': False, 'country': 'USA', 'id': '1440747239593242632', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance https://t.co/h7q2eFsMoY\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/h7q2eFsMoY'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance \"}, {'verified': False, 'country': 'USA', 'id': '1440746729180073989', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance: * COVID-19 Vaccine\u2026 https://t.co/4nJG1L3RIC #IndiaBehindThreats #PAKvENG #WeDonotTrustTEPS\", 'tweet_lang': 'en', 'hashtags': ['IndiaBehindThreats', 'PAKvENG', 'WeDonotTrustTEPS'], 'mentions': [], 'tweet_urls': ['https://t.co/4nJG1L3RIC'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance: * COVID-19 Vaccine\u2026    \"}, {'verified': False, 'country': 'USA', 'id': '1440746623672279043', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Data Reveal That A Second J and J Vaccine Dose Increases Efficacy https://t.co/tmQcZImc9l', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/tmQcZImc9l'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Data Reveal That A Second J and J Vaccine Dose Increases Efficacy '}, {'verified': False, 'country': 'USA', 'id': '1440745587012341763', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Single dose J&amp;J vaccine efficacy (symptomatic infection) rose to\u2026\\n\\n54% after 6 months \ud83e\udd37\\u200d\u2642\ufe0f \\n\\nI doubt 1 dose J&amp;J vaccine will get full approval with ~50% VE after 6 mo.\\n\\nThe 2 dose (given the preliminary numbers) will eventually get full approval but not for some time, I think. https://t.co/YSNG9i6KCi', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/YSNG9i6KCi'], 'tweet_date': '2021-09-22T19:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Single dose J&amp;J vaccine efficacy (symptomatic infection) rose to\u2026\\n\\n54% after 6 months \ud83e\udd37\\u200d\u2642\ufe0f \\n\\nI doubt 1 dose J&amp;J vaccine will get full approval with ~50% VE after 6 mo.\\n\\nThe 2 dose (given the preliminary numbers) will eventually get full approval but not for some time, I think. '}, {'verified': False, 'country': 'USA', 'id': '1440743019515314176', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'If you\u2019re not vaccinated, you have a significantly higher probability of contracting the virus, potentially being the source of a mutation in the virus\u2019 conserved DNA creating a new strain like delta that decreases the efficacy of everyone\u2019s vaccine* fixed it https://t.co/Akr6Vi8vfS', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Akr6Vi8vfS'], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'If you\u2019re not vaccinated, you have a significantly higher probability of contracting the virus, potentially being the source of a mutation in the virus\u2019 conserved DNA creating a new strain like delta that decreases the efficacy of everyone\u2019s vaccine* fixed it '}, {'verified': False, 'country': 'USA', 'id': '1440742824861831169', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"#ACIP asks whether $PFE vaccine EUA fact sheet will address mixing of different vaccines; @US_FDA's Doran Fink says EUA fact sheet likely would say data not available to inform safety/efficacy of mixing vaccines or  interchangeability of products.\", 'tweet_lang': 'en', 'hashtags': ['ACIP'], 'mentions': ['US_FDA'], 'tweet_urls': [], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \" asks whether $PFE vaccine EUA fact sheet will address mixing of different vaccines; 's Doran Fink says EUA fact sheet likely would say data not available to inform safety/efficacy of mixing vaccines or  interchangeability of products.\"}, {'verified': False, 'country': 'USA', 'id': '1440742605512343552', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Is The Moderna Vaccine More Protective Than Pfizer Over The Long Term? https://t.co/38rcA8GMtW A couple of studies published in the past few weeks show that the disparity between the efficacy of Pfizer and Moderna is small but real', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/38rcA8GMtW'], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Is The Moderna Vaccine More Protective Than Pfizer Over The Long Term?  A couple of studies published in the past few weeks show that the disparity between the efficacy of Pfizer and Moderna is small but real'}, {'verified': False, 'country': 'USA', 'id': '1440741353835544584', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Radio Havana Cuba | Cuban vaccine Abdala has high efficacy rate in serious COVID-19 patients: https://t.co/RgNf1Fx9He', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/RgNf1Fx9He'], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Radio Havana Cuba | Cuban vaccine Abdala has high efficacy rate in serious COVID-19 patients: '}, {'verified': False, 'country': 'USA', 'id': '1440739259984408583', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Great News!!\\n\\n#CLOVER\u2019s COVID19 Protein subunit Vaccine with CpG 1018/Alum, demonstrates 79% efficacy against #Delta in Global Phase 2/3 #SPECTRA Trial!\u2019\\n\\n1st vaccine to demonstrate significant efficacy ag Delta in a double-blind, randomized trial \\n\\nhttps://t.co/OTTjkqfx3g https://t.co/rw7yBSxCGG', 'tweet_lang': 'en', 'hashtags': ['CLOVER', 'Delta', 'SPECTRA'], 'mentions': [], 'tweet_urls': ['https://t.co/OTTjkqfx3g'], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Great News!!\\n\\n\u2019s COVID19 Protein subunit Vaccine with CpG 1018/Alum, demonstrates 79% efficacy against  in Global Phase 2/3  Trial!\u2019\\n\\n1st vaccine to demonstrate significant efficacy ag Delta in a double-blind, randomized trial \\n\\n https://t.co/rw7yBSxCGG'}, {'verified': False, 'country': 'USA', 'id': '1440737563749224451', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'If there was an actual zombie apacalypse, but we had a 100% effective vaccine for zombification with no side effects, would a vaccine mandate be fought? If yes, okay. If no, what makes it different? Is it the severity of the outbreak and the efficacy and effects of the vaccine?', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'If there was an actual zombie apacalypse, but we had a 100% effective vaccine for zombification with no side effects, would a vaccine mandate be fought? If yes, okay. If no, what makes it different? Is it the severity of the outbreak and the efficacy and effects of the vaccine?'}, {'verified': False, 'country': 'USA', 'id': '1440736726612254734', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Are taking care of two people that had Corona virus I had one breakthrough infection very insignificant J&amp;J works make no mistakes about it\\nJ&amp;J Says Second Dose of Vaccine Increases Efficacy to 94% https://t.co/OMe8L3dMiz via @democracynow', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['democracynow'], 'tweet_urls': ['https://t.co/OMe8L3dMiz'], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Are taking care of two people that had Corona virus I had one breakthrough infection very insignificant J&amp;J works make no mistakes about it\\nJ&amp;J Says Second Dose of Vaccine Increases Efficacy to 94%  via '}, {'verified': False, 'country': 'USA', 'id': '1440734729389555721', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Idk if this makes sense but anywho, I like Azelia Bank\u2019s music but I refuse to vibe with her. \ud83e\udd37\ud83c\udffc\\u200d\u2642\ufe0f *she\u2019s literally denied preps efficacy and said it was a death trap. Idk mate. I know she apologized but this is just as stupid as nicki with her cousins nuts comment on the vaccine.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Idk if this makes sense but anywho, I like Azelia Bank\u2019s music but I refuse to vibe with her. \ud83e\udd37\ud83c\udffc\\u200d\u2642\ufe0f *she\u2019s literally denied preps efficacy and said it was a death trap. Idk mate. I know she apologized but this is just as stupid as nicki with her cousins nuts comment on the vaccine.'}, {'verified': False, 'country': 'USA', 'id': '1440734269211496464', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Clover\u2019s COVID-19 Vaccine Candidate\\xa0Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest - Clover Biopharmaceuticals https://t.co/diI2oiBr02', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/diI2oiBr02'], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Clover\u2019s COVID-19 Vaccine Candidate\\xa0Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest - Clover Biopharmaceuticals '}, {'verified': False, 'country': 'USA', 'id': '1440733552165810178', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"This week's Eagle's Eye View:  empagliflozin improves CV outcomes irrespective of blood pressure; efficacy of the COVID-19 vaccine at 6 months post-vaccination; and the protection of the COVID-19 booster dose in Israel. Check it out!\\n https://t.co/vjJaYoYs1O\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/vjJaYoYs1O'], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"This week's Eagle's Eye View:  empagliflozin improves CV outcomes irrespective of blood pressure; efficacy of the COVID-19 vaccine at 6 months post-vaccination; and the protection of the COVID-19 booster dose in Israel. Check it out!\\n \"}, {'verified': False, 'country': 'USA', 'id': '1440732176962572289', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance https://t.co/GrmeGtKlLP via @GoogleNews\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['googlenews'], 'tweet_urls': ['https://t.co/GrmeGtKlLP'], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance  via @GoogleNews\"}, {'verified': False, 'country': 'USA', 'id': '1440731890026041348', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'COVID-19 vaccine efficacy and effectiveness\u2014the elephant (not) in the room - The Lancet Microbe https://t.co/hJ1dyRKADx', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/hJ1dyRKADx'], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'COVID-19 vaccine efficacy and effectiveness\u2014the elephant (not) in the room - The Lancet Microbe '}, {'verified': False, 'country': 'USA', 'id': '1440730967073648640', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"I am pro vaccination. There are too many humans on earth so a few side effects shouldn't be a detriment for greater benefit of curbing spread. However enforcing a mandate will only backfire because we know the vaccine efficacy is doubtful and certainly know that it dimnishes.\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"I am pro vaccination. There are too many humans on earth so a few side effects shouldn't be a detriment for greater benefit of curbing spread. However enforcing a mandate will only backfire because we know the vaccine efficacy is doubtful and certainly know that it dimnishes.\"}, {'verified': False, 'country': 'USA', 'id': '1440730253769379842', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Johnson &amp; Johnson says additional dose boosts Covid vaccine efficacy https://t.co/3Y3kwIp0xC via @statnews', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['statnews'], 'tweet_urls': ['https://t.co/3Y3kwIp0xC'], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Johnson &amp; Johnson says additional dose boosts Covid vaccine efficacy  via '}, {'verified': False, 'country': 'USA', 'id': '1440730215152439301', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Johnson &amp; Johnson says additional dose boosts Covid vaccine efficacy. https://t.co/lQfZCRD3vr', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/lQfZCRD3vr'], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Johnson &amp; Johnson says additional dose boosts Covid vaccine efficacy. '}, {'verified': False, 'country': 'USA', 'id': '1440730206096920576', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '5 things for health marketers to know: 9/22/21\\nhttps://t.co/il5c0oL9bL\\n\\n- 2nd dose of J&amp;J vaccine boosts efficacy to 94%\\n- Aerie Pharmaceuticals fires CEO\\n- #Apple tech aims to diagnose depression\\n- ...\\n\\n@Reuters @endpts @WSJ @CNBC @nytimes \\n#Healthcare #COVID19 #Boosters https://t.co/RUqq9q9HOo', 'tweet_lang': 'en', 'hashtags': ['Apple', 'Healthcare', 'COVID19', 'Boosters'], 'mentions': ['Reuters', 'endpts', 'WSJ', 'CNBC', 'nytimes'], 'tweet_urls': ['https://t.co/il5c0oL9bL'], 'tweet_date': '2021-09-22T18:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '5 things for health marketers to know: 9/22/21\\n\\n\\n- 2nd dose of J&amp;J vaccine boosts efficacy to 94%\\n- Aerie Pharmaceuticals fires CEO\\n-  tech aims to diagnose depression\\n- ...\\n\\n     \\n   https://t.co/RUqq9q9HOo'}, {'verified': False, 'country': 'USA', 'id': '1440729889116540936', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Scientists had hoped the C19-vaccines to have 50-60% efficacy. \u201cWe would have all seen that as great result and been happy with it. ..now, we\u2019re debating whether 96.3% vaccine efficacy for Moderna versus 88.8% for Pfizer is a big deal.\u201d\\u2066@apoorva_nyc\\u2069 https://t.co/AhkyWgh2E5', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['apoorva_nyc'], 'tweet_urls': ['https://t.co/AhkyWgh2E5'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Scientists had hoped the C19-vaccines to have 50-60% efficacy. \u201cWe would have all seen that as great result and been happy with it. ..now, we\u2019re debating whether 96.3% vaccine efficacy for Moderna versus 88.8% for Pfizer is a big deal.\u201d\\u2066\\u2069 '}, {'verified': False, 'country': 'USA', 'id': '1440728146425245698', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The CDC snd NIH assurances to the public about vaccine efficacy and effectiveness of the mask against Covid sars2 is a deception bordering on fraud. This is a violation of Trade practices and consumer protection. @pnjaban @TuckerCarlson', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['pnjaban', 'TuckerCarlson'], 'tweet_urls': [], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The CDC snd NIH assurances to the public about vaccine efficacy and effectiveness of the mask against Covid sars2 is a deception bordering on fraud. This is a violation of Trade practices and consumer protection.  '}, {'verified': False, 'country': 'USA', 'id': '1440728037109092363', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Let\u2019s parlay this into vaccine mandate efficacy. Gain for having: normalcy. Loss for not: sports, movies, bars, restaurants, concerts, gyms, planes. Love, your friendly neighborhood live event creative director. https://t.co/xl6ikm7Evw', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/xl6ikm7Evw'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Let\u2019s parlay this into vaccine mandate efficacy. Gain for having: normalcy. Loss for not: sports, movies, bars, restaurants, concerts, gyms, planes. Love, your friendly neighborhood live event creative director. '}, {'verified': False, 'country': 'USA', 'id': '1440727937100120077', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial https://t.co/r0u6yeCCj0 via @Yahoo\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['Yahoo'], 'tweet_urls': ['https://t.co/r0u6yeCCj0'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial  via \"}, {'verified': False, 'country': 'USA', 'id': '1440727705603899399', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"$DVAX: Dynavax shares +21% after the Co reported that Clover's COVID-19 vaccine candidate demonstrates 79% efficacy... https://t.co/jImOaaRjFu\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/jImOaaRjFu'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"$DVAX: Dynavax shares +21% after the Co reported that Clover's COVID-19 vaccine candidate demonstrates 79% efficacy... \"}, {'verified': False, 'country': 'USA', 'id': '1440727511629922307', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance https://t.co/CTRBZAAjb2\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/CTRBZAAjb2'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance \"}, {'verified': False, 'country': 'USA', 'id': '1440727496517844992', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance: COVID-19 Vaccine Developed\u2026 https://t.co/eBaBm7Ex5I #IndiaBehindThreats #PAKvENG #WeDonotTrustTEPS\", 'tweet_lang': 'en', 'hashtags': ['IndiaBehindThreats', 'PAKvENG', 'WeDonotTrustTEPS'], 'mentions': [], 'tweet_urls': ['https://t.co/eBaBm7Ex5I'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance: COVID-19 Vaccine Developed\u2026    \"}, {'verified': False, 'country': 'USA', 'id': '1440727496341614593', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"I wasn't going to get the deadly blood clot vaxx but after watching this hilarious Family Guy skit I've been convinced of vaccine efficacy and safety! Big thanks to Seth MacFarlane and his team of J**s who make this wonderful show \u263a\ufe0f https://t.co/Ywy63XhdI4\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/Ywy63XhdI4'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"I wasn't going to get the deadly blood clot vaxx but after watching this hilarious Family Guy skit I've been convinced of vaccine efficacy and safety! Big thanks to Seth MacFarlane and his team of J**s who make this wonderful show \u263a\ufe0f \"}, {'verified': False, 'country': 'USA', 'id': '1440727478960459787', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance https://t.co/9wxuui2umN\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/9wxuui2umN'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance \"}, {'verified': False, 'country': 'USA', 'id': '1440727478708756494', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance https://t.co/skCdKsKDUM #news #topstories #berkleybearnews\", 'tweet_lang': 'en', 'hashtags': ['news', 'topstories', 'berkleybearnews'], 'mentions': [], 'tweet_urls': ['https://t.co/skCdKsKDUM'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial - Yahoo Finance    \"}, {'verified': False, 'country': 'USA', 'id': '1440727353634668552', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Opinion: There is no choice between vaccinating Americans and vaccinating the world. We must do both. https://t.co/U9rJoobL27 Question: Should we not focus on individuals at risk around the world given the fact that natural immunity protects and vaccine efficacy wanes? https://t.co/kNdtaT6rT8', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/U9rJoobL27'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Opinion: There is no choice between vaccinating Americans and vaccinating the world. We must do both.  Question: Should we not focus on individuals at risk around the world given the fact that natural immunity protects and vaccine efficacy wanes? https://t.co/kNdtaT6rT8'}, {'verified': True, 'country': 'USA', 'id': '1440725345133465604', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'J&amp;J Says Second Dose of Vaccine Increases Efficacy to 94% https://t.co/lQUflgZbFY', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/lQUflgZbFY'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'J&amp;J Says Second Dose of Vaccine Increases Efficacy to 94% '}, {'verified': False, 'country': 'USA', 'id': '1440722831818432524', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '#Measles cases are rising. Despite its 93% efficacy rate, declining #MMR vaccinations rates have left more people vulnerable to the vaccine preventable disease: https://t.co/dQk8wZRTFg https://t.co/BD4r7GRFpO', 'tweet_lang': 'en', 'hashtags': ['Measles', 'MMR'], 'mentions': [], 'tweet_urls': ['https://t.co/dQk8wZRTFg'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ' cases are rising. Despite its 93% efficacy rate, declining  vaccinations rates have left more people vulnerable to the vaccine preventable disease:  https://t.co/BD4r7GRFpO'}, {'verified': False, 'country': 'USA', 'id': '1440722419728072709', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Puerto Rico has published one of the most comprehensive studies in the globe about COVID-19 vaccine efficacy through time by demography and type of vaccine. See the thread below. \ud83d\udc47\ud83c\udffd https://t.co/01uZfIaq6t', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/01uZfIaq6t'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Puerto Rico has published one of the most comprehensive studies in the globe about COVID-19 vaccine efficacy through time by demography and type of vaccine. See the thread below. \ud83d\udc47\ud83c\udffd '}, {'verified': False, 'country': 'USA', 'id': '1440719872753737737', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Interesting original claim that phiffer and Moderna had approximately 95% efficacy when no one could come up with a flu vaccine any better then a little over 50%. So was the 95% just a motivational ploy to get it. Explanations welcome', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Interesting original claim that phiffer and Moderna had approximately 95% efficacy when no one could come up with a flu vaccine any better then a little over 50%. So was the 95% just a motivational ploy to get it. Explanations welcome'}, {'verified': False, 'country': 'USA', 'id': '1440719280824152069', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'I bet the vaccine has 90% efficacy against the next variant.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'I bet the vaccine has 90% efficacy against the next variant.'}, {'verified': False, 'country': 'USA', 'id': '1440718742632079366', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'So important. Chasing vaccine efficacy against infection sets an impossible goal. Need to focus on preventing serious illness. https://t.co/ts3KTa5g0f', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/ts3KTa5g0f'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'So important. Chasing vaccine efficacy against infection sets an impossible goal. Need to focus on preventing serious illness. '}, {'verified': False, 'country': 'USA', 'id': '1440717534756360201', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'https://t.co/lbfL7C0EQk', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/lbfL7C0EQk'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ''}, {'verified': False, 'country': 'USA', 'id': '1440716949726453773', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'GREAT!!!\\n\\nthe efficacy of the Pfizer-BioNTech vaccine against hospitalization fell from 91 percent to 77 percent after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period.\\n\\nModerna vs. Pfizer: https://t.co/FEkoAXJXNG', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/FEkoAXJXNG'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'GREAT!!!\\n\\nthe efficacy of the Pfizer-BioNTech vaccine against hospitalization fell from 91 percent to 77 percent after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period.\\n\\nModerna vs. Pfizer: '}, {'verified': False, 'country': 'USA', 'id': '1440716525476855810', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'And let\u2019s not even get into efficacy. How is it that some data showed that Pfizer\u2019s vaccine producing only half the amount of antibodies as moderna? And they want to be fast tracked to booster shot approval? https://t.co/JjDTPOWTXe', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/JjDTPOWTXe'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'And let\u2019s not even get into efficacy. How is it that some data showed that Pfizer\u2019s vaccine producing only half the amount of antibodies as moderna? And they want to be fast tracked to booster shot approval? '}, {'verified': False, 'country': 'USA', 'id': '1440715371552526340', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$DVAX- Dynavax with a short interest of 20% and their partner Clover\u2019s COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest \u2013 chatter @\\xa0#wallstreetbets https://t.co/mjYxf6y4sj', 'tweet_lang': 'en', 'hashtags': ['wallstreetbets'], 'mentions': [], 'tweet_urls': ['https://t.co/mjYxf6y4sj'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$DVAX- Dynavax with a short interest of 20% and their partner Clover\u2019s COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest \u2013 chatter @\\xa0 '}, {'verified': False, 'country': 'USA', 'id': '1440715257836544011', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Research published on Friday by the Centers for Disease Control and Prevention found that the efficacy of the Pfizer-BioNTech vaccine against hospitalization fell from 91 percent to 77 percent after a four-month period following the second shot. https://t.co/eXsUpPxAF0', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/eXsUpPxAF0'], 'tweet_date': '2021-09-22T17:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Research published on Friday by the Centers for Disease Control and Prevention found that the efficacy of the Pfizer-BioNTech vaccine against hospitalization fell from 91 percent to 77 percent after a four-month period following the second shot. '}, {'verified': False, 'country': 'USA', 'id': '1440714032978087939', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Instead of calling us names, how about you get us the efficacy data for the vaccine vs covid ( and its many variants) you know something useful, till then, call me whatever you like &amp; I'll do the same statist. https://t.co/oD2zF2NNgW\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/oD2zF2NNgW'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Instead of calling us names, how about you get us the efficacy data for the vaccine vs covid ( and its many variants) you know something useful, till then, call me whatever you like &amp; I'll do the same statist. \"}, {'verified': False, 'country': 'USA', 'id': '1440713778136379401', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The efficacy of the #Pfizer -BioNTech vaccine against hospitalization fell from 91 percent to 77 percent after a four-month period following the second shot. The #Moderna vaccine showed no decline over the same period. #rokoteteho #koronafi \\n\\nvia @NYTimes https://t.co/v38grdlOYn', 'tweet_lang': 'en', 'hashtags': ['Pfizer', 'Moderna', 'rokoteteho', 'koronafi'], 'mentions': ['nytimes'], 'tweet_urls': ['https://t.co/v38grdlOYn'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The efficacy of the  -BioNTech vaccine against hospitalization fell from 91 percent to 77 percent after a four-month period following the second shot. The  vaccine showed no decline over the same period.   \\n\\nvia @NYTimes '}, {'verified': False, 'country': 'USA', 'id': '1440711553066549258', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '.@CloverBiopharma &amp; @CEPIvaccines report 100% efficacy for SCB-2019 #vaccine vs severe #COVID19 &amp; #hospitalization\\n\\nPh2/3 #ClinicalTrials showed 84% efficacy vs mod-to-severe COVID19 &amp; 79% efficacy against #SARSCoV2 #Delta #variant\\n\\nhttps://t.co/3vFSzNNVGM\\n@DynavaxCorp https://t.co/RNt7xygGXl', 'tweet_lang': 'en', 'hashtags': ['vaccine', 'COVID19', 'hospitalization', 'ClinicalTrials', 'SARSCoV2', 'Delta', 'variant'], 'mentions': ['CloverBiopharma', 'CEPIvaccines', 'DynavaxCorp'], 'tweet_urls': ['https://t.co/3vFSzNNVGM'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '. &amp;  report 100% efficacy for SCB-2019  vs severe  &amp; \\n\\nPh2/3  showed 84% efficacy vs mod-to-severe COVID19 &amp; 79% efficacy against   \\n\\n\\n https://t.co/RNt7xygGXl'}, {'verified': False, 'country': 'USA', 'id': '1440711486813478913', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T2a. In summary, there is still much to be learned on how to best assess COVID-19 vaccine efficacy in patients with CKD. mABs are a useful tool to fight against SARS-COV2 though a lot of barriers to adoption and distribution remain. #nephjc https://t.co/BDSedeWwzt', 'tweet_lang': 'en', 'hashtags': ['nephjc'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T2a. In summary, there is still much to be learned on how to best assess COVID-19 vaccine efficacy in patients with CKD. mABs are a useful tool to fight against SARS-COV2 though a lot of barriers to adoption and distribution remain.  https://t.co/BDSedeWwzt'}, {'verified': False, 'country': 'USA', 'id': '1440711422510469125', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Exactly .. they need YEARS to test the Safety &amp; Efficacy of a new vaccine \ud83d\udc89\ud83e\udd37\ud83c\udffc\\u200d\u2640\ufe0f \u2026common sense, logic, actual SCIENCE! https://t.co/TPxsLUD4Pt', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/TPxsLUD4Pt'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Exactly .. they need YEARS to test the Safety &amp; Efficacy of a new vaccine \ud83d\udc89\ud83e\udd37\ud83c\udffc\\u200d\u2640\ufe0f \u2026common sense, logic, actual SCIENCE! '}, {'verified': False, 'country': 'USA', 'id': '1440710252853297159', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Waning Pfizer vaccine efficacy for hospitalizations seen in one US real world setting. p&lt;.05 for &gt;65yr olds. Trend for 50-64 year olds. ACIP meeting slide https://t.co/0bdHk27gq3 https://t.co/D9uvYRV0aa', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/0bdHk27gq3'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Waning Pfizer vaccine efficacy for hospitalizations seen in one US real world setting. p&lt;.05 for &gt;65yr olds. Trend for 50-64 year olds. ACIP meeting slide  https://t.co/D9uvYRV0aa'}, {'verified': False, 'country': 'USA', 'id': '1440709975295152131', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Efficacy of 2 dose Pfizer vaccine through 6 months shows no apparent drop in protection against severe disease. \\n\\nSee the graph where blue is placebo and red is vaccine group, dots being severe cases. \\n\\nThe insert graph represents the first 3 weeks. \\n\\nhttps://t.co/omtedt3aJT https://t.co/XvYAVnDd73', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/omtedt3aJT'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Efficacy of 2 dose Pfizer vaccine through 6 months shows no apparent drop in protection against severe disease. \\n\\nSee the graph where blue is placebo and red is vaccine group, dots being severe cases. \\n\\nThe insert graph represents the first 3 weeks. \\n\\n https://t.co/XvYAVnDd73'}, {'verified': False, 'country': 'USA', 'id': '1440709140368617484', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The vaccine efficacy was 84.4%.', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The vaccine efficacy was 84.4%.'}, {'verified': False, 'country': 'USA', 'id': '1440707779304452107', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Since I sent facts about the vaccine &amp; the division of the country that got 12k IMP, I\\'ve not gotten more than 200 since. Tweeting this Pfizer statement may explain it. They make no claim of vaccine efficacy on kids, only it\\'s safety. Yet all you hear is \"Safe AND effective. https://t.co/tkZ7rBqTAg', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Since I sent facts about the vaccine &amp; the division of the country that got 12k IMP, I\\'ve not gotten more than 200 since. Tweeting this Pfizer statement may explain it. They make no claim of vaccine efficacy on kids, only it\\'s safety. Yet all you hear is \"Safe AND effective. https://t.co/tkZ7rBqTAg'}, {'verified': False, 'country': 'USA', 'id': '1440707019191635985', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"2021-SEP-22 11:55am\\n$DVAX #DynavaxCorp Dynavax up 25.67% = $441 million gain.\\n\\n(Sep 22) Dynavax partner Clover's COVID-19 vaccine shows 79% efficacy against Delta variant - Seeking https://t.co/nCpmRrBLGd\", 'tweet_lang': 'en', 'hashtags': ['DynavaxCorp'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"2021-SEP-22 11:55am\\n$DVAX  Dynavax up 25.67% = $441 million gain.\\n\\n(Sep 22) Dynavax partner Clover's COVID-19 vaccine shows 79% efficacy against Delta variant - Seeking https://t.co/nCpmRrBLGd\"}, {'verified': False, 'country': 'USA', 'id': '1440706999805612034', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'The difference in efficacy between Pfizer and Moderna vaccines over time | via @NYTimes #COVID #vax #vaccine  https://t.co/aUPJQPRRoY', 'tweet_lang': 'en', 'hashtags': ['COVID', 'vax', 'vaccine'], 'mentions': ['nytimes'], 'tweet_urls': ['https://t.co/aUPJQPRRoY'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'The difference in efficacy between Pfizer and Moderna vaccines over time | via @NYTimes     '}, {'verified': False, 'country': 'USA', 'id': '1440706476452941826', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '.@MayorGinther this is what @ColumbusGov needs to be focusing efforts towards; community education and promotion of vaccine efficacy and safety. moving backwards by an attempt to mandate masking is only hurting your platform and showcasing your ineffectual ability to govern. https://t.co/kBAa5Cvha7', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['MayorGinther', 'ColumbusGov'], 'tweet_urls': ['https://t.co/kBAa5Cvha7'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '. this is what  needs to be focusing efforts towards; community education and promotion of vaccine efficacy and safety. moving backwards by an attempt to mandate masking is only hurting your platform and showcasing your ineffectual ability to govern. '}, {'verified': False, 'country': 'USA', 'id': '1440706463765196800', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'M\u2019y concern is vaccine efficacy after the 120 mark', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'M\u2019y concern is vaccine efficacy after the 120 mark'}, {'verified': False, 'country': 'USA', 'id': '1440706314456363023', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Breaking: To date, none of these studies has provided credible evidence of substantially declining protection against severe disease, even when there appear to be declines over time in vaccine efficacy against symptomatic disease.\\xa0\u2026https://t.co/jjQwZ5F6tF https://t.co/umJYVkfgHV', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/jjQwZ5F6tF', 'https://t.co/umJYVkfgHV'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Breaking: To date, none of these studies has provided credible evidence of substantially declining protection against severe disease, even when there appear to be declines over time in vaccine efficacy against symptomatic disease.\\xa0\u2026 '}, {'verified': False, 'country': 'USA', 'id': '1440705389939474436', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'COVID-19 vaccine efficacy and effectiveness\u2014the elephant (not) in the room - The Lancet Microbe \\u2066@thejournal_ie\\u2069 Can you please fact check the Lancet? I want to be sure that their deep dive is accurate.  https://t.co/qinek3jwXB', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['thejournal_ie'], 'tweet_urls': ['https://t.co/qinek3jwXB'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'COVID-19 vaccine efficacy and effectiveness\u2014the elephant (not) in the room - The Lancet Microbe \\u2066\\u2069 Can you please fact check the Lancet? I want to be sure that their deep dive is accurate.  '}, {'verified': False, 'country': 'USA', 'id': '1440704261302587395', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'https://t.co/28DGYiGTx0', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/28DGYiGTx0'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': ''}, {'verified': False, 'country': 'USA', 'id': '1440704174048505868', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Vaccine efficacy matters most in immunocompromised and high risk patients like dialysis and transplant patients, especially in terms of survival. #NephJC https://t.co/ZGDXF4Vl9f', 'tweet_lang': 'en', 'hashtags': ['NephJC'], 'mentions': [], 'tweet_urls': ['https://t.co/ZGDXF4Vl9f'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Vaccine efficacy matters most in immunocompromised and high risk patients like dialysis and transplant patients, especially in terms of survival.  '}, {'verified': False, 'country': 'USA', 'id': '1440703937204482059', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T0g: Here is a table summarizing COVID-19 vaccine efficacy in transplant patients. There is poor effect in terms of antibodies and cellular response. Immunosuppressive agents might interfere with the antigen presentation with the mRNA vaccines \u2192 Leading to booster dose! #nephjc https://t.co/N6Q3H3Hejl', 'tweet_lang': 'en', 'hashtags': ['nephjc'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T0g: Here is a table summarizing COVID-19 vaccine efficacy in transplant patients. There is poor effect in terms of antibodies and cellular response. Immunosuppressive agents might interfere with the antigen presentation with the mRNA vaccines \u2192 Leading to booster dose!  https://t.co/N6Q3H3Hejl'}, {'verified': False, 'country': 'USA', 'id': '1440703431350513664', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'https://t.co/BH0X0g7ojN\\n\\nAnother banger by @EduEngineer', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['EduEngineer'], 'tweet_urls': ['https://t.co/BH0X0g7ojN'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '\\n\\nAnother banger by '}, {'verified': False, 'country': 'USA', 'id': '1440702678871404554', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T0f: Here is a summary of COVID-19 vaccine efficacy in dialysis patients. antibody response after 1 dose is suboptimal and increases after 2 doses\\n #NephJC https://t.co/00Gba1NcBF', 'tweet_lang': 'en', 'hashtags': ['NephJC'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T0f: Here is a summary of COVID-19 vaccine efficacy in dialysis patients. antibody response after 1 dose is suboptimal and increases after 2 doses\\n  https://t.co/00Gba1NcBF'}, {'verified': False, 'country': 'USA', 'id': '1440702427410354176', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T0e: Assessing vaccine efficacy has been also addressed by @EdjCarr. Check out https://t.co/TORLhhAwH4 and https://t.co/TuNVTWKvtq\\nWhat are your thoughts? #NephJC', 'tweet_lang': 'en', 'hashtags': ['NephJC'], 'mentions': ['EdjCarr'], 'tweet_urls': ['https://t.co/TORLhhAwH4', 'https://t.co/TuNVTWKvtq'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T0e: Assessing vaccine efficacy has been also addressed by . Check out  and \\nWhat are your thoughts? '}, {'verified': False, 'country': 'USA', 'id': '1440701923804409857', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T0c: How should we assess vaccine efficacy among CKD patients? #NephJC\\n        1- Antibody titer\\n        2- Antibody threshold\\n        3- Cellular Response\\n        4- All \\n        5-Infections/Hospitalization/Deaths https://t.co/B2ci4jlPTg', 'tweet_lang': 'en', 'hashtags': ['NephJC'], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T0c: How should we assess vaccine efficacy among CKD patients? \\n        1- Antibody titer\\n        2- Antibody threshold\\n        3- Cellular Response\\n        4- All \\n        5-Infections/Hospitalization/Deaths https://t.co/B2ci4jlPTg'}, {'verified': False, 'country': 'USA', 'id': '1440701723236913158', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'As an Indian living outside India, amid the Covishield controversy, I am more interested in India\u2019s indigenously developed vaccine Covaxin. We are told studies in India have proven its efficacy. Then why is USA and Europe not recognizing Covaxin. Why is Indian government not\u2026', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': [], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'As an Indian living outside India, amid the Covishield controversy, I am more interested in India\u2019s indigenously developed vaccine Covaxin. We are told studies in India have proven its efficacy. Then why is USA and Europe not recognizing Covaxin. Why is Indian government not\u2026'}, {'verified': False, 'country': 'USA', 'id': '1440701564264411153', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '100% commie BULLSHIT. These \ud83d\udca9 heads should be recalled. They are now going to decide what constitutes \"misinformation\". Guess what the first thing deemed so, was? Anything questioning vaccine safety or efficacy. Clark Cty residents can no longer...\\n\\nhttps://t.co/1LR94C8qMd', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/1LR94C8qMd'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '100% commie BULLSHIT. These \ud83d\udca9 heads should be recalled. They are now going to decide what constitutes \"misinformation\". Guess what the first thing deemed so, was? Anything questioning vaccine safety or efficacy. Clark Cty residents can no longer...\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440701421049966598', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'T0a: I honestly am still waiting for the pandemic to pass, but since we are still dealing with COVID-19 let\u2019s delve into vaccine efficacy in kidney patients. Here is an excellent resource that we will be using  https://t.co/9JoPoAdh3J  #NephJC https://t.co/c73wJZX8eA', 'tweet_lang': 'en', 'hashtags': ['NephJC'], 'mentions': [], 'tweet_urls': ['https://t.co/9JoPoAdh3J'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'T0a: I honestly am still waiting for the pandemic to pass, but since we are still dealing with COVID-19 let\u2019s delve into vaccine efficacy in kidney patients. Here is an excellent resource that we will be using     https://t.co/c73wJZX8eA'}, {'verified': False, 'country': 'USA', 'id': '1440701277403418625', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '$INO INOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico PR Newswire https://t.co/mT4ZcXkbVM #smallcapsdaily #smallcaps #microcap #stocks #trading #profits', 'tweet_lang': 'en', 'hashtags': ['smallcapsdaily', 'smallcaps', 'microcap', 'stocks', 'trading', 'profits'], 'mentions': [], 'tweet_urls': ['https://t.co/mT4ZcXkbVM'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '$INO INOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800, in Mexico PR Newswire       '}, {'verified': False, 'country': 'USA', 'id': '1440701061975535622', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'As discussions on putting the pandemic behind us take center stage at #UNGA, we share the recently published blog by Infectious Diseases expert Anton Luchytsky, which thoroughly unpacks the safety and efficacy of the #COVID19 vaccine. Read more&gt;&gt; https://t.co/iPq6Uvv7lr #UNGA76', 'tweet_lang': 'en', 'hashtags': ['UNGA', 'COVID19', 'UNGA76'], 'mentions': [], 'tweet_urls': ['https://t.co/iPq6Uvv7lr'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'As discussions on putting the pandemic behind us take center stage at , we share the recently published blog by Infectious Diseases expert Anton Luchytsky, which thoroughly unpacks the safety and efficacy of the  vaccine. Read more&gt;&gt;  76'}, {'verified': False, 'country': 'USA', 'id': '1440699981795495949', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'the efficacy of the Pfizer-BioNTech vaccine against hospitalization\\xa0fell from 91 percent to 77 percent\\xa0after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period.\\nhttps://t.co/866ZN9BZCc', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/866ZN9BZCc'], 'tweet_date': '2021-09-22T16:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'the efficacy of the Pfizer-BioNTech vaccine against hospitalization\\xa0fell from 91 percent to 77 percent\\xa0after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period.\\n'}, {'verified': False, 'country': 'USA', 'id': '1440699835699515401', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Clover's #COVID19 vaccine candidate met the primary and secondary efficacy endpoints in SPECTRA, our global Phase 2/3 clinical trial and demonstrated 79% efficacy against COVID-19 of any severity caused by the globally dominant #Delta strain. Learn more: https://t.co/nfh3w43R0Q https://t.co/Iu9CGnkLZp\", 'tweet_lang': 'en', 'hashtags': ['COVID19', 'Delta'], 'mentions': [], 'tweet_urls': ['https://t.co/nfh3w43R0Q'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Clover's  vaccine candidate met the primary and secondary efficacy endpoints in SPECTRA, our global Phase 2/3 clinical trial and demonstrated 79% efficacy against COVID-19 of any severity caused by the globally dominant  strain. Learn more:  https://t.co/Iu9CGnkLZp\"}, {'verified': False, 'country': 'USA', 'id': '1440699567737950208', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Abdala, one of the three vaccines endorsed by Cuban regulators for emergency use, is a three-shot formula that authorities say showed an efficacy of 92.28% in last-stage clinical trials.\\nhttps://t.co/wL2RyrLJgz', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/wL2RyrLJgz'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Abdala, one of the three vaccines endorsed by Cuban regulators for emergency use, is a three-shot formula that authorities say showed an efficacy of 92.28% in last-stage clinical trials.\\n'}, {'verified': False, 'country': 'USA', 'id': '1440698481916534810', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Vaccine efficacy values from the trials have always been suspicious https://t.co/d4n373abg2 https://t.co/Ii7JWy6yLR', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/d4n373abg2', 'https://t.co/Ii7JWy6yLR'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Vaccine efficacy values from the trials have always been suspicious  '}, {'verified': False, 'country': 'USA', 'id': '1440697475686301705', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"$DVAX COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial PR Newswire +20.36% https://t.co/ws8LbFaArc #smallcapsdaily #smallcaps #microcap #stocks #trading #profits\", 'tweet_lang': 'en', 'hashtags': ['smallcapsdaily', 'smallcaps', 'microcap', 'stocks', 'trading', 'profits'], 'mentions': [], 'tweet_urls': ['https://t.co/ws8LbFaArc'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"$DVAX COVID-19 Vaccine Developed by Clover Biopharmaceuticals Using Dynavax's CpG 1018 Adjuvant Meets Primary and Secondary Efficacy Endpoints in Global Phase 2/3 Trial PR Newswire +20.36%       \"}, {'verified': True, 'country': 'USA', 'id': '1440696226987450384', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Moderna\u2019s vaccine appeared to be more protective over the long term than the Pfizer vaccine. Efficacy of the Pfizer vaccine against hospitalization fell from 91% to 77% after a four-month period following the 2nd shot. Moderna vaccine showed no decline \ud83d\udc89  https://t.co/po0TRTrQs1', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/po0TRTrQs1'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Moderna\u2019s vaccine appeared to be more protective over the long term than the Pfizer vaccine. Efficacy of the Pfizer vaccine against hospitalization fell from 91% to 77% after a four-month period following the 2nd shot. Moderna vaccine showed no decline \ud83d\udc89  '}, {'verified': False, 'country': 'USA', 'id': '1440694762898526224', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Research published by @CDCgov found the efficacy of Pfizer-BioNTech vaccine against hospitalization fell from 91 percent to 77 percent after a 4-month period following the second shot. The #Moderna vaccine showed no decline over the same period. @nytimes', 'tweet_lang': 'en', 'hashtags': ['Moderna'], 'mentions': ['CDCgov', 'nytimes'], 'tweet_urls': [], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Research published by  found the efficacy of Pfizer-BioNTech vaccine against hospitalization fell from 91 percent to 77 percent after a 4-month period following the second shot. The  vaccine showed no decline over the same period. '}, {'verified': False, 'country': 'USA', 'id': '1440694085447143424', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Initial hopes \"that the vaccines would have an efficacy of 50 or 60%. \u201cWe would have all seen that as great result and been happy with it\u201d...\u201cFast forward to now, and we\u2019re debating whether 96.3 percent vaccine efficacy for Moderna versus 88.8 percent for Pfizer is a big deal.\u201d https://t.co/BWGqNnf8Uo', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/BWGqNnf8Uo'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Initial hopes \"that the vaccines would have an efficacy of 50 or 60%. \u201cWe would have all seen that as great result and been happy with it\u201d...\u201cFast forward to now, and we\u2019re debating whether 96.3 percent vaccine efficacy for Moderna versus 88.8 percent for Pfizer is a big deal.\u201d '}, {'verified': False, 'country': 'USA', 'id': '1440693990269931537', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'J&amp;J Says Second Dose of Vaccine Increases Efficacy to 94% https://t.co/nFaXGgIANG via @democracynow', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['democracynow'], 'tweet_urls': ['https://t.co/nFaXGgIANG'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'J&amp;J Says Second Dose of Vaccine Increases Efficacy to 94%  via '}, {'verified': False, 'country': 'USA', 'id': '1440693967754985482', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Study shows Johnson &amp; Johnson\u2019s COVID-19 vaccine is more effective when given as a two-dose regimen, company says https://t.co/c7BUCs6aCw', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/c7BUCs6aCw'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Study shows Johnson &amp; Johnson\u2019s COVID-19 vaccine is more effective when given as a two-dose regimen, company says '}, {'verified': False, 'country': 'USA', 'id': '1440693619665608704', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Studies continue to show promising results in the efficacy of the COVID-19 vaccine in pregnant women. Methodist Physicians Clinic OB/GYN Dr. Tifany Somer-Shely weighs in on the science regarding Mom and Baby. Thanks to @KETV for sharing this information: https://t.co/q1uwCEmemd', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['KETV'], 'tweet_urls': ['https://t.co/q1uwCEmemd'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Studies continue to show promising results in the efficacy of the COVID-19 vaccine in pregnant women. Methodist Physicians Clinic OB/GYN Dr. Tifany Somer-Shely weighs in on the science regarding Mom and Baby. Thanks to  for sharing this information: '}, {'verified': False, 'country': 'USA', 'id': '1440692941635260424', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Where is the efficacy data for the COVID vaccine vs ALL Variants of COVID?  Anyone? @CDCgov @US_FDA  @POTUS  @SenateGOP @TheDemocrats  Why are you wanting to mandate the vaccine but not the reporting of the efficacy data? https://t.co/K844OJAqIN', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['CDCgov', 'US_FDA', 'POTUS', 'SenateGOP', 'TheDemocrats'], 'tweet_urls': [], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Where is the efficacy data for the COVID vaccine vs ALL Variants of COVID?  Anyone?         Why are you wanting to mandate the vaccine but not the reporting of the efficacy data? https://t.co/K844OJAqIN'}, {'verified': False, 'country': 'USA', 'id': '1440692178649444362', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'This paper looked at vaccine efficacy across 3 different vaccines at different locales in the USA pre- and post-Delta.  They claim vaccine efficacy remained relatively stable, despite the dramatic concurrent rise of Delta variant prevalence\\nhttps://t.co/jIBv8kWPqj', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/jIBv8kWPqj'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'This paper looked at vaccine efficacy across 3 different vaccines at different locales in the USA pre- and post-Delta.  They claim vaccine efficacy remained relatively stable, despite the dramatic concurrent rise of Delta variant prevalence\\n'}, {'verified': False, 'country': 'USA', 'id': '1440691593934110737', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': \"Like I said, the anti-vaxxers are just frantically working their way through the medicine cabinet, trying out anything that isn't a vaccine -- lack of efficacy and safety testing be damned! https://t.co/qciN23pMPK\", 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/qciN23pMPK'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': \"Like I said, the anti-vaxxers are just frantically working their way through the medicine cabinet, trying out anything that isn't a vaccine -- lack of efficacy and safety testing be damned! \"}, {'verified': True, 'country': 'USA', 'id': '1440689771936829451', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Our partner @CloverBiopharma has today announced positive efficacy #COVID19 vaccine data from their Phase 2/3 trial testing against multiple variants \u2013 including the predominant Delta variant \ud83d\udc89\ud83d\udc49https://t.co/SnKiYqmeNA https://t.co/GO3mqDqNlo', 'tweet_lang': 'en', 'hashtags': ['COVID19'], 'mentions': ['CloverBiopharma'], 'tweet_urls': ['https://t.co/SnKiYqmeNA'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Our partner  has today announced positive efficacy  vaccine data from their Phase 2/3 trial testing against multiple variants \u2013 including the predominant Delta variant \ud83d\udc89\ud83d\udc49 https://t.co/GO3mqDqNlo'}, {'verified': True, 'country': 'USA', 'id': '1440688607077933065', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'According to @JNJNews, its #COVID19 vaccine works better as a 2-dose regimen than the original single dose, and the shot\u2019s efficacy did not wane over time. \\n\\nhttps://t.co/VneecXRBMz', 'tweet_lang': 'en', 'hashtags': ['COVID19'], 'mentions': ['JNJNews'], 'tweet_urls': ['https://t.co/VneecXRBMz'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'According to , its  vaccine works better as a 2-dose regimen than the original single dose, and the shot\u2019s efficacy did not wane over time. \\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440688297588654088', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'A major problem with this is J&amp;J\\'s one selling point for their shot was \"one and done\". If they require boosters too, then they are no better. J&amp;J says booster shot greatly improves its COVID-19 vaccine\u2019s efficacy as experts await FDA decision https://t.co/LQn43t128c', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/LQn43t128c'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'A major problem with this is J&amp;J\\'s one selling point for their shot was \"one and done\". If they require boosters too, then they are no better. J&amp;J says booster shot greatly improves its COVID-19 vaccine\u2019s efficacy as experts await FDA decision '}, {'verified': False, 'country': 'USA', 'id': '1440687858159734797', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'You lost the plot right where you represented American Liberals and American Conservatives as on opposite sides. This renders your analysis more or less moot.\\n\\nPretty spot on to this point, though. \\n\\nAs vaccine efficacy continues to drop to zero with no changes in strategy\u2026 https://t.co/brJFKhQrZo', 'tweet_lang': 'en', 'hashtags': [], 'mentions': [], 'tweet_urls': ['https://t.co/brJFKhQrZo'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'You lost the plot right where you represented American Liberals and American Conservatives as on opposite sides. This renders your analysis more or less moot.\\n\\nPretty spot on to this point, though. \\n\\nAs vaccine efficacy continues to drop to zero with no changes in strategy\u2026 '}, {'verified': False, 'country': 'USA', 'id': '1440686340056571920', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': 'Clover Biopharmaceuticals announced Wednesday that its #Covid19 vaccine candidate showed 79% efficacy against the Delta variant in a Phase II/III trial, and 67% efficacy against Covid-19 overall.\\n\\nhttps://t.co/zugAVykrbB', 'tweet_lang': 'en', 'hashtags': ['Covid19'], 'mentions': [], 'tweet_urls': ['https://t.co/zugAVykrbB'], 'tweet_date': '2021-09-22T15:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': 'Clover Biopharmaceuticals announced Wednesday that its  vaccine candidate showed 79% efficacy against the Delta variant in a Phase II/III trial, and 67% efficacy against Covid-19 overall.\\n\\n'}, {'verified': False, 'country': 'USA', 'id': '1440683560994689028', 'replied_to_tweet_id': None, 'replied_to_user_id': None, 'tweet_text': '[Press release \u2013 not published yet] J&amp;J says booster shot at two months provided 75% protection against moderate to severe COVID-19 globally and 94% of such cases in the U.S. \u2013 via @JNJNews\\n\\nPress release: https://t.co/717ICtytDA\\n\\nCommentary: https://t.co/a7ybyEvUCN', 'tweet_lang': 'en', 'hashtags': [], 'mentions': ['JNJNews'], 'tweet_urls': ['https://t.co/717ICtytDA', 'https://t.co/a7ybyEvUCN'], 'tweet_date': '2021-09-22T14:00:00Z', 'geolocation': None, 'tweet_emoticons': [], 'reply_text': None, 'text_en': '[Press release \u2013 not published yet] J&amp;J says booster shot at two months provided 75% protection against moderate to severe COVID-19 globally and 94% of such cases in the U.S. \u2013 via \\n\\nPress release: \\n\\nCommentary: '}]"